Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3023465	s-gamma	g/l (g/l)	11994	26619	0.00%
3023465	s-gamma	— (—)	2093	2774	100.00%	Distribution not available
3023465	gamma-glob	g/l (g/l)	725	2834	0.00%
3023465	s-gamma	g/l_______ (g/l)	619	1918	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Erysipelas, including avohilmo

2621

8637

2.32

312.92

2.2

2.1

10.42

10.08

g/l

3.16

2364

7590

General symptoms and signs

3346

7034

2.45

307.65

2.4

2.1

10.12

10.21

g/l

0.43

3034

6264

Influenza and pneumonia

3528

9900

2.26

307.65

3.1

2.0

10.03

10.16

g/l

0.76

3203

8808

ILD medications: immunosuppressive drugs

2982

7486

3.82

307.65

4.6

1.7

10.08

10.27

g/l

1.11

2778

6612

Acute renal failure

1361

3606

4.17

307.65

2.8

2.2

9.90

10.22

g/l

1.42

1248

3111

Polyneuropathies and other disorders of the peripheral nervous system

1604

3693

4.96

307.65

2.5

2.3

9.80

10.20

g/l

3.03

1444

3251

Unspecified kidney failure

754

1572

5.49

307.65

2.7

2.2

10.04

10.32

g/l

0.71

697

1353

Other bacterial diseases

3860

9649

2.76

307.65

2.9

2.0

10.35

10.08

g/l

2.43

3514

8520

Multiple myeloma

486

412

20.03

307.65

21.2

1.5

11.08

10.55

g/l

0.51

461

351

Oral corticosteroids

3956

9464

2.54

307.65

2.2

2.4

9.94

10.26

g/l

3.68

3598

8351

Pain in limb

2975

7910

2.47

307.65

2.2

2.3

9.70

10.41

g/l

14.46

2695

7021

Multiple myeloma, including Hilmo

684

666

15.80

307.65

18.5

1.4

11.01

10.40

g/l

0.85

650

574

Other and unspecified anaemias

2985

6959

4.47

307.65

2.6

2.3

10.40

10.17

g/l

1.40

2688

6024

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

5229

8892

4.23

307.65

2.5

2.1

10.24

10.08

g/l

1.25

4756

7830

Implicit Sepsis

3210

9061

2.73

307.65

2.5

2.2

10.06

10.13

g/l

0.38

2843

8047

Malaise and fatigue

2259

5817

3.21

307.65

2.2

2.1

10.25

10.24

g/l

0.04

1994

5131

Tramadol

2882

6692

2.68

307.65

2.4

1.9

9.91

10.37

g/l

5.57

2592

5940

Chronic kidney disease

2491

5265

5.18

307.65

2.3

2.2

10.05

10.31

g/l

1.84

2301

4511

All pneumoniae

3475

10133

2.30

307.65

3.1

2.0

10.02

10.16

g/l

0.93

3155

9010

Glomerular diseases

1069

2735

4.34

307.65

2.8

2.3

9.67

10.30

g/l

3.66

998

2445

All kidney diseases

4207

9188

3.21

307.65

2.4

2.2

10.00

10.19

g/l

1.76

3832

8129

ILD medications

4238

8321

2.85

307.65

3.0

1.7

10.01

10.34

g/l

3.83

3854

7317

Liquid cancers

2107

4696

4.77

307.65

7.7

1.4

10.52

10.13

g/l

1.66

1964

4094

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3419

10245

2.29

307.65

3.1

2.0

10.07

10.15

g/l

0.45

3092

9113

Fever of other and unknown origin

2328

6398

3.30

307.65

3.8

2.1

10.30

10.24

g/l

0.19

2131

5669

Implicit Sepsis, including avohilmo

3314

9243

2.67

307.65

2.5

2.2

10.06

10.12

g/l

0.29

2937

8240

All chronic kidney diseases

3428

6635

4.49

307.65

2.4

2.3

10.02

10.22

g/l

1.43

3163

5793

Bacterial infection, other or unspecified, including avohilmo

2967

7903

3.27

307.65

3.2

2.1

10.21

10.13

g/l

0.33

2695

6901

Renal failure

3384

7087

4.53

307.65

2.5

2.2

10.07

10.27

g/l

1.43

3108

6111

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

486

412

20.03

307.65

21.2

1.5

11.08

10.55

g/l

0.51

461

351

L04AX Other immunosuppressants

2351

8566

2.88

307.65

5.4

1.7

10.18

10.10

g/l

0.29

2174

7633

Infections, IBD-co-morbidities

599

620

7.19

307.65

4.2

2.2

10.07

10.41

g/l

0.58

545

559

Gout

1442

4018

3.30

307.65

3.2

2.4

9.86

10.39

g/l

3.89

1320

3523

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3085

7959

2.34

307.65

3.0

1.9

10.03

10.19

g/l

1.04

2805

7063

Autoimmune diseases excluding thyroid diseases

3563

8705

2.28

307.65

2.0

2.5

10.42

10.07

g/l

3.95

3258

7701

First line medication for Crohn's disease

3861

8216

2.61

307.65

3.1

1.6

9.96

10.39

g/l

5.69

3526

7226

Second line medication for Crohn's disease

2383

8753

2.85

307.65

5.3

1.7

10.19

10.08

g/l

0.43

2204

7800

Renal tubulo-interstitial diseases

4097

9437

3.36

307.65

2.4

2.3

10.05

10.19

g/l

1.08

3713

8339

Other soft tissue disorders, not elsewhere classified

3174

7989

2.33

307.65

2.3

9.71

10.42

g/l

15.02

2882

7089

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3228

8963

2.51

307.65

2.4

2.2

10.06

10.12

g/l

0.30

2882

8016

Other bacterial diseases, including avohilmo

3866

9273

2.70

307.65

2.8

2.0

10.29

10.07

g/l

1.74

3528

8185

Bacterial infection, other or unspecified

2783

7598

3.30

307.65

3.3

2.1

10.20

10.11

g/l

0.38

2522

6624

Other systemic involvement of connective tissue

1386

4392

3.40

307.65

1.8

2.4

10.57

10.12

g/l

2.65

1243

3843

Condition for Implicit Sepsis (Organ dysfunction codes)

3231

9207

2.52

307.65

2.5

2.2

10.05

10.12

g/l

0.32

2877

8212

Bacterial Sepsis

2365

6859

3.03

307.65

3.0

2.2

10.18

10.15

g/l

0.09

2101

6033

Heart failure, not strict

3241

7931

2.89

307.65

2.6

2.3

9.96

10.25

g/l

2.83

2923

7007

Other and unspecified polyneuropathies, also in other diseases

1482

3256

5.27

307.65

2.1

2.3

9.82

10.17

g/l

2.45

1330

2861

Anaemias

970

549

12.09

307.65

2.4

1.2

10.44

10.29

g/l

0.34

914

501

Other anaemias

2999

7005

4.44

307.65

2.5

2.3

10.40

10.17

g/l

1.49

2701

6068

Multiple myeloma and malignant plasma cell neoplasms

686

768

13.43

307.65

18.4

1.6

10.96

10.43

g/l

0.68

652

672

Pneumonias (Asthma/COPD co-morbidities)

3466

10122

2.30

307.65

3.1

2.0

10.02

10.16

g/l

0.95

3144

8999

Heart failure,strict

2249

6295

2.62

307.65

2.3

2.4

10.21

10.30

g/l

0.36

2024

5502

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

921

705

23.75

307.65

7.7

1.3

11.84

10.29

g/l

8.39

838

611

Inflammatory bowel disease treatment related agents

4049

9521

2.43

307.65

2.1

2.4

10.10

10.25

g/l

1.11

3678

8404

Osteopathies and chondropathies

2305

8728

2.52

307.65

3.0

2.2

9.74

10.22

g/l

5.41

1990

7746

3085

7959

2.34

307.65

3.0

1.9

10.03

10.19

g/l

1.04

2805

7063

Autoimmune diseases excluding thyroid diseases, strict definition

3436

8417

2.28

307.65

2.0

2.5

10.44

10.08

g/l

4.03

3143

7437

Aplastic and other anaemias

3131

7311

4.33

307.65

2.5

2.3

10.38

10.17

g/l

1.28

2819

6343

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

636

1227

6.15

307.65

3.3

2.3

12.06

10.19

g/l

10.69

572

1069

Polyarthropathies

2816

6132

3.09

307.65

2.5

2.4

10.22

10.28

g/l

0.24

2587

5462

ILD medications: prednisolone, methylprednisolone, prednisone

4069

8298

2.83

307.65

2.2

1.7

9.99

10.34

g/l

4.34

3687

7294

Examination and observation for other reasons

2203

4255

3.04

307.65

2.4

2.2

10.10

10.38

g/l

1.83

2013

3850

Liquid cancers, including Hilmo

2241

5324

4.08

307.65

7.3

1.4

10.51

10.10

g/l

1.97

2083

4649

Implicit bacterial Sepsis, including avohilmo

2293

6767

2.99

307.65

2.8

2.2

10.07

10.15

g/l

0.31

2032

5947

Dialysis, with operation codes

844

1649

5.86

307.65

3.9

2.2

9.66

10.26

g/l

2.63

796

1464

Systemic connective tissue disorders

1835

5680

3.48

307.65

1.9

2.4

10.39

10.10

g/l

1.72

1651

4963

Pneumonia, organism unspecified

3231

9698

2.36

307.65

3.0

2.0

10.06

10.14

g/l

0.43

2907

8615

Other systemic involvement of connective tissue (FG)

1361

3429

4.22

307.65

1.8

2.6

10.55

10.15

g/l

2.07

1219

2981

Metabolic disorders

3275

8441

2.40

307.65

2.4

2.2

9.90

10.36

g/l

6.68

2961

7479

Implicit bacterial Sepsis

2108

6406

3.00

307.65

2.9

2.1

10.07

10.17

g/l

0.37

1870

5612

Primary_lymphoid and hematopoietic malignant neoplasms

1767

4006

5.03

307.65

8.8

1.4

10.42

10.21

g/l

0.55

1663

3486

Finngen Rheumatological endpoints

2875

7404

2.26

304.05

2.1

2.4

10.27

10.20

g/l

0.29

2612

6610

Persons encountering health services for specific procedures and health care

3365

9663

2.11

302.53

2.6

2.1

9.93

10.24

g/l

3.24

3075

8559

Abnormal findings on examination of blood, without diagnosis

2034

7623

2.54

301.42

2.7

2.4

10.69

10.17

g/l

4.79

1854

6762

Nephropathy related operations

759

1794

4.78

300.06

4.0

2.3

9.57

10.23

g/l

3.00

720

1606

Heart failure and antihypertensive medication

1019

1743

4.03

297.01

2.3

2.6

10.23

10.37

g/l

0.32

935

1538

Glomerular disorders in diseases classified elsewhere

735

1714

4.84

295.56

2.8

2.3

9.96

10.32

g/l

0.96

685

1535

Disorders of lipoprotein metabolism and other lipidaemias

2849

8013

2.23

294.71

2.3

2.2

9.82

10.36

g/l

8.31

2567

7078

Nutritional anaemias

2091

8542

2.44

289.42

2.1

2.3

10.34

10.19

g/l

0.75

1834

7500

Explicit Sepsis, including avohilmo

1852

6808

2.58

286.08

3.1

2.1

10.68

10.15

g/l

3.17

1653

6000

Oedema, not elsewhere classified

1336

4531

3.03

284.50

2.3

2.2

10.13

10.19

g/l

0.19

1181

3977

Care involving dialysis

559

1084

5.97

281.62

2.6

2.1

9.33

10.37

g/l

6.45

526

974

Asthma, unspecified (mode), excluding more controls

1676

4516

2.74

281.39

2.2

1.9

9.84

10.22

g/l

2.56

1517

4008

Gout, FINNGEN

1442

5288

2.89

278.03

3.2

2.3

9.86

10.32

g/l

3.45

1320

4613

Septicaemia

1771

6509

2.60

277.76

3.1

2.1

10.68

10.14

g/l

3.18

1580

5661

Explicit Sepsis

1812

6731

2.56

276.83

3.1

2.1

10.69

10.17

g/l

3.05

1617

5929

Other and unspecified iron deficiency

1531

5819

2.77

276.21

2.0

2.3

10.25

10.16

g/l

0.34

1342

5089

Pure hypercholesterolaemia

2647

7788

2.23

276.15

2.3

9.80

10.36

g/l

8.58

2388

6864

Iron deficiency anaemia

1826

7406

2.54

275.62

2.0

2.3

10.26

10.19

g/l

0.28

1597

6506

Heart failure, strict

2460

7872

2.27

269.47

2.2

2.4

10.21

10.18

g/l

0.13

2207

6863

Codeine

2724

6835

2.21

268.93

2.1

1.9

9.92

10.38

g/l

5.98

2455

6076

Other heart diseases

1242

2589

3.21

267.98

2.4

2.1

10.07

10.25

g/l

0.61

1152

2339

Provisional assignment of new diseases of uncertain etiology

1992

8648

2.37

263.22

2.9

2.1

10.02

10.21

g/l

0.96

1794

7650

Codes for special purposes

1994

8662

2.37

263.04

2.9

2.1

10.02

10.21

g/l

1.00

1795

7663

Implicit viral Sepsis, including avohilmo

1347

4945

2.87

259.93

2.8

2.1

9.83

10.12

g/l

1.39

1201

4332

Autoimmune diseases related-to ILD

2799

11592

2.07

259.13

2.1

2.3

10.50

10.07

g/l

4.99

2545

10269

Hypertensive diseases (excluding secondary)

1337

2624

3.05

256.04

2.2

2.1

9.99

10.24

g/l

1.07

1244

2365

All-cause Heart Failure

2400

7778

2.24

255.36

2.3

2.4

10.22

10.18

g/l

0.14

2153

6773

Hypertension, essential

2199

5425

2.35

254.37

2.2

2.3

10.00

10.28

g/l

1.98

2019

4797

Diseases of arteries, arterioles and capillaries (FINNGEN)

890

1690

3.82

248.75

2.4

2.2

9.91

10.24

g/l

1.20

820

1501

Diverticular disease of intestine

2593

7766

2.15

245.41

2.5

2.3

10.06

10.23

g/l

1.09

2325

6882

Reimbursement for rheumatic diseases

2045

9280

2.27

244.36

1.7

2.4

10.69

10.00

g/l

8.81

1882

8169

Asthma, unspecified (mode)

1742

5182

2.50

244.31

2.1

1.9

9.85

10.21

g/l

2.60

1572

4587

Dental caries

1069

3362

3.17

243.28

3.9

2.1

9.99

10.13

g/l

0.36

973

3022

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3490

9876

1.92

237.53

2.1

2.4

10.17

10.19

g/l

0.06

3202

8685

Opioids

2732

6864

2.10

236.56

2.4

1.9

10.07

10.38

g/l

2.67

2476

6103

Other arthritis (FG)

1153

4128

2.92

233.16

2.3

2.5

10.21

10.16

g/l

0.13

1052

3660

Acute tubulo-interstitial nephritis

2077

8093

2.23

232.98

2.3

2.2

10.30

10.19

g/l

0.47

1831

7075

Certain infectious and parasitic diseases

2747

6733

2.09

232.43

2.5

1.9

10.14

10.17

g/l

0.14

2496

5925

Osteoporosis

1286

4475

2.82

232.07

2.2

9.77

10.20

g/l

2.69

1060

3875

Diseases of oesophagus, stomach and duodenum

3290

10326

1.92

231.10

2.1

2.3

10.00

10.21

g/l

1.77

2916

9234

Other septicaemia, including avohilmo

1569

6153

2.50

229.23

2.8

2.1

10.65

10.14

g/l

2.73

1398

5337

Pain in joint

1851

4880

2.40

227.93

2.1

2.3

9.97

10.46

g/l

4.37

1646

4327

Hypertensive diseases

2139

5473

2.26

226.07

2.1

2.3

10.03

10.28

g/l

1.60

1964

4840

Other septicaemia

1537

6049

2.51

225.33

2.8

2.0

10.66

10.14

g/l

2.78

1367

5237

Pain, not elsewhere classified

1009

3419

3.08

225.09

2.7

2.1

9.67

10.18

g/l

2.93

918

3027

Dyspnoea

2971

11295

1.95

225.02

2.4

2.3

9.88

10.24

g/l

4.41

2649

10046

Erysipelas

2009

8027

2.23

224.88

2.2

2.1

10.42

10.12

g/l

2.03

1810

7038

Medical observation and evaluation for suspected diseases and conditions

1951

4302

2.38

224.72

2.2

10.05

10.39

g/l

2.20

1717

3886

Hypertension

2134

5473

2.25

224.20

2.1

2.3

10.03

10.28

g/l

1.65

1959

4840

Caries of dentine

954

3031

3.21

222.85

3.7

2.1

9.92

10.16

g/l

0.68

865

2733

Codeine or tramadol medication

3417

10076

1.88

220.48

2.2

2.3

9.93

10.28

g/l

4.44

3070

8947

Covid-19 confirmed case

1539

6527

2.47

220.11

3.0

2.2

10.02

10.25

g/l

1.06

1370

5746

Transplanted organ and tissue status

542

1253

4.81

219.34

5.3

2.2

9.34

10.12

g/l

3.18

520

1129

Other diseases of blood and blood-forming organs, wide

1003

3480

3.08

217.47

3.4

2.3

10.38

10.18

g/l

0.55

930

3085

Asthma, excluding more controls

2023

4634

2.29

216.04

2.1

1.9

9.88

10.21

g/l

2.43

1846

4121

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

425

498

6.38

211.41

2.4

10.55

10.50

g/l

0.06

400

441

Polymyalgia rheumatica

779

2389

3.60

211.16

1.8

2.4

9.44

10.21

g/l

5.61

684

2056

Abnormalities of breathing

2531

7237

2.04

209.84

2.3

2.2

9.90

10.28

g/l

3.99

2274

6464

Autoimmune diseases

3200

8740

1.90

208.12

2.1

2.5

10.42

10.07

g/l

3.64

2903

7732

Other specific joint derangements/joint disorders

2095

6174

2.16

205.49

2.1

2.4

9.90

10.25

g/l

3.03

1872

5532

Other heart diseases, wide

2503

7679

2.01

202.48

2.3

2.2

10.04

10.15

g/l

0.52

2292

6868

L04AD Calcineurin inhibitors

525

1260

4.56

201.57

2.5

9.62

10.32

g/l

2.57

510

1151

Any gastric operation

1993

4559

2.24

200.44

2.3

1.9

10.15

10.20

g/l

0.17

1789

4100

GASTRO-related operations

1993

4559

2.24

200.44

2.3

1.9

10.15

10.20

g/l

0.17

1789

4100

Other specified/unspecified arthritis

1025

3743

2.87

199.97

2.2

2.4

10.22

g/l

0.02

932

3327

Hypertensive heart and/or renal disease

1098

2927

2.89

199.49

2.1

2.5

10.10

10.43

g/l

1.48

999

2495

Exposure to unspecified factor

3121

11754

1.84

199.25

2.3

10.07

10.18

g/l

0.73

2758

10497

Low back pain

2357

8035

2.03

198.27

2.6

2.1

9.80

10.36

g/l

7.97

2117

7138

Cerebrovascular diseases (FINNGEN)

911

2079

3.18

197.31

2.1

2.2

10.19

10.20

g/l

0.02

821

1854

Used for control exclusion in common control thyroid runs

2963

7998

1.90

195.38

2.2

2.5

10.32

10.10

g/l

1.57

2683

7081

Gout, idiopatic and unspecified

1193

4788

2.66

195.34

2.1

2.4

9.94

10.31

g/l

2.35

1087

4217

Ulcer of lower limb, not elsewhere classified

793

2572

3.36

195.21

2.4

2.3

10.24

10.15

g/l

0.20

723

2237

L04AA Selective immunosuppressants

889

3057

3.08

194.90

1.8

2.3

10.13

10.08

g/l

0.11

848

2749

Other diseases of intestines

2932

8803

1.89

194.24

2.3

2.2

10.06

10.25

g/l

1.38

2628

7868

Cardiovascular diseases (excluding rheumatic etc)

1318

2938

2.62

192.86

2.2

2.0

10.28

10.24

g/l

0.09

1236

2664

Asthma (only as main-diagnosis), excluding more controls

1842

4634

2.25

192.05

2.1

1.9

9.78

10.21

g/l

3.48

1677

4121

Complications of surgical and medical care, not elsewhere classified

3099

11567

1.83

190.77

2.3

10.17

10.16

g/l

0.03

2777

10272

Diseases of arteries, arterioles and capillaries

2441

9375

1.97

190.38

2.2

2.4

10.08

10.22

g/l

0.84

2192

8221

Pain in throat and chest

2390

7200

2.01

190.33

2.3

2.2

9.93

10.28

g/l

3.40

2170

6427

Viral Sepsis

923

3286

2.98

190.19

3.2

2.1

9.65

10.06

g/l

1.65

826

2876

Implicit viral Sepsis

920

3282

2.97

188.85

3.2

2.1

9.65

10.06

g/l

1.62

823

2872

Asthma (mode)

2115

5355

2.12

188.82

2.1

1.9

9.89

10.19

g/l

2.21

1935

4749

Asthma

2133

5310

2.12

188.74

2.1

1.9

9.83

10.20

g/l

3.25

1948

4708

Disorders resulting from impaired renal tubular function

297

465

7.80

188.68

2.4

2.6

10.08

10.77

g/l

1.50

287

421

Oxycodone

1459

5465

2.37

187.33

4.7

2.0

9.69

10.38

g/l

5.09

1273

4802

Type 2 diabetes, wide definition

2598

8695

1.93

187.30

2.0

2.5

10.01

10.19

g/l

1.14

2341

7698

Persons encountering health services in other circumstances, wide

3397

9923

1.79

186.52

2.1

2.4

10.21

10.19

g/l

0.06

3096

8720

Preparatory care for dialysis

336

613

6.60

182.83

2.3

2.8

9.59

10.51

g/l

2.95

318

559

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2350

10832

1.94

182.52

2.5

2.3

10.33

10.14

g/l

1.04

2106

9558

Symptoms and signs involving the skin and subcutaneous tissue

2330

11661

1.94

182.40

2.4

2.3

9.87

10.19

g/l

2.92

2088

10363

Diabetic nephropathy, excluding more controls

732

1865

3.47

181.11

1.9

2.2

9.91

10.14

g/l

0.75

680

1635

Headache

1755

6415

2.16

180.52

2.1

9.63

10.17

g/l

6.66

1582

5719

Other disorders of fluid, electrolyte and acid-base balance

1242

4919

2.49

179.31

2.5

2.3

10.21

10.41

g/l

0.62

1090

4271

Symptoms and signs involving cognition, perception, emotional state and behaviour

2925

10978

1.82

177.64

2.1

2.3

9.97

10.21

g/l

1.98

2597

9830

Other disorders of skin and subcutaneous tissue

2448

11165

1.90

177.36

2.3

10.19

10.16

g/l

0.14

2196

9865

Syncope and collapse

1459

5442

2.31

176.96

2.3

2.2

9.91

10.27

g/l

2.31

1252

4790

Coagulation defects, purpura and other haemorrhagic conditions

829

2900

3.04

176.61

2.4

2.3

10.50

10.19

g/l

1.04

767

2573

Heart failure and bmi 25plus

1317

3715

2.48

173.81

2.2

2.6

10.46

10.14

g/l

1.45

1174

3181

Gout, unspecified

986

3827

2.76

173.33

2.2

2.3

9.97

10.33

g/l

1.79

905

3362

Non-Hodgkin lymphoma, all, including Hilmo

656

2051

3.47

171.28

3.0

1.4

9.75

10.17

g/l

1.13

616

1787

Disturbances of skin sensation

947

3597

2.75

170.86

1.9

2.3

9.76

10.19

g/l

2.64

860

3239

Enlarged lymph nodes

614

1833

3.54

170.31

2.1

2.3

10.55

10.20

g/l

0.88

576

1627

Disorders of calcium metabolism

390

856

5.13

169.16

4.0

2.4

9.41

10.50

g/l

3.89

342

763

Asthma (only as main-diagnosis)

1940

5310

2.09

169.15

2.1

1.9

9.82

10.20

g/l

2.89

1761

4708

Glomerulonephritis

503

1341

4.12

167.89

2.9

2.5

9.27

10.32

g/l

5.29

477

1207

Disorders of mineral metabolism

452

1121

4.43

166.63

3.6

2.3

9.67

10.39

g/l

2.25

397

997

Gout, strict definition

903

3430

2.83

166.19

2.2

2.5

9.91

10.31

g/l

2.11

825

3020

Spondylopathies

2432

7733

1.90

165.61

2.6

2.2

9.85

10.37

g/l

6.78

2196

6842

Rheumatoid arthritis

1134

4179

2.50

164.73

1.9

2.5

10.40

10.26

g/l

0.46

1041

3674

Small fibre neuropathy

260

411

7.87

164.41

2.6

2.4

9.31

10.66

g/l

4.54

233

367

Cardiovascular diseases

1130

2330

2.62

162.28

2.1

1.8

10.48

10.28

g/l

0.62

1055

2119

Disorders of thyroid, IBD co-morbidities

429

638

4.75

159.92

2.2

2.3

9.72

10.41

g/l

1.96

393

573

Speech therapy

1043

4324

2.54

158.18

2.2

2.3

9.92

10.19

g/l

1.16

988

3792

Fall on same level

3127

9728

1.74

157.87

2.3

10.11

10.23

g/l

0.73

2713

8871

Dorsalgia

2720

8117

1.81

154.92

2.4

2.1

9.90

10.37

g/l

6.41

2432

7210

Certain infectious and parasitic diseases, including avohilmo

1895

4717

2.05

154.15

2.4

1.9

10.16

10.17

g/l

0.01

1734

4133

Lower back pain or/and sciatica

3142

11640

1.71

152.49

2.5

2.2

9.80

10.26

g/l

7.38

2812

10352

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

129

24.72

151.80

11.7

1.2

15.91

10.40

g/l

6.07

121

Atrial fibrillation and flutter

852

1978

2.87

151.62

2.6

2.2

10.14

10.21

g/l

0.16

783

1760

Follow-up examination after treatment for conditions other than malignant neoplasms

1267

3708

2.34

151.21

2.3

2.1

9.96

10.28

g/l

1.69

1142

3351

Care involving use of rehabilitation procedures

1909

9079

1.94

149.01

2.4

2.2

9.86

10.22

g/l

3.22

1797

8015

Extracorporeal dialysis

364

845

4.89

147.90

2.5

2.4

9.19

10.46

g/l

6.04

342

769

Symptoms and signs concerning food and fluid intake

469

1294

3.87

147.00

2.0

2.3

10.00

10.23

g/l

0.55

420

1134

Other necrotizing vasculopathies (FG)

338

740

5.12

146.94

1.5

2.9

9.59

10.32

g/l

1.84

302

646

Other CVD (FINNGEN)

479

971

4.01

146.48

2.9

2.2

9.98

10.39

g/l

0.94

412

840

Bleeding

2619

10618

1.77

146.17

2.3

2.4

10.33

10.10

g/l

1.67

2324

9409

Non-ischemic cardiomyopathy

1264

4581

2.29

145.92

2.4

10.34

10.22

g/l

0.36

1126

3947

Complications of medical and surgical care

2306

11735

1.81

144.63

2.5

2.3

10.12

10.16

g/l

0.12

2066

10400

Benign neoplasm of colon, rectum, anus and anal canal

2217

10521

1.83

142.76

2.4

10.17

10.18

g/l

0.04

1933

9304

Abnormalities of gait and mobility

618

2087

3.22

142.05

1.9

2.3

9.87

10.30

g/l

1.86

567

1847

Diseases of the skin and subcutaneous tissue

2654

7626

1.78

141.00

2.3

2.2

10.32

10.13

g/l

1.20

2386

6769

Other pulmonary diagnosis

2032

5358

1.94

140.81

2.6

1.9

10.16

10.20

g/l

0.14

1853

4751

Secondary hypertension

324

688

4.98

140.80

2.1

2.2

9.46

10.38

g/l

3.02

307

604

Cardiac arrhythmias

1426

4323

2.16

140.71

2.4

2.3

10.09

10.25

g/l

0.66

1309

3903

Endocrine, nutritional and metabolic diseases

1802

4590

2.01

140.52

2.2

2.3

10.00

10.46

g/l

3.80

1647

4120

Excluding asthma or asthma-COPD overlap

2029

5358

1.93

140.00

2.6

1.9

10.18

10.20

g/l

0.06

1851

4751

Symptoms and signs involving the urinary system

2411

10446

1.78

139.66

2.1

2.4

10.10

10.18

g/l

0.40

2103

9281

Hyperlipidaemia, other/unspecified

1377

6003

2.14

139.00

2.2

2.3

9.81

10.37

g/l

5.29

1215

5242

Symptoms and signs involving the nervous and musculoskeletal systems

1881

10205

1.89

138.71

2.2

2.3

9.61

10.21

g/l

9.12

1703

9018

Nephrotic syndrome

218

339

7.61

138.53

2.7

2.5

8.60

10.55

g/l

5.79

210

310

Bacterial pneumonia, not elsewhere classified

1349

5703

2.15

137.92

3.7

2.0

10.02

10.20

g/l

0.68

1270

5000

Asthma (diagnoses ohter than nonallergic)

2549

12090

1.74

137.58

2.1

2.3

9.80

10.24

g/l

5.68

2300

10729

Bacterial pneumoniae

1396

6000

2.11

136.40

3.7

2.0

10.05

10.21

g/l

0.55

1307

5263

Neurological diseases, wide definition

535

717

3.82

136.38

2.2

10.14

10.45

g/l

0.63

497

649

COPD/asthma related infections

2726

7959

1.74

136.30

2.9

1.9

10.06

10.19

g/l

0.71

2455

7063

COPD/asthma/ILD related infections

2726

7959

1.74

136.30

2.9

1.9

10.06

10.19

g/l

0.71

2455

7063

Asthma-related infections

1823

9586

1.90

135.93

2.3

9.84

10.21

g/l

2.75

1648

8455

Asthma, hospital admission 2, infections

1823

9586

1.90

135.93

2.3

9.84

10.21

g/l

2.75

1648

8455

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2716

10153

1.72

135.87

2.7

2.2

9.90

10.24

g/l

3.35

2437

9117

Continuous positive airway pressure

645

1839

3.05

135.71

2.3

2.4

10.45

10.29

g/l

0.34

564

1651

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

974

2497

2.51

135.06

2.4

2.1

10.53

10.24

g/l

0.96

898

2249

Valvular heart disease excluding rheumatic fever

1516

5402

2.06

134.72

2.5

2.4

10.22

10.18

g/l

0.10

1355

4741

Purpura and other haemorrhagic conditions

590

1995

3.16

134.20

2.4

10.62

10.20

g/l

1.15

545

1766

COPD differential diagnosis

2004

5356

1.91

133.49

2.6

1.9

10.18

10.19

g/l

0.03

1831

4750

ILD differential diagnosis

2002

5355

1.91

133.00

2.6

1.9

10.17

10.19

g/l

0.06

1829

4749

Non-rheumatic valve diseases

1509

5391

2.06

132.87

2.5

2.4

10.22

10.19

g/l

0.09

1348

4731

Kidney transplant status

276

560

5.52

131.24

1.7

2.5

9.28

10.26

g/l

3.27

270

515

Adjustment and management of implanted device

808

3261

2.63

130.52

2.6

2.1

10.31

10.30

g/l

0.01

739

2810

Other dorsopathies, not elsewhere classified

2660

8123

1.73

130.06

2.3

2.1

9.95

10.37

g/l

5.29

2386

7216

Constipation

2683

10905

1.70

129.80

2.7

2.2

9.85

10.24

g/l

4.33

2345

9750

Pain (limb, back, neck, head abdominally)

1911

5085

1.92

129.06

2.3

10.13

10.50

g/l

2.68

1725

4488

Osteoporosis with pathological fracture (FG)

382

1012

4.16

128.93

2.0

2.6

9.71

10.19

g/l

1.00

306

848

Malignant immunoproliferative diseases

143

154

14.53

128.82

10.5

2.2

15.08

10.63

g/l

4.91

133

138

Diabetic nephropathy

739

2851

2.75

128.49

1.9

2.0

9.90

10.16

g/l

0.98

686

2526

Other necrotizing vasculopathies

391

1059

4.10

128.37

1.7

2.7

9.61

10.38

g/l

2.35

352

937

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

732

1266

2.95

128.13

2.2

1.9

10.25

10.16

g/l

0.18

674

1137

Intestinal infectious diseases

2685

12071

1.68

127.85

2.9

2.2

9.91

10.21

g/l

2.82

2416

10720

Intestinal infectious diseases, including avohilmo, including avohilmo

3249

11312

1.63

127.84

2.8

2.2

9.96

10.22

g/l

2.48

2921

10039

Hypertensive Heart Disease

895

2818

2.51

126.90

2.1

2.5

10.08

10.44

g/l

1.55

802

2401

Dermatitis and eczema

3145

11643

1.62

125.32

2.1

2.3

10.20

10.15

g/l

0.22

2836

10334

Heart failure and coronary heart disease

1639

6062

1.96

124.60

2.0

2.5

10.19

10.27

g/l

0.28

1482

5238

Chronic gastritis

1044

4795

2.27

124.50

2.2

2.4

10.15

10.24

g/l

0.28

921

4209

Symptoms and signs involving the circulatory and respiratory systems

2483

7243

1.74

124.50

2.2

10.11

10.28

g/l

1.03

2256

6470

Atrial fibrillation and flutter with reimbursement

732

1704

2.80

123.71

2.7

2.2

10.45

10.23

g/l

0.57

671

1506

Haemorrhage from respiratory passages

1199

5097

2.15

123.61

2.2

2.3

10.79

10.26

g/l

3.17

1075

4461

Complications of procedures, not elsewhere classified

2375

11359

1.72

123.31

2.2

2.3

10.23

10.16

g/l

0.33

2131

10081

Seropositive rheumatoid arthritis

824

3419

2.49

122.21

1.9

2.6

10.56

10.11

g/l

2.03

755

2977

Other and unspecified dermatitis

1628

8785

1.90

122.12

2.2

2.3

10.16

10.10

g/l

0.20

1463

7784

Dizziness and giddiness

2241

10210

1.74

121.59

2.1

2.4

9.90

10.21

g/l

2.68

1981

9107

Malignant neoplasm, including Hilmo

2299

7774

1.75

121.06

3.5

1.4

10.01

10.12

g/l

0.50

2104

6926

Hypothyroidism (congenital or acquired)

409

566

4.12

120.20

2.5

1.2

9.56

10.31

g/l

3.08

384

517

Dermatitis

1889

10462

1.81

120.19

2.2

2.4

10.15

10.12

g/l

0.13

1696

9278

Any reimbursement code in KELA

1118

2487

2.29

119.65

2.5

1.5

10.18

10.34

g/l

0.48

1045

2192

Hypothyroidism, levothyroxine purchases

407

564

4.12

119.62

2.4

1.2

9.62

10.31

g/l

2.61

382

515

Hypothyroidism and >3 levothyroxin purchases

407

564

4.12

119.62

2.4

1.2

9.62

10.31

g/l

2.61

382

515

Cardiomyopathy

673

2588

2.74

119.35

2.5

2.3

10.07

10.21

g/l

0.34

624

2261

Soft tissue disorders

2614

8024

1.69

118.70

2.3

10.04

10.42

g/l

3.96

2364

7120

Spinal stenosis

1702

6838

1.89

117.53

2.3

2.2

9.65

10.38

g/l

10.62

1502

6003

Malignant neoplasm, wide definition

2295

7818

1.74

117.50

3.5

1.4

10.01

10.13

g/l

0.55

2104

6963

Diarrhoea and gastroenteritis of presumed infectious origin

1996

10282

1.77

116.82

2.8

2.1

9.84

10.21

g/l

3.11

1792

9133

STROKE

1582

5648

1.93

116.06

2.4

2.5

10.01

10.27

g/l

1.45

1404

4997

Diabetes, varying definitions

2688

9552

1.66

115.50

2.0

2.4

9.92

10.22

g/l

2.70

2412

8487

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

29.80

115.25

13.4

1.2

16.69

10.27

g/l

4.87

Diabetes mellitus

2696

9553

1.66

115.24

2.0

2.4

9.92

10.22

g/l

2.79

2419

8489

Malignant neoplasm

2257

7755

1.74

114.77

3.8

1.4

10.00

10.12

g/l

0.58

2067

6903

Malignant neoplasm

2257

7766

1.73

114.22

3.8

1.4

10.00

10.12

g/l

0.54

2069

6912

Other disorders of urethra and urinary system

2030

8153

1.77

113.58

2.2

2.3

9.93

10.23

g/l

2.27

1807

7248

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1906

8558

1.80

113.53

2.1

2.5

10.08

10.23

g/l

0.72

1695

7507

Depression medications

436

576

3.87

113.38

1.8

1.2

10.19

10.29

g/l

0.18

418

527

Parasetamol

1672

4483

1.91

113.31

2.4

2.0

10.11

10.52

g/l

2.71

1509

4072

Chronic lymphocytic leukaemia

224

440

6.05

112.44

2.5

1.4

8.37

10.37

g/l

7.57

208

379

Chronic lymphocytic leukaemia, helper endpoint

224

440

6.05

112.44

2.5

1.4

8.37

10.37

g/l

7.57

208

379

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

224

440

6.05

112.44

2.5

1.4

8.37

10.37

g/l

7.57

208

379

Disorders of parathyroid gland

828

3577

2.40

111.44

2.3

2.2

9.50

10.19

g/l

5.53

726

3105

Type 2 diabetes

2644

9435

1.65

111.17

2.0

2.5

9.93

10.21

g/l

2.46

2370

8375

Disorders of other endocrine glands

1319

6741

1.98

111.06

2.4

2.2

9.63

10.20

g/l

5.46

1174

5962

Spondylosis

1688

7321

1.85

110.91

2.2

9.71

10.34

g/l

8.45

1503

6477

Diaphragmatic hernia

1280

6616

2.00

110.69

2.3

10.16

10.20

g/l

0.12

1125

5806

Myalgia

737

3055

2.50

110.68

2.0

2.2

9.67

10.33

g/l

4.31

656

2713

Certain disorders involving the immune mechanism

685

2763

2.60

110.23

2.8

2.2

9.73

10.16

g/l

1.58

635

2479

Amyloidosis

186

314

7.20

109.96

7.4

2.2

8.59

11.06

g/l

5.68

176

280

Asthma-related pneumonia

1261

6468

2.01

109.85

2.4

2.3

9.89

10.28

g/l

1.93

1152

5621

Diseases of the musculoskeletal system and connective tissue

1135

2640

2.19

109.76

2.3

2.2

10.42

g/l

0.01

1038

2359

Other antidepressants

2812

8951

1.63

109.75

2.1

2.4

9.94

10.33

g/l

4.77

2474

8021

Other disorders of kidney and ureter

574

2137

2.87

109.75

2.4

10.06

10.25

g/l

0.47

540

1900

Genitourinary diseases

1331

3303

2.06

109.58

2.1

2.3

10.07

10.58

g/l

3.43

1229

2967

Asthma, hospital admissions 3, pneumonia

1261

6478

2.00

109.34

2.4

2.3

9.89

10.28

g/l

1.92

1152

5629

Asthma-related pneumonia or sepsis

1261

6478

2.00

109.34

2.4

2.3

9.89

10.28

g/l

1.92

1152

5629

Bacterial pneumonia (organism specified)

1491

7316

1.90

108.99

3.9

2.1

10.07

10.28

g/l

0.77

1395

6364

ILD medications: azathioprine

435

1382

3.28

108.77

1.8

1.6

10.90

10.22

g/l

1.85

404

1236

464

1540

3.15

107.91

2.3

10.08

10.13

g/l

0.08

427

1379

Other special examinations and investigations of persons without complaint or reported diagnosis

1597

4302

1.91

107.72

2.4

2.2

10.18

10.39

g/l

0.92

1431

3886

Rheumatoid arthritis, including avohilmo

1253

6491

1.99

107.35

1.9

2.4

10.40

10.04

g/l

2.10

1147

5683

Other disorders involving the immune mechanism, not elsewhere classified

192

338

6.52

107.32

2.2

2.5

10.08

10.60

g/l

0.65

182

310

Hypercalcemia

279

683

4.68

106.43

3.9

2.6

9.39

10.50

g/l

2.91

249

601

Benign neoplasm: Colon

1849

10129

1.76

106.05

2.4

10.14

10.19

g/l

0.17

1603

8948

Non-follicular lymphoma

466

1587

3.19

105.86

2.7

2.5

9.51

10.33

g/l

2.83

438

1405

Amyloidosis, other/unspecified

166

262

7.91

105.38

8.0

2.2

8.39

10.79

g/l

5.54

159

234

Diseases of liver

1143

5780

2.04

105.01

1.8

2.4

11.72

9.99

g/l

21.22

1002

5179

Other functional intestinal disorders

1365

6622

1.92

104.00

2.6

2.3

9.83

10.26

g/l

2.79

1195

5830

Hypothyroidism, drug reimbursement

282

435

4.65

103.99

2.2

1.2

10.00

10.19

g/l

0.29

266

393

Abnormal findings on diagnostic imaging of lung

1661

8970

1.80

103.78

2.5

2.4

10.46

10.16

g/l

1.51

1476

7882

Other/unspecified dorsalgia

1114

5518

2.05

103.73

2.7

2.1

9.81

10.33

g/l

3.88

988

4870

Insulin medication

1807

8689

1.76

103.40

2.1

2.5

10.12

10.25

g/l

0.50

1630

7662

Other and unspecified diseases of blood and blood-forming organs

189

344

6.50

102.88

5.2

2.5

10.75

10.65

g/l

0.08

180

317

Myelodysplastic syndrome, including Hilmo

213

432

5.75

102.69

2.3

1.4

11.56

10.42

g/l

2.10

193

373

Neoplasms

1600

4571

1.86

101.01

2.7

1.2

10.23

10.25

g/l

0.04

1475

4113

1254

6584

1.93

99.64

2.3

9.71

10.18

g/l

3.43

1133

5829

Fracture of lumbar spine and pelvis

881

4133

2.22

99.19

2.3

2.2

9.93

10.19

g/l

0.91

714

3579

Lymphoid leukaemia

309

853

4.04

99.08

2.8

2.7

8.93

10.60

g/l

5.87

290

760

Antihypertensive medication - note that there are other indications

1069

2648

2.14

99.01

2.0

2.2

10.24

10.45

g/l

0.66

992

2392

Other medical care

1534

7218

1.83

98.93

3.3

2.2

10.12

10.23

g/l

0.36

1381

6293

Use of hypnotics and sedatives

2882

10658

1.57

98.75

2.6

2.3

9.90

10.25

g/l

3.76

2559

9534

Gastro-oesophageal reflux disease

1933

9753

1.70

98.54

2.0

2.4

9.96

10.20

g/l

1.54

1667

8721

Hypertensive Renal Disease

222

480

5.19

98.24

2.0

2.7

10.10

10.62

g/l

0.86

213

416

Acquired haemolytic anaemia

179

324

6.59

98.21

3.5

2.2

9.86

10.58

g/l

0.84

168

288

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1843

10771

1.71

97.87

2.4

2.3

10.21

10.16

g/l

0.16

1655

9521

Chronic lower respiratory diseases

3131

10844

1.54

97.73

2.1

2.4

9.96

10.23

g/l

2.74

2843

9628

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2501

9328

1.62

97.68

2.0

2.5

10.06

10.21

g/l

0.94

2238

8277

Arthropathies

2114

6373

1.70

97.34

2.2

2.3

10.17

10.28

g/l

0.51

1923

5695

Other diseases of urinary system

2631

9383

1.60

97.18

2.2

2.3

10.08

10.23

g/l

0.95

2359

8401

Other disorders of white blood cells

281

734

4.24

97.11

2.2

2.5

10.13

10.36

g/l

0.27

255

661

Persons encountering health services for examination and investigation

1566

4302

1.85

96.32

2.3

2.2

10.27

10.39

g/l

0.41

1406

3886

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

175

313

6.40

96.19

2.1

2.5

9.91

10.70

g/l

1.22

166

286

Haemolytic anaemias

206

431

5.43

95.15

3.3

2.3

10.05

10.72

g/l

0.87

194

383

Gastrointestinal diseases

1251

3195

1.99

94.96

2.5

1.9

10.30

10.19

g/l

0.29

1133

2893

Disorders of lens

1947

7206

1.71

94.86

2.6

2.4

10.10

10.22

g/l

0.54

1734

6531

Cerebrovascular diseases

2295

9968

1.63

94.81

2.3

2.4

10.14

10.17

g/l

0.12

1993

8861

3070

10243

1.54

94.80

3.1

2.0

9.93

10.25

g/l

3.22

2744

9069

Neurological diseases

1998

5936

1.71

94.72

2.2

2.4

10.10

10.41

g/l

2.15

1797

5322

Venous thromboembolism

1739

9939

1.73

94.00

2.6

2.3

10.05

10.19

g/l

0.65

1562

8715

Injuries to the abdomen, lower back, lumbar spine and pelvis

1298

6990

1.88

93.75

2.4

2.2

9.87

10.22

g/l

2.03

1085

6164

Disorders of choroid and retina

2425

10806

1.60

93.43

2.3

2.4

10.32

10.14

g/l

0.99

2119

9609

Other intervertebral disc disorders

2168

7941

1.65

93.12

2.3

2.2

9.77

10.36

g/l

7.11

1936

7041

Any event in cancer register

2283

8305

1.63

92.25

3.4

1.5

9.93

10.17

g/l

1.61

2086

7426

Disorders of eyelid, lacrimal system and orbit

2455

11544

1.58

91.76

2.3

9.93

10.21

g/l

2.57

2169

10274

Thrombocytopenia, unspecified

340

1045

3.53

91.63

2.0

2.5

10.69

10.35

g/l

0.56

312

943

Chronic periodontitis, including avohilmo

2750

11490

1.55

91.49

2.5

2.3

10.20

10.13

g/l

0.36

2411

10272

Periodontitis

2750

11485

1.55

91.17

2.5

2.3

10.19

10.13

g/l

0.26

2414

10265

Viral pneumonia

483

1803

2.82

91.06

3.8

1.9

9.81

10.22

g/l

0.88

445

1587

Other arrhythmias

1624

7028

1.76

90.74

2.2

2.3

9.77

10.14

g/l

3.45

1451

6261

Nerve, nerve root and plexus disorders

2904

11550

1.53

90.50

2.2

2.3

9.83

10.24

g/l

5.77

2600

10267

Infections of the skin and subcutaneous tissue

1607

9276

1.74

90.29

2.6

2.3

10.22

10.16

g/l

0.22

1453

8315

Dialysis

196

409

5.33

90.22

2.4

2.0

9.27

10.41

g/l

2.91

188

375

Azathioprine

435

1559

2.90

88.05

1.8

2.5

10.90

10.04

g/l

2.72

404

1401

Falls/tendency to fall

2597

8377

1.57

88.05

2.2

2.3

10.14

10.24

g/l

0.56

2278

7656

Hard cardiovascular diseases

2249

8358

1.62

87.99

2.2

2.4

10.00

10.19

g/l

1.23

2037

7426

Hyperparathyroidism

703

3137

2.32

87.86

2.4

2.2

9.56

10.21

g/l

4.34

620

2708

COPD (mode)

958

3716

2.07

87.85

1.8

1.9

10.07

10.13

g/l

0.14

844

3245

Other external causes of accidental injury

1970

5949

1.68

87.34

2.3

10.18

10.30

g/l

0.52

1738

5429

Paroxysmal tachycardia

530

1710

2.64

87.30

1.9

2.2

10.32

10.25

g/l

0.14

483

1515

Hernia

2512

10844

1.56

87.24

2.4

2.2

10.06

10.17

g/l

0.56

2223

9641

Cough

1153

5769

1.91

87.22

2.5

2.2

10.04

10.21

g/l

0.58

1028

5104

Other joint disorders

2010

6371

1.67

87.00

2.0

2.3

10.11

10.28

g/l

0.89

1810

5693

Sicca syndrome [Sjögren]

352

1138

3.32

86.95

1.7

2.6

12.13

10.07

g/l

8.11

318

1004

All influenza

802

3813

2.17

86.94

4.6

1.9

10.00

10.21

g/l

0.53

719

3353

Dorsopathies

2504

8127

1.58

86.87

2.4

2.1

9.92

10.37

g/l

5.58

2252

7219

Intracranial trauma

1319

4884

1.85

86.83

2.3

9.97

10.41

g/l

2.96

1154

4409

Explicit bacterial Sepsis, including avohilmo

431

1563

2.91

86.14

4.4

2.1

11.02

10.12

g/l

1.67

386

1384

Streptococcal septicaemia, including avohilmo

381

1297

3.13

85.82

4.3

2.1

11.13

10.18

g/l

1.56

341

1131

Viral hepatitis, IBD co-morbidity

139

217

6.69

85.50

1.7

1.9

12.88

10.23

g/l

4.39

126

204

Injuries to the head

2917

11615

1.51

84.93

2.3

10.03

10.20

g/l

1.26

2563

10404

Peripheral artery disease

1514

6984

1.76

84.64

2.1

2.4

9.97

10.28

g/l

1.99

1358

6068

SLE (Finngen)

173

343

5.60

84.41

1.8

2.4

11.54

10.17

g/l

2.73

160

308

Diabetes, insulin treatment (Kela reimbursement)

2697

10627

1.53

84.02

1.9

2.4

10.04

10.18

g/l

0.85

2421

9420

Injuries to the hip and thigh

1571

8361

1.72

83.93

2.2

2.3

9.99

10.25

g/l

1.43

1261

7432

Abnormal weight loss

412

1488

2.97

83.70

2.0

2.4

10.08

10.26

g/l

0.39

366

1323

Weight loss

431

1596

2.88

83.32

2.2

2.4

10.03

10.22

g/l

0.44

384

1416

Coxarthrosis [arthrosis of hip](FG)

1531

6137

1.75

83.13

2.2

2.6

9.98

10.27

g/l

1.80

1358

5424

Persons encountering health services for specific procedures, not carried out

314

974

3.41

82.37

2.2

2.1

10.31

10.49

g/l

0.27

297

882

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2669

11396

1.52

82.08

2.6

2.2

9.91

10.22

g/l

2.96

2397

10114

Type 2 diabetes, strict (exclude DM1)

2470

9375

1.55

82.03

2.0

2.5

9.96

10.22

g/l

1.98

2196

8314

Type 2 diabetes, definitions combined

2455

9313

1.56

81.71

2.0

2.5

9.95

10.22

g/l

2.07

2181

8258

Other diseases of intestine

561

2372

2.47

81.56

2.4

2.3

9.81

10.16

g/l

1.16

522

2104

Unspecified haematuria

1375

6437

1.79

81.36

2.3

2.5

10.31

10.30

g/l

0.04

1218

5713

Other diseases of blood and blood-forming organs

311

974

3.46

81.30

4.2

2.5

10.70

10.31

g/l

0.62

286

879

DVT of lower extremities and pulmonary embolism

1370

7916

1.77

81.18

2.8

2.3

9.99

10.22

g/l

1.09

1227

6931

Isolated proteinuria

159

305

5.92

81.02

3.1

2.7

9.78

10.83

g/l

1.59

150

274

Accidents

1939

5949

1.66

80.94

2.2

2.3

10.21

10.30

g/l

0.34

1711

5429

Sulfasalazine

773

3722

2.13

80.90

1.8

2.4

10.56

10.10

g/l

2.26

711

3289

Sciatica+with lumbago

1391

7126

1.76

80.88

2.2

9.68

10.32

g/l

7.00

1252

6334

Other bacterial intestinal infections, including avohilmo

770

3715

2.14

80.69

3.4

2.1

10.02

10.27

g/l

0.67

683

3266

Streptococcal septicaemia

366

1264

3.08

80.36

4.5

2.1

11.18

10.18

g/l

1.62

328

1099

Explicit bacterial Sepsis

414

1526

2.86

80.22

4.6

2.1

11.06

10.13

g/l

1.66

371

1353

Insulin, combination of fast acting with intermediate-acting or long-acting

1807

10197

1.64

80.17

2.1

2.4

10.12

10.24

g/l

0.44

1630

9019

IgA nephropathy (IgA glomerulonephritis)

144

257

6.46

79.55

2.0

2.6

9.73

10.74

g/l

1.79

135

234

Insulin, intermediate and long-acting

1632

9604

1.67

79.36

2.0

2.4

10.16

10.22

g/l

0.20

1470

8505

Other and unspecified disorders of white blood cells

214

535

4.46

78.84

2.1

2.6

10.14

10.58

g/l

0.48

198

482

Other arthrosis

1447

5635

1.75

78.81

2.1

2.5

9.88

10.23

g/l

2.48

1302

5009

Presence of cardiac and vascular implants and grafts

1497

6519

1.73

78.49

1.8

2.4

10.17

10.30

g/l

0.54

1284

5769

Pruritus

418

1565

2.81

78.44

2.0

2.4

9.88

10.24

g/l

0.80

378

1393

Seronegative rheumatoid arthritis

390

1414

2.90

77.76

2.1

2.8

10.09

10.23

g/l

0.23

358

1250

Other symptoms and signs involving cognitive functions and awareness

1498

7953

1.71

77.37

2.2

2.4

10.06

10.26

g/l

0.89

1275

7010

Other cataract

1368

5891

1.77

77.36

2.6

2.3

10.13

10.23

g/l

0.34

1215

5311

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2607

11057

1.51

77.22

2.4

2.3

10.37

10.13

g/l

1.84

2331

9854

Senile cataract

1799

6748

1.65

77.06

2.6

2.4

10.14

10.22

g/l

0.29

1589

6101

Pulmonary heart disease, diseases of pulmonary circulation

1094

6048

1.87

76.90

2.5

2.3

10.13

10.18

g/l

0.13

988

5278

Giant cell arteritis

237

651

4.09

76.88

1.6

2.7

9.50

10.50

g/l

2.62

208

570

Hernia of abdominal wall, postoperative

536

2261

2.43

76.25

2.3

2.1

10.13

10.28

g/l

0.30

482

2040

Bronchitis

2864

11754

1.48

76.04

3.2

2.1

9.90

10.23

g/l

3.42

2569

10435

Diseases of the eye and adnexa

1680

5045

1.69

75.97

2.3

2.1

10.13

10.27

g/l

0.56

1545

4593

Diabetes medication

2645

10395

1.50

75.94

1.9

2.4

10.01

10.21

g/l

1.39

2363

9222

Other diseases of pleura

1506

7897

1.70

75.68

2.4

2.3

10.31

10.25

g/l

0.19

1348

6915

Other acute lower respiratory infections

1510

8700

1.68

75.38

3.2

2.1

9.81

10.29

g/l

4.06

1365

7688

Mood disorders, excluding more controls

2418

9407

1.53

75.23

2.1

2.4

9.78

10.23

g/l

5.35

2149

8460

Vasculitis limited to skin, not elsewhere classified

163

343

5.45

75.11

2.2

2.5

10.81

10.62

g/l

0.17

157

311

Chronic apical periodontitis

2881

11073

1.48

74.85

2.3

2.2

10.03

10.19

g/l

0.99

2543

9891

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1675

10421

1.64

74.80

2.3

10.21

10.13

g/l

0.30

1497

9221

Unspecified privation

396

1481

2.82

74.73

2.0

2.3

10.04

10.34

g/l

0.68

365

1328

Type 2 diabetes, definitions combined, including avohilmo

2413

9241

1.53

74.62

2.0

2.5

9.96

10.22

g/l

2.00

2151

8201

Other bacterial intestinal infections

631

2912

2.25

74.49

3.5

2.1

10.01

10.30

g/l

0.79

560

2549

Other specified/unspecified systemic involvement of connective tissue

240

674

3.85

74.24

1.8

2.8

11.78

10.27

g/l

3.39

227

596

Gonarthrosis [arthrosis of knee](FG)

1877

6765

1.62

74.20

2.1

2.5

9.98

10.22

g/l

1.64

1683

6005

Diseases of the digestive system

1424

8489

1.70

74.03

2.2

2.3

10.35

10.23

g/l

0.42

1280

7459

Atherosclerosis, excluding cerebral and coronary sclerosis

1421

6650

1.73

73.91

2.0

2.4

9.90

10.28

g/l

2.72

1279

5770

Hyperkalaemia

278

863

3.48

73.75

2.5

2.3

9.63

10.53

g/l

2.63

250

743

Non-Hodgkin lymphoma, all

235

659

3.93

73.49

3.5

1.4

10.35

10.36

g/l

0.01

225

563

Diseases of the respiratory system

1542

4573

1.71

73.35

2.6

1.9

10.24

10.28

g/l

0.10

1395

4034

Statin medication

1459

4823

1.73

73.26

2.1

2.5

9.86

10.53

g/l

6.41

1336

4283

Benign neoplasms

2374

8538

1.53

73.10

2.3

2.2

10.14

10.32

g/l

1.10

2130

7672

Implicit fungal Sepsis, including avohilmo

309

1028

3.22

72.80

3.0

2.3

9.60

10.20

g/l

1.47

270

914

Symptoms and signs involving the digestive system and abdomen

2530

8473

1.51

72.68

2.2

2.3

10.11

10.28

g/l

1.06

2270

7520

Hypo-osmolality and hyponatraemia

613

2814

2.25

71.82

2.6

2.1

10.13

10.33

g/l

0.42

528

2416

Other nutritional deficiencies

1693

9730

1.61

71.43

1.9

2.4

10.11

10.09

g/l

0.07

1523

8756

Other autoimmune haemolytic anaemias

108

164

8.29

71.29

2.8

2.2

10.56

10.23

g/l

0.22

102

146

Other retinal disorders

1948

9579

1.57

71.15

2.3

2.4

10.17

10.16

g/l

0.02

1688

8465

Other disorders of veins

1215

6957

1.76

71.00

2.1

2.3

10.52

10.04

g/l

3.27

1068

6157

Obesity related asthma

994

5467

1.87

70.66

1.9

2.4

9.72

10.18

g/l

2.98

895

4880

Systemic lupus erythematosus

173

399

4.79

70.55

1.8

2.3

11.54

10.28

g/l

2.39

160

361

Asthma, hospital admissions , main diagnosis only

2102

12111

1.53

69.89

2.0

2.3

9.82

10.21

g/l

3.55

1895

10759

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2342

12305

1.50

69.88

2.8

2.2

10.08

10.16

g/l

0.33

2095

10970

Disorders of gallbladder, biliary tract and pancreas

2640

11297

1.47

69.05

2.3

10.24

10.15

g/l

0.41

2344

10054

Fibrosis and cirrhosis of liver

328

1164

3.02

68.98

1.6

2.6

13.64

10.16

g/l

18.46

300

1049

Polyuria

778

3996

2.02

68.95

2.0

2.5

9.99

10.30

g/l

1.34

688

3549

Asthma, including avohilmo

2997

11573

1.44

68.71

2.1

2.4

9.91

10.26

g/l

4.05

2713

10267

Undetermined asthma, excluding more controls

378

1434

2.73

68.47

2.1

1.7

9.62

10.16

g/l

1.66

339

1247

Fracture of rib(s), sternum and thoracic spine

1013

5674

1.84

68.20

2.6

2.3

10.20

10.21

g/l

0.04

869

5017

Pulmonary embolism

982

5451

1.86

68.18

2.6

2.3

10.02

10.18

g/l

0.54

886

4777

Benzodiazepine use

2610

12148

1.47

68.12

2.2

2.3

9.89

10.22

g/l

3.26

2265

10885

Factors influencing health status and contact with health services

680

1565

2.22

68.09

2.5

2.0

10.39

10.60

g/l

0.43

616

1403

Osteonecrosis

272

875

3.35

68.07

7.3

2.1

9.06

10.51

g/l

4.56

250

794

Pulmonary heart disease

982

5459

1.85

67.85

2.6

2.3

10.02

10.18

g/l

0.53

886

4785

Idiopathic gout

400

1586

2.69

67.76

2.2

2.3

9.52

10.32

g/l

3.79

360

1401

Urinary track infection

1253

3582

1.78

67.67

2.1

9.89

9.99

g/l

0.31

1123

3175

Injuries to the thorax

1390

8488

1.67

67.66

2.4

2.3

10.18

10.21

g/l

0.08

1207

7547

Irritable bowel syndrome

718

3604

2.04

67.10

2.3

2.2

9.54

10.17

g/l

4.28

637

3202

Arthrosis

1743

6007

1.61

67.03

2.2

2.4

10.02

10.28

g/l

1.54

1574

5345

Cystitis

2145

8467

1.53

66.22

2.2

2.3

10.11

10.22

g/l

0.49

1894

7538

Chronic rhinitis, nasopharyngitis and pharyngitis

881

4758

1.90

66.20

2.1

2.3

9.99

10.18

g/l

0.69

792

4254

Other and unspecified vasculitis limited to skin

144

305

5.40

65.86

2.3

2.4

10.74

10.71

g/l

0.02

139

273

Other disorders of lacrimal gland

1062

6086

1.79

65.79

2.7

2.3

9.82

10.09

g/l

1.28

930

5393

Other gastritis (incl. Duodenitis)

721

3664

2.03

65.71

2.3

2.4

10.33

10.26

g/l

0.14

638

3243

Bacterial intestinal infections, IBD co-morbidities

629

3047

2.14

65.62

3.6

2.1

10.03

10.20

g/l

0.38

559

2677

Secondary and unspecified malignant neoplasm of lymph nodes

334

1228

2.89

65.49

1.7

1.4

8.99

10.20

g/l

4.28

313

1071

Need for other prophylactic measures

241

738

3.52

65.30

2.5

9.85

10.30

g/l

0.85

233

664

Ischemic heart diseases

2190

8729

1.52

65.12

2.3

2.4

9.91

10.20

g/l

2.32

1989

7701

Other abnormal findings of blood chemistry

210

591

3.85

64.92

3.1

2.5

10.22

10.30

g/l

0.09

201

536

Acute bronchitis

1187

6897

1.72

64.78

3.2

2.2

9.80

10.30

g/l

3.46

1073

6051

Concussion

1096

4856

1.77

64.76

2.2

2.3

9.96

10.42

g/l

2.87

955

4382

Temporal arteritis

202

560

4.04

64.73

1.6

2.7

9.51

10.49

g/l

2.08

176

485

Visual disturbances and blindness

1488

9341

1.62

64.53

2.3

9.92

10.14

g/l

1.14

1311

8238

Fibromyalgia

273

900

3.17

64.47

2.2

2.0

9.60

10.27

g/l

2.18

251

820

Acute myeloid leukaemia and myelodysplastic syndromes

146

319

5.21

64.29

1.7

1.4

11.30

10.64

g/l

0.73

133

277

Percutaneous Coronary Intervention

2113

8579

1.52

64.04

2.1

2.5

9.98

10.21

g/l

1.57

1936

7561

Covid-19 suspected case

545

2515

2.23

63.78

2.5

2.2

10.09

10.18

g/l

0.18

509

2281

Abdominal and pelvic pain

2469

8473

1.48

63.65

2.3

9.99

10.28

g/l

2.45

2221

7520

Depression or dysthymia

1743

6068

1.59

63.47

2.3

2.4

9.92

10.33

g/l

3.44

1526

5499

Chronic nephritic syndrome

182

473

4.23

63.41

2.8

2.7

9.39

10.47

g/l

2.28

173

431

Vocal cord dysfunction

308

945

2.94

63.35

2.6

2.5

10.07

10.13

g/l

0.06

270

868

Soft tissue disorders related to use, overuse and pressure

805

4291

1.93

63.31

2.3

2.4

9.75

10.32

g/l

3.31

719

3799

Obesity

1566

9385

1.60

63.27

1.8

2.3

10.06

10.10

g/l

0.15

1415

8444

Visual disturbances

1378

8547

1.65

63.18

2.3

2.2

9.93

10.14

g/l

1.08

1237

7577

Obesity and other hyperalimentation

1574

9433

1.59

63.18

1.8

2.3

10.06

10.11

g/l

0.17

1421

8485

ILD, hospital admission 2, with pulmonary infections

384

1541

2.63

63.06

2.5

1.9

10.56

10.22

g/l

0.72

358

1344

Polyarthrosis

651

2899

2.09

62.76

2.3

2.5

9.70

10.24

g/l

2.38

560

2525

Myelodysplastic syndrome

102

168

7.36

61.90

1.9

1.3

11.74

10.75

g/l

0.89

144

Emergency coronary revascularization (for ACS)

2329

9649

1.48

61.51

2.0

2.5

9.98

10.21

g/l

1.69

2125

8476

Coxarthrosis

1376

5443

1.66

61.18

2.2

2.5

10.01

10.28

g/l

1.42

1217

4817

Asthma/COPD (KELA code 203)

2347

10843

1.46

60.34

2.1

2.4

9.69

10.23

g/l

7.54

2100

9628

Type 1 diabetes

633

3153

2.05

60.25

1.8

2.4

10.21

10.27

g/l

0.10

588

2833

Any mental disorder

2728

9619

1.44

60.17

2.1

2.4

9.99

10.23

g/l

1.96

2402

8646

Cardiomyopathy, other and unspecified

290

1036

2.97

59.96

2.3

10.07

10.25

g/l

0.28

271

903

Disorders of lacrimal system

1237

7440

1.67

59.92

2.6

2.3

9.89

10.14

g/l

1.30

1079

6573

Seropositive rheumatoid arthritis, wide

824

4514

1.88

59.85

1.9

2.3

10.56

10.09

g/l

2.27

755

3956

Endocarditis

167

425

4.29

59.75

2.0

2.4

11.55

10.43

g/l

1.41

156

376

Fracture of femur

945

4841

1.81

59.65

2.3

2.2

10.30

g/l

0.01

708

4230

Coronary revascularization (ANGIO or CABG)

2090

8583

1.50

59.60

2.1

2.5

9.96

10.21

g/l

1.74

1914

7564

Cardiomyopathy in other diseases

13.40

59.37

7.7

2.1

8.14

10.90

g/l

3.51

Abnormal findings on examination of urine, without diagnosis

198

570

3.78

59.35

3.2

2.6

9.77

10.52

g/l

1.34

185

516

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

803

4376

1.89

59.34

1.9

2.3

10.57

10.09

g/l

2.31

736

3836

Other/unspecified seropositive rheumatoid arthritis

816

4474

1.88

59.12

1.9

2.3

10.57

10.09

g/l

2.32

747

3918

Insulin, fast-acting

1002

5821

1.76

59.01

1.9

2.3

9.95

10.23

g/l

1.11

913

5172

Conduction disorders

885

3935

1.85

58.97

2.3

2.2

10.10

10.23

g/l

0.38

774

3419

Biological medication for rheuma

445

1953

2.35

58.95

1.5

2.3

10.73

10.10

g/l

2.36

423

1797

Dysphagia

798

4353

1.89

58.61

2.3

2.4

9.95

10.30

g/l

1.60

695

3837

SLE, strict definition

161

406

4.37

58.52

1.8

1.9

11.57

10.28

g/l

2.43

149

370

SLE, ICD10

161

406

4.37

58.52

1.8

1.9

11.57

10.28

g/l

2.43

149

370

Non-allergic asthma (mode), excluding more controls

470

2094

2.28

58.49

2.0

1.8

9.73

10.14

g/l

1.13

430

1835

Other dialysis

154

377

4.56

58.48

2.5

2.8

9.26

10.50

g/l

3.14

148

344

Major coronary heart disease event

2240

9217

1.47

58.37

2.2

2.5

9.98

10.20

g/l

1.54

2039

8122

Undetermined asthma

378

1551

2.52

58.30

2.1

1.7

9.62

10.14

g/l

1.61

339

1359

Cutaneous abscess, furuncle and carbuncle

710

3736

1.95

58.06

2.0

2.3

10.20

10.23

g/l

0.04

651

3367

Nausea and vomiting

785

4154

1.89

58.04

2.9

2.3

9.66

10.26

g/l

3.38

702

3620

Postmenopausal osteoporosis with pathological fracture

301

1124

2.89

57.98

2.1

2.2

9.82

10.06

g/l

0.40

237

973

Shoulder lesions

1892

7564

1.52

57.22

2.2

2.4

9.86

10.38

g/l

5.40

1689

6698

Enterocolitis due to Clostridium difficile

403

1728

2.45

57.20

4.1

2.3

9.91

10.31

g/l

0.90

362

1518

GI-bleeding

1033

6119

1.73

57.07

2.2

2.3

10.34

10.28

g/l

0.13

927

5349

Giant cell arteritis with polymyalgia rheumatica

202

610

3.70

56.96

1.6

2.6

9.51

10.46

g/l

2.11

176

533

External causes of morbidity and mortality

1483

4654

1.62

56.87

2.3

2.2

10.22

10.31

g/l

0.29

1319

4239

Episodal and paroxysmal disorders

2607

9341

1.43

56.55

2.0

2.4

10.01

10.28

g/l

2.20

2322

8333

Any death

1866

8787

1.51

56.27

3.0

2.3

10.40

10.03

g/l

2.14

1663

7763

Sleep disorders (combined)

2760

10314

1.41

56.15

2.0

2.4

10.08

10.23

g/l

1.02

2440

9194

Other (not insulin) diabetes medications

2464

10186

1.44

56.10

1.9

2.4

10.04

10.20

g/l

0.97

2194

9025

Marginal zone B-cell lymphoma, including Hilmo

109

210

6.11

55.97

2.7

1.4

10.31

10.30

g/l

0.01

103

179

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

510

2432

2.19

55.84

1.5

2.5

13.06

10.06

g/l

21.94

450

2198

Diffuse large B-cell lymphoma

222

715

3.37

55.77

1.6

1.4

8.76

10.32

g/l

6.80

204

621

Diffuse large B-cell lymphoma, including Hilmo

222

715

3.37

55.77

1.6

1.4

8.76

10.32

g/l

6.80

204

621

Diffuse large B-cell lymphoma, helper endpoint

222

715

3.37

55.77

1.6

1.4

8.76

10.32

g/l

6.80

204

621

Chronic periodontitis, complicated

1587

10191

1.55

55.68

2.6

2.4

10.28

10.12

g/l

0.63

1411

9117

Mood [affective] disorders

2504

11378

1.42

55.58

2.1

2.3

9.78

10.19

g/l

5.10

2232

10149

Mood disorders

2509

11388

1.42

55.48

2.1

2.3

9.78

10.19

g/l

5.00

2237

10158

Anxiety disorders, excluding more controls

1967

8524

1.49

55.45

2.2

2.4

9.83

10.18

g/l

3.15

1761

7687

Unspecified fall

1421

8976

1.58

55.42

2.2

2.3

9.98

10.21

g/l

1.22

1199

7966

Abnormalities of heart beat

931

5223

1.76

55.24

2.2

9.82

10.24

g/l

2.09

813

4580

Lumbar disc prolapse

1565

7545

1.56

55.22

2.3

2.2

9.68

10.34

g/l

8.73

1413

6722

Obesity, other/unspecified

813

4535

1.83

55.02

1.6

2.3

9.91

10.12

g/l

0.92

749

4104

Systemic lupus erythematosus, unspecified

142

342

4.59

54.95

1.8

2.0

11.52

10.29

g/l

2.10

132

313

Primary hyperparathyroidism

413

1828

2.38

54.72

2.7

2.4

9.48

10.20

g/l

3.18

358

1598

Other diseases of the digestive system

1022

6107

1.72

54.70

2.2

2.3

10.31

10.29

g/l

0.04

912

5345

Other respiratory diseases principally affecting the interstitium

642

3354

1.99

54.49

2.5

2.3

10.42

10.24

g/l

0.43

596

2927

Immunodeficiency with predominantly antibody defects

128

286

4.97

54.49

5.4

2.1

7.56

10.41

g/l

8.60

117

269

Other diseases of pericardium

188

554

3.65

54.18

1.6

2.5

10.09

10.40

g/l

0.33

168

481

Immunodeficiencies

187

550

3.66

54.04

4.8

2.4

8.04

10.47

g/l

8.38

170

502

Other anxiety disorders

971

4831

1.73

53.95

1.8

2.2

9.79

10.18

g/l

2.19

877

4393

Solid cancers, including Hilmo

1964

7776

1.49

53.93

2.3

1.4

9.94

10.12

g/l

1.03

1787

6922

Prurigo nodularis

135

319

4.76

53.84

1.7

3.0

10.37

10.34

g/l

0.02

122

285

Retention of urine

1082

5286

1.69

53.62

2.0

2.5

10.39

10.35

g/l

0.12

945

4685

Calcific aortic valvular stenosis, operated

1030

5970

1.71

53.56

2.3

10.55

10.23

g/l

1.32

914

5150

Calcific aortic valvular stenosis

1030

5970

1.71

53.56

2.3

10.55

10.23

g/l

1.32

914

5150

Calcific aortic valvular stenosis, diagnosis (helper)

1029

5966

1.71

53.44

2.3

10.55

10.23

g/l

1.36

913

5146

Operations 2 for CAVS

1029

5966

1.71

53.44

2.3

10.55

10.23

g/l

1.36

913

5146

Anxiety (asthma-related co-morbidities)

1292

6166

1.61

53.39

1.9

2.3

9.80

10.17

g/l

2.54

1164

5610

Ischaemic heart disease, wide definition

2096

8930

1.47

53.34

2.4

9.87

10.22

g/l

3.06

1905

7867

Calcific aortic valvular stenosis, including rheumatic fever

1032

5986

1.71

53.27

2.3

10.55

10.23

g/l

1.33

916

5163

Diseases of oral cavity, salivary glands and jaws

1565

5212

1.57

53.18

2.4

2.1

10.28

10.26

g/l

0.06

1366

4634

Other diseases of liver

544

2702

2.08

52.98

2.0

2.4

11.31

9.97

g/l

8.05

486

2440

Cardiomyopathies, Primary/intrinsic

396

1740

2.37

52.92

1.9

2.3

10.19

10.23

g/l

0.06

362

1516

Other diseases of arteries and capillaries

327

1322

2.60

52.88

2.2

2.5

9.99

10.27

g/l

0.48

291

1174

Gonarthrosis

1577

5805

1.56

52.70

2.0

2.4

10.00

10.28

g/l

1.79

1421

5155

Other and unspecified coagulation defects

186

554

3.58

52.52

2.5

2.6

10.28

10.50

g/l

0.25

175

503

Cirrhosis of liver, NAS

242

848

3.08

52.48

1.6

2.7

13.92

10.31

g/l

14.22

224

766

Other diseases of anus and rectum

857

4918

1.78

52.17

2.2

2.3

10.31

10.28

g/l

0.05

721

4315

Other (seronegative) rheumatoid arthritis, wide

594

3067

2.00

51.98

2.0

2.3

10.12

10.17

g/l

0.11

540

2687

Cardiomyopathy (excluding other)

406

1821

2.32

51.67

1.9

2.3

10.25

10.15

g/l

0.18

372

1587

Biguanides

2427

10460

1.42

51.59

1.9

2.4

10.04

10.20

g/l

0.87

2170

9274

AV-block

594

2601

2.01

51.45

2.4

2.3

10.26

10.32

g/l

0.10

517

2218

Insulin, fast-acting or short human

1005

6066

1.69

51.40

1.9

2.3

9.96

10.24

g/l

1.10

916

5382

Other CVD

718

3960

1.88

51.36

2.6

2.3

9.96

10.27

g/l

1.09

598

3420

Malignant neoplasm of skin, including Hilmo

1432

6211

1.57

51.18

2.6

1.4

9.93

10.10

g/l

0.79

1267

5459

Hypokalaemia

394

1753

2.34

51.09

2.6

2.2

10.42

10.31

g/l

0.14

350

1522

Later onset COPD, excluding more controls

686

2804

1.93

50.99

1.6

1.9

10.19

10.13

g/l

0.12

594

2389

Depression

2273

10783

1.42

50.84

2.1

2.3

9.80

10.18

g/l

4.12

2028

9646

Early onset COPD, excluding more controls

530

2641

2.06

50.72

2.1

1.9

9.64

10.20

g/l

2.15

484

2345

Hypotension

644

3456

1.93

50.39

2.7

2.3

9.97

10.28

g/l

1.00

529

2986

Zoster [herpes zoster], including avohilmo

1483

9495

1.53

50.38

3.0

2.3

10.10

10.15

g/l

0.15

1300

8354

Convulsions, not elsewhere classified

517

2523

2.06

50.32

1.8

2.2

10.14

10.27

g/l

0.24

468

2253

Subjective visual disturbances

723

4022

1.84

49.83

2.3

9.92

10.16

g/l

0.78

653

3571

Other coagulation defects

251

917

2.88

49.68

2.5

10.32

10.34

g/l

0.02

233

823

COPD

1354

7147

1.57

49.55

1.9

2.4

10.07

10.26

g/l

0.75

1202

6270

ILD, hospital admissions 3, with pneumonia sepsis

328

1374

2.52

49.31

2.4

1.9

10.46

10.32

g/l

0.21

305

1200

Viral infections characterized by skin and mucous membrane lesions

1092

6794

1.64

49.31

3.4

2.2

9.98

10.19

g/l

0.67

991

6044

Type 1 diabetes, wide definition, subgroup 1

489

2394

2.09

48.99

1.8

2.4

10.08

10.24

g/l

0.32

448

2178

Urticaria and erythema

869

5109

1.73

48.97

2.2

10.34

10.11

g/l

0.76

781

4566

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1342

5844

1.58

48.90

2.6

1.4

10.07

10.11

g/l

0.11

1182

5111

Other neurological diseases

2001

10908

1.44

48.75

2.2

2.4

9.89

10.21

g/l

2.85

1742

9656

All anxiety disorders

1304

6511

1.57

48.73

1.9

2.3

9.82

10.15

g/l

2.13

1176

5900

Exposure to other specified factors

1938

11650

1.44

48.63

2.1

2.3

10.03

10.14

g/l

0.52

1701

10470

Other headache syndromes

1008

6153

1.66

48.48

1.8

2.5

9.61

10.15

g/l

4.17

899

5509

Abnormal findings on diagnostic imaging of other body structures

468

2279

2.13

48.38

2.8

2.4

10.11

10.16

g/l

0.08

426

2016

Selective serotonin reuptake inhibitors

2402

8952

1.41

48.32

2.2

2.4

10.02

10.33

g/l

2.78

2139

8022

Obesity due to excess calories

1106

6941

1.62

48.21

1.8

2.4

10.20

10.11

g/l

0.34

997

6259

Symptoms and signs involving speech and voice

949

5748

1.69

48.21

2.6

2.3

9.76

10.17

g/l

2.24

843

5072

Stroke, including SAH

1828

9086

1.47

47.89

2.3

2.4

10.15

10.22

g/l

0.28

1588

8046

Secondary uncertain malignant neoplasm

435

2070

2.18

47.79

1.8

1.4

9.40

10.15

g/l

2.02

399

1794

Gingivitis and periodontal diseases

2471

9220

1.40

47.51

2.4

2.2

10.22

10.17

g/l

0.22

2163

8209

Noninfective enteritis and colitis

1145

7271

1.60

47.24

2.4

2.2

10.14

10.17

g/l

0.08

1027

6479

Sleep apnoea

2393

10928

1.40

47.11

2.1

2.4

9.99

10.17

g/l

1.26

2140

9778

Benign neoplasm: Colon, unspecified

816

4790

1.76

47.06

2.4

2.3

10.07

10.20

g/l

0.33

686

4217

Non-invasive ventilation

518

2251

2.02

46.69

3.1

2.4

9.41

10.23

g/l

3.85

475

2024

Sequelae of external causes of morbidity and mortality

760

4382

1.78

46.49

2.3

10.07

10.16

g/l

0.21

708

3876

Stroke, excluding SAH

1763

8807

1.47

46.47

2.3

2.4

10.18

10.22

g/l

0.15

1527

7789

General examination and investigation of persons without complaint and reported diagnosis

1296

4293

1.58

46.43

2.2

9.57

10.39

g/l

9.05

1120

3879

Diabetic retinopathy, excluding more controls

740

2293

1.86

46.42

1.9

2.1

10.05

10.11

g/l

0.14

663

2018

Overexertion and strenuous or repetitive movements

304

1262

2.51

46.27

2.5

2.4

9.66

10.29

g/l

1.96

273

1150

Abnormal involuntary movements

420

1998

2.18

46.15

2.3

9.33

10.31

g/l

6.28

373

1780

Trochanteric bursitis

432

2076

2.15

46.07

2.1

2.3

9.42

10.43

g/l

5.18

381

1830

Disorder of lipoprotein metabolism, unspecified

425

2034

2.17

46.06

1.9

2.3

9.84

10.30

g/l

1.17

382

1767

Other diseases of hard tissues of teeth

1505

5162

1.53

46.04

2.3

2.1

10.13

10.24

g/l

0.39

1305

4592

Secondary right heart disease

196

659

3.23

45.94

1.9

2.5

10.49

10.69

g/l

0.22

182

586

Non-allergic asthma (mode)

470

2305

2.07

45.81

2.0

1.9

9.73

10.09

g/l

0.96

430

2022

Amputation

379

1743

2.28

45.73

2.2

2.3

10.24

10.39

g/l

0.26

343

1508

Motor neuron disease ALS

102

219

5.18

45.65

1.3

2.1

10.08

10.76

g/l

0.61

199

Other inflammation of eyelid, including avohilmo

1011

6291

1.63

45.60

2.6

2.3

10.16

10.12

g/l

0.11

899

5661

Fungal Sepsis

181

582

3.35

45.52

3.4

2.3

9.29

10.40

g/l

2.09

163

524

Malignant neoplasm of skin

1358

6044

1.55

45.47

2.6

1.4

9.92

10.11

g/l

0.82

1198

5301

Agranulocytosis

357

1604

2.32

45.43

4.0

2.4

10.55

10.21

g/l

0.50

341

1433

Injuries to the shoulder and upper arm

2188

12190

1.40

45.41

2.5

2.3

9.99

10.19

g/l

1.36

1904

10879

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1219

7583

1.56

45.29

2.1

2.2

10.03

10.04

g/l

0.03

1085

6778

Solid cancers

1883

7702

1.45

45.26

2.3

1.4

9.93

10.12

g/l

1.05

1709

6849

ILD, hospital admissions

538

2824

1.98

45.26

2.4

2.3

10.49

10.22

g/l

0.69

502

2480

Seropositive rheumatoid arthritis, strict definition

462

2296

2.09

45.22

1.7

2.3

10.77

10.18

g/l

2.03

425

2037

Peripheral artery operations in Hilmo

447

2200

2.11

44.97

2.3

10.19

10.35

g/l

0.32

399

1911

Motor neuron disease (with DMD)

102

222

5.09

44.86

1.3

2.1

10.08

10.73

g/l

0.57

201

Other interstitial pulmonary diseases

542

2862

1.97

44.76

2.4

2.3

10.51

10.20

g/l

0.87

506

2509

Interstitial lung disease

542

2870

1.96

44.39

2.4

2.3

10.51

10.22

g/l

0.79

506

2517

Interstitial lung disease endpoints

542

2870

1.96

44.39

2.4

2.3

10.51

10.22

g/l

0.79

506

2517

Mycoses, including avohilmo

2238

12392

1.39

44.30

2.3

10.13

10.14

g/l

0.05

1979

11078

Neurotic, stress-related and somatoform disorders

2026

9958

1.42

44.19

2.2

2.3

9.84

10.13

g/l

2.59

1818

8939

Other reaction to severe stress, and adjustment disorders

731

4210

1.76

44.10

2.4

2.2

9.89

10.20

g/l

1.14

674

3835

Idiopathic thrombocytopenic purpura

132

355

4.05

43.86

2.5

2.4

11.03

10.63

g/l

0.31

122

316

Basal cell carcinoma, including Hilmo

1288

5726

1.55

43.56

2.6

1.4

10.08

10.11

g/l

0.08

1122

5004

Nonalcoholic fatty liver disease

303

1291

2.44

43.54

1.9

2.5

10.95

10.19

g/l

2.06

276

1175

Special screening examination for infectious and parasitic diseases

425

1468

2.14

43.47

2.3

2.2

10.11

10.26

g/l

0.29

382

1386

Ischaemic Stroke, excluding all haemorrhages

1671

8548

1.46

43.32

2.3

2.4

10.19

10.23

g/l

0.12

1446

7537

Anxiety disorders

2046

10067

1.41

43.29

2.2

2.3

9.83

10.13

g/l

2.59

1834

9030

Other and unspecified immunodeficiencies with predominantly antibody defects

129

6.74

43.24

5.6

2.3

6.71

10.17

g/l

10.38

120

Conjunctivitis

1731

9755

1.44

43.15

2.3

2.2

10.09

10.10

g/l

0.05

1546

8709

Lichen simplex chronicus and prurigo

229

861

2.81

43.14

1.9

2.7

10.22

g/l

0.00

208

768

Candidiasis, including avohilmo

773

4569

1.73

42.98

2.5

2.2

9.99

10.14

g/l

0.43

675

4047

Major coronary heart disease event excluding revascularizations

1695

7779

1.46

42.88

2.3

2.5

10.03

10.24

g/l

1.05

1511

6801

Need for immunization against other single viral diseases

204

5.20

42.60

2.9

2.5

9.88

10.53

g/l

0.69

186

Allergic conjunctivitis

1253

7988

1.53

42.49

2.0

2.2

10.02

10.03

g/l

0.02

1116

7153

Rash and other nonspecific skin eruption

304

1314

2.41

42.37

2.3

10.53

10.27

g/l

0.40

283

1169

Coronary atherosclerosis

1744

7700

1.45

42.20

2.4

2.5

9.89

10.24

g/l

2.71

1576

6742

Pericarditis

142

411

3.71

42.13

1.9

2.2

10.92

10.37

g/l

0.55

128

363

Other noninfective gastroenteritis and colitis

655

3716

1.80

42.12

2.6

2.3

10.02

10.18

g/l

0.40

586

3275

Rotator cuff syndrome

1542

7283

1.48

42.00

2.3

2.4

9.87

10.37

g/l

4.43

1372

6456

Type 1 diabetes, wide definition

502

2620

1.96

41.97

1.8

2.3

10.05

10.29

g/l

0.55

460

2366

Chronic ulcer of skin, not elsewhere classified

259

1051

2.60

41.82

2.1

2.2

10.18

10.30

g/l

0.14

235

923

Open wound of head

1443

9275

1.48

41.79

2.1

2.3

10.04

10.24

g/l

0.99

1248

8268

Implicit fungal Sepsis

166

534

3.35

41.77

3.6

2.3

9.08

10.44

g/l

2.94

149

481

Psychiatric diseases

2345

8589

1.38

41.70

2.2

2.4

10.00

10.24

g/l

1.73

2063

7756

Asthma and allergy, excluding more controls

232

872

2.68

41.56

1.9

1.5

9.65

10.33

g/l

2.14

211

787

Anaemia in chronic diseases classified elsewhere

118

306

4.26

41.49

1.9

2.6

9.52

10.75

g/l

2.16

107

274

Iron deficiency anaemia secondary to blood loss (chronic)

500

2634

1.96

41.31

2.1

2.3

10.38

10.21

g/l

0.29

429

2304

Arthropathies in other diseases classified elsewhere

136

388

3.76

41.22

2.7

2.6

10.27

10.25

g/l

0.02

120

347

Disorders of conjunctiva

1949

10883

1.40

40.93

2.3

2.2

10.04

10.13

g/l

0.41

1742

9708

Methotrexate

367

1735

2.18

40.82

1.8

2.5

10.35

10.05

g/l

0.59

338

1524

Amputation of toe

279

1187

2.49

40.79

2.1

2.5

10.34

10.35

g/l

0.00

252

1055

Tumor necrosis factor alpha inhibitors

364

1713

2.18

40.78

1.4

2.3

10.84

10.15

g/l

2.40

343

1576

Gastroduodenal ulcer

777

4662

1.70

40.59

2.1

2.4

10.28

10.37

g/l

0.20

690

4097

Other pulmonary heart/vessel disease

202

739

2.94

40.56

1.9

2.5

10.53

10.54

g/l

0.01

186

657

Open wound of lower leg

446

2273

2.02

40.52

2.0

2.3

9.65

10.25

g/l

2.22

395

2010

Abnormal serum enzyme levels

885

5310

1.65

40.49

2.2

2.4

10.24

g/l

0.01

813

4740

Pleural effusion

529

2862

1.92

40.48

2.6

2.3

10.49

10.26

g/l

0.53

488

2506

Substance abuse, excluding more controls

1315

7402

1.50

40.45

1.7

2.4

10.17

10.29

g/l

0.45

1141

6723

Chronic sinusitis

1027

6600

1.58

40.33

2.5

2.3

9.69

10.18

g/l

3.54

938

5905

ILD, hospital admissions 1, main diag only

480

2525

1.98

40.24

2.5

2.4

10.64

10.22

g/l

1.17

447

2217

Other chronic obstructive pulmonary disease

1269

6967

1.52

40.22

1.8

2.5

10.00

10.26

g/l

1.18

1125

6114

Other infectious diseases, including avohilmo

303

1341

2.36

40.09

2.4

2.3

10.17

10.36

g/l

0.23

282

1202

Diabetic neuropathy

409

2031

2.10

40.09

2.1

10.13

g/l

0.00

374

1804

Viral pneumonia (unknown virus, not influenza)

220

842

2.74

39.87

3.1

2.5

9.84

10.40

g/l

0.98

206

763

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1259

5692

1.53

39.85

2.6

1.4

9.99

10.10

g/l

0.36

1105

4974

Allergic asthma (mode), excluding more controls

419

2038

2.04

39.72

1.9

1.7

9.75

10.20

g/l

1.62

386

1825

Adverse effects, not elsewhere classified

469

2444

1.97

39.67

2.3

10.07

10.21

g/l

0.31

440

2214

Superficial injury of head

677

3951

1.75

39.42

2.1

2.2

9.97

10.18

g/l

0.66

589

3482

Voice disturbances

726

4335

1.71

39.11

2.8

2.3

9.58

10.14

g/l

3.64

657

3840

Osteomyelitis

230

911

2.66

39.08

2.2

10.32

10.44

g/l

0.14

211

829

Other diseases of upper respiratory tract

2688

10587

1.33

38.78

2.3

10.06

10.26

g/l

1.47

2401

9388

Fracture of shoulder and upper arm

977

6273

1.58

38.72

2.7

2.3

10.08

10.19

g/l

0.31

828

5545

Functional dyspepsia

676

3978

1.73

38.29

2.2

2.3

9.72

10.17

g/l

1.98

609

3559

Volume depletion

311

1423

2.27

37.85

2.0

2.2

10.26

10.51

g/l

0.37

260

1222

Nonorganic sleeping disorders, excluding more controls

444

2308

1.96

37.70

1.7

2.3

9.85

10.32

g/l

1.74

402

2113

Urticaria

661

3880

1.73

37.62

2.2

10.11

10.13

g/l

0.04

591

3486

Personality disorders, excluding more controls

475

2519

1.91

37.54

1.7

2.3

9.93

10.24

g/l

0.91

436

2334

Somatoform disorder

408

2068

2.02

37.54

2.5

2.3

9.64

10.36

g/l

3.19

361

1867

Diseases of pulp and periapical tissues and dental caries

1713

6218

1.43

37.32

2.2

2.3

10.20

10.23

g/l

0.10

1497

5511

Asthma and allergy

232

921

2.53

37.18

1.9

1.5

9.65

10.23

g/l

1.66

211

827

Disorders of continuity of bone

271

1178

2.38

37.15

3.9

2.1

9.59

10.30

g/l

1.72

240

1075

Injury, poisoning and certain other consequences of external causes

1145

3746

1.55

37.05

2.3

10.36

g/l

0.00

1022

3397

Eosinophilic disease (BM)

126

6.04

36.98

2.5

1.3

10.08

11.00

g/l

0.67

114

L01XX Other antineoplastic agents

235

974

2.57

36.62

3.4

2.5

10.18

10.43

g/l

0.30

215

868

Reactive arthropathies, FINNGEN

188

692

2.82

36.60

2.4

2.7

10.28

10.41

g/l

0.15

168

619

Basal cell carcinoma

1217

5592

1.51

36.52

2.6

1.4

9.99

10.10

g/l

0.38

1063

4883

Zoster [herpes zoster]

572

3268

1.80

36.42

4.0

2.2

10.03

10.26

g/l

0.44

499

2844

Injuries to the knee and lower leg

2815

11697

1.31

36.29

2.0

2.4

9.81

10.24

g/l

6.47

2494

10441

Myocardial infarction

1367

6607

1.47

36.17

2.2

2.5

10.07

10.26

g/l

0.79

1211

5761

Rare circulating lymphoid malignancy, including Hilmo

120

345

3.76

36.14

4.6

1.4

9.62

10.48

g/l

0.80

114

303

Deforming dorsopathies

661

3925

1.71

36.10

2.4

2.2

9.72

10.28

g/l

3.06

582

3467

Cellulitis

592

3419

1.77

36.04

3.1

2.3

10.23

10.19

g/l

0.07

536

3059

Sleep apnoea, including avohilmo

2417

11046

1.34

36.01

2.0

2.4

9.99

10.17

g/l

1.29

2159

9884

Marginal zone B-cell lymphoma

114

6.58

35.77

2.0

1.3

10.79

10.16

g/l

0.42

Drug-induced osteoporosis with pathological fracture

100

259

4.42

35.76

1.5

2.7

9.04

10.36

g/l

1.59

231

Papulosquamous disorders

1006

6630

1.54

35.71

2.2

2.4

10.18

10.14

g/l

0.10

903

5922

Other disorders of bone

456

2448

1.91

35.30

3.7

2.0

9.71

10.25

g/l

1.83

410

2243

Diseases of the myoneural junction and muscle

385

1962

2.03

35.30

1.8

2.3

9.93

10.30

g/l

0.78

324

1734

Dental caries, including avohilmo

1870

6947

1.39

35.28

2.2

2.3

10.19

10.21

g/l

0.06

1636

6174

Other inflammation of eyelid

416

2176

1.97

35.17

2.9

2.3

10.25

10.26

g/l

0.01

358

1937

Psoriatic and enteropathic arthropathies

278

1251

2.29

35.01

1.7

2.6

10.38

10.22

g/l

0.22

253

1130

Cholelithiasis, broad definition with cholecystitis

2162

10774

1.35

35.00

2.3

10.21

10.15

g/l

0.23

1920

9558

Other peripheral vascular diseases

255

1112

2.39

34.95

1.9

2.4

9.92

10.37

g/l

0.97

231

999

Peripheral arterial reconstruction

570

3302

1.78

34.79

2.2

2.4

9.74

10.28

g/l

2.49

514

2872

Diseases of spleen

210

4.65

34.67

2.1

2.2

10.36

10.60

g/l

0.18

190

Atopic dermatitis

1171

6319

1.49

34.65

1.8

2.3

10.18

10.08

g/l

0.38

1054

5705

Acute upper respiratory infections

2536

11629

1.32

34.54

3.1

2.1

9.93

10.24

g/l

2.80

2270

10308

Other general symptoms and signs

135

422

3.29

34.45

1.4

2.5

10.03

10.79

g/l

0.85

122

382

Injuries to the elbow and forearm

1681

10470

1.39

34.27

2.2

2.3

9.88

10.15

g/l

1.74

1451

9351

Dental operations

1626

5962

1.42

34.14

2.3

2.1

10.22

10.27

g/l

0.15

1425

5302

Diseases of pulp and periapical tissues, including avohilmo

2472

9728

1.33

34.10

2.2

2.3

10.18

10.21

g/l

0.13

2185

8654

Hypothyroidism, strict autoimmune

1582

7421

1.41

34.06

2.0

2.4

10.10

10.08

g/l

0.08

1400

6524

L04AC Interleukin inhibitors

177

658

2.80

33.89

1.6

2.4

10.56

10.19

g/l

0.50

167

607

Other and unspecified types of non-Hodgkin lymphoma, hilmo

172

637

2.90

33.82

3.1

2.7

9.90

10.64

g/l

0.96

157

569

Pacemaker

1122

7107

1.50

33.75

2.1

2.3

10.21

10.26

g/l

0.13

965

6172

Allergic asthma (mode)

419

2161

1.92

33.61

1.9

1.7

9.75

10.19

g/l

1.58

386

1937

Spondylopathies in diseases classified elsewhere

159

5.32

33.48

21.2

1.3

8.55

11.43

g/l

2.61

140

Spondylopathies (FG)

290

1351

2.20

33.42

1.9

2.6

10.56

10.17

g/l

0.80

274

1217

Other degenerative diseases of the nervous system

747

3366

1.65

33.33

1.8

2.4

10.24

10.42

g/l

0.46

636

2985

Progressive vascular leukoencephalopathy

185

718

2.78

33.33

2.2

2.5

10.16

10.45

g/l

0.42

159

625

Spondyloarthritis

440

2381

1.89

33.27

2.2

2.3

10.77

10.11

g/l

2.11

414

2112

Acute sinusitis

1117

6921

1.48

32.86

3.4

2.0

9.64

10.18

g/l

4.53

1007

6221

All influenza (not pneumonia)

358

1819

2.02

32.74

4.7

1.9

9.92

10.28

g/l

0.60

320

1630

Haemorrhage, not elsewhere classified

144

491

3.11

32.70

2.7

2.5

10.03

10.43

g/l

0.48

133

430

Other and unspecified effects of external causes

593

3522

1.71

32.43

2.2

10.14

10.18

g/l

0.08

549

3182

Recurrent or chronic depression

816

3584

1.60

32.39

2.1

2.4

9.71

10.29

g/l

3.70

731

3304

Paralytic ileus and intestinal obstruction

689

4257

1.65

32.38

2.9

2.3

9.97

10.26

g/l

0.94

617

3741

Polyarthritis, unspecified

127

405

3.33

32.32

2.5

2.4

10.43

10.46

g/l

0.02

120

360

In situ neoplasms

1087

7435

1.49

32.29

2.4

2.3

9.90

10.21

g/l

1.42

955

6509

Gastric ulcer

526

3037

1.78

32.28

2.0

2.4

10.09

10.33

g/l

0.50

463

2663

Other symptoms and signs involving the nervous and musculoskeletal systems

994

6675

1.51

32.17

2.2

2.3

9.53

10.25

g/l

6.68

902

5924

Other disorders of eye and adnexa

366

1889

1.99

32.12

1.9

2.3

9.98

10.29

g/l

0.61

341

1699

Phobic anxiety disorders

230

986

2.37

32.04

2.2

2.1

10.28

10.50

g/l

0.30

214

915

Complications of internal orthopaedic prosthetic devices, implants and grafts

679

4209

1.65

31.89

2.0

2.3

10.10

10.12

g/l

0.05

589

3649

Myeloproliferative diseases

279

1315

2.22

31.88

2.7

2.4

10.82

10.34

g/l

0.81

247

1167

1377

8776

1.42

31.60

1.7

2.4

10.45

10.23

g/l

0.98

1210

7933

Other chronic obstructive pulmonary disease, including avohilmo

1510

8989

1.40

31.49

1.8

2.5

9.94

10.25

g/l

1.85

1334

7946

Migraine with aura

467

2614

1.81

31.35

1.6

2.3

9.83

10.18

g/l

1.21

425

2377

Benign neoplasm of other and ill-defined parts of digestive system

526

3069

1.76

31.24

2.2

2.4

9.84

10.16

g/l

1.00

469

2707

Rheumatism, unspecified

344

1757

2.01

31.17

2.1

2.4

9.80

10.39

g/l

1.80

314

1541

Cholelithiasis

2060

10647

1.33

31.07

2.3

10.16

10.14

g/l

0.08

1829

9436

Other diseases of lip and oral mucosa

1030

7028

1.49

30.89

2.6

2.3

9.97

10.09

g/l

0.39

899

6284

Missing teeth due to accident, extraction or parodontitis

1645

10852

1.37

30.76

2.3

2.4

10.13

g/l

0.02

1361

9725

Acute upper respiratory infections of multiple and unspecified sites

1739

9397

1.36

30.67

3.3

2.1

9.84

10.23

g/l

3.11

1569

8380

Alcohol use disorder, Swedish definition

1309

8470

1.42

30.60

1.7

2.4

10.43

10.23

g/l

0.84

1148

7661

Bipolar affective disorders

365

1908

1.95

30.60

1.9

2.3

9.69

10.30

g/l

1.97

337

1754

Reactive arthropathies

222

969

2.37

30.23

2.2

2.5

10.29

g/l

0.00

197

873

Acetic acid derivatives and related substances

667

2082

1.68

30.21

2.2

2.3

10.18

10.67

g/l

1.79

599

1858

1424

8955

1.40

30.17

1.7

2.4

10.41

10.22

g/l

0.80

1253

8099

Migraine without aura

342

1755

1.98

30.15

2.2

9.97

10.20

g/l

0.48

317

1614

DVT of lower extremities

537

3179

1.73

30.14

3.1

2.2

10.06

10.09

g/l

0.06

472

2803

Meniscus derangement

1230

5712

1.44

30.10

2.2

2.4

9.90

10.25

g/l

2.00

1102

5084

Coxibs

660

2090

1.68

30.04

2.2

2.3

9.96

10.66

g/l

3.48

593

1866

Caries of dentine, including avohilmo

1949

7469

1.35

29.94

2.2

2.3

10.20

g/l

0.01

1700

6650

Hypertrophic cardiomyopathy

159

602

2.82

29.92

2.5

2.7

9.81

10.54

g/l

1.26

148

544

Phlebitis and thrombophlebitis (not including DVT)

596

3630

1.68

29.91

2.8

2.3

9.91

10.06

g/l

0.37

536

3217

Artrosis, including avohilmo

1894

7755

1.35

29.90

2.1

2.4

10.13

10.26

g/l

0.66

1690

6970

Other metabolic disorders

305

1517

2.06

29.70

3.6

2.2

9.55

10.33

g/l

2.31

290

1353

Injuries to unspecified part of trunk, limb or body region

296

1463

2.09

29.58

2.1

2.4

9.74

10.29

g/l

1.42

264

1308

Disorders of muscles

265

1255

2.17

29.53

1.7

2.2

9.93

10.31

g/l

0.85

243

1129

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

430

2405

1.84

29.53

2.0

1.4

9.11

10.19

g/l

4.91

401

2114

Intracranial injury

1410

9545

1.39

29.29

2.2

2.3

10.04

10.23

g/l

0.93

1218

8486

Etanercept

172

679

2.63

29.28

1.4

2.4

10.88

10.32

g/l

0.91

164

626

Myocardial infarction, strict

1257

6308

1.43

29.26

2.1

2.5

10.04

10.27

g/l

1.04

1118

5499

Pain in thoracic spine

360

1906

1.93

29.21

2.7

2.1

9.73

10.29

g/l

1.62

325

1690

Noninfectious colitis NAS

360

1911

1.93

29.13

2.7

2.3

9.80

10.30

g/l

1.33

329

1703

Hypoparathyroidism

144

528

2.92

28.90

1.6

2.3

9.30

10.36

g/l

1.96

120

470

Sequelae with surgical and medical care as external cause

575

3507

1.68

28.85

2.2

2.3

10.13

10.19

g/l

0.10

532

3092

Sub-endpoint used in defining T1D endpoints

669

4152

1.61

28.80

1.8

2.2

10.24

10.27

g/l

0.05

618

3696

Valvular operations

388

2118

1.88

28.80

1.6

2.3

11.03

10.25

g/l

2.33

348

1834

Other disorders of skin and subcutaneous tissue, not elsewhere classified

404

2236

1.86

28.73

2.2

9.91

10.18

g/l

0.61

349

1963

Cervicalgia

507

2991

1.73

28.65

2.3

2.2

9.66

10.33

g/l

3.07

442

2646

Postprocedural endocrine and metabolic disorders, not elsewhere classified

283

1389

2.09

28.61

3.7

2.2

9.46

10.27

g/l

2.49

268

1237

Other extrapyramidal and movement disorders in other diseases

675

4287

1.61

28.61

2.3

9.90

10.14

g/l

0.77

594

3795

Angina pectoris

1491

7231

1.39

28.57

2.4

2.5

9.92

10.25

g/l

2.14

1357

6321

Other abnormalities of plasma proteins

202

4.34

28.52

5.5

2.8

10.64

10.85

g/l

0.11

178

Myeloproliferative diseases (CML excluded)

252

1194

2.21

28.49

2.9

2.5

11.03

10.34

g/l

1.27

223

1062

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

251

1185

2.19

28.35

3.5

2.3

9.96

10.30

g/l

0.48

231

1063

Myocardial infarction, without ST-elevation

1195

7676

1.43

28.33

2.1

2.4

9.96

10.29

g/l

1.77

1053

6694

Non-selective monoamine reuptake inhibitors

908

5893

1.50

28.32

2.2

2.4

9.69

10.27

g/l

3.92

810

5218

Raynaud syndrome

235

1082

2.25

28.25

1.6

2.5

10.31

10.28

g/l

0.04

213

975

Sequelae of cerebrovascular disease

1070

6373

1.46

28.25

2.1

2.3

10.42

10.25

g/l

0.57

889

5601

Superficial injury of lower leg

606

3762

1.64

28.02

1.8

2.3

9.67

10.19

g/l

2.42

525

3342

Superficial injury of hip and thigh

430

2445

1.80

27.85

2.0

2.3

9.65

10.24

g/l

2.43

361

2168

Sequelae of other external causes

180

746

2.52

27.83

2.6

9.93

10.41

g/l

0.84

171

671

Psoriasis

693

4453

1.58

27.79

1.9

2.4

10.41

10.13

g/l

0.86

625

3996

Other viral diseases, including avohilmo

713

4565

1.56

27.46

3.4

2.1

9.79

10.16

g/l

1.43

678

4149

Other infectious diseases

241

1137

2.21

27.45

2.5

2.3

10.22

10.35

g/l

0.16

223

1016

Hypocalcemia

101

313

3.51

27.31

5.1

2.6

9.53

10.30

g/l

0.94

289

Metatarsalgia

244

1155

2.17

27.27

2.3

9.65

10.29

g/l

1.81

221

1038

Adalimumab

219

992

2.27

27.27

1.4

2.4

10.94

10.18

g/l

1.72

208

916

Migraine

947

5023

1.48

27.26

2.0

2.4

9.86

10.15

g/l

1.53

862

4549

Other viral diseases

570

3493

1.65

27.26

3.7

2.1

9.84

10.21

g/l

1.09

543

3176

Stomatitis and related lesions

482

2848

1.73

27.15

2.5

2.3

9.99

10.19

g/l

0.45

434

2546

Charcot foot

195

4.25

27.14

2.5

3.0

10.08

10.88

g/l

0.72

174

Budesonide

314

1632

1.97

26.97

2.0

2.4

10.48

10.02

g/l

0.88

281

1455

Other encephalitis

100

309

3.46

26.95

1.9

2.8

10.62

10.35

g/l

0.15

284

Special screening examination for other diseases and disorders

273

1350

2.07

26.94

2.6

2.3

9.49

10.21

g/l

2.45

254

1225

Systemic atrophies primarily affecting the central nervous system

157

624

2.67

26.81

1.4

2.7

9.89

10.63

g/l

1.23

144

558

Systemic sclerosis (FG)

242

3.81

26.79

2.0

2.9

10.30

10.37

g/l

0.04

214

Viral pneumonia (known virus, not influenza)

112

373

3.22

26.75

6.2

2.7

9.50

10.60

g/l

1.15

100

330

Pyogenic arthritis

192

834

2.39

26.63

3.1

2.5

10.44

g/l

0.01

176

738

Extrapyramidal and movement disorders

1047

7380

1.44

26.62

2.1

2.4

9.82

10.20

g/l

2.22

915

6508

Disorders of sclera, cornea, iris and ciliary body

1285

9369

1.39

26.54

2.3

10.33

10.11

g/l

0.97

1162

8344

Other specified and unspecified disorders of eye and adnexa

132

483

2.89

26.46

2.3

2.4

10.62

10.43

g/l

0.15

123

436

Mycoses

690

4483

1.57

26.37

3.0

2.4

9.87

10.16

g/l

0.88

620

3990

Decubitus ulcer and pressure area

218

1008

2.26

26.25

1.8

2.3

10.62

10.39

g/l

0.26

189

883

Substance use, excluding alcohol

420

2409

1.78

26.24

1.6

2.4

10.00

10.14

g/l

0.24

352

2223

Heart failure and hypertrophic cardiomyopathy

263

3.74

26.13

3.0

2.7

10.28

10.70

g/l

0.34

233

Cerebral palsy and other paralytic syndromes

295

1522

1.99

26.11

2.2

2.3

10.03

10.27

g/l

0.39

266

1369

Injuries to the ankle and foot

1509

9618

1.35

26.02

2.1

2.3

9.91

10.13

g/l

1.23

1356

8681

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

787

5278

1.51

25.86

2.4

2.2

9.74

10.13

g/l

1.87

710

4694

Disorders of skin appendages

1037

7280

1.43

25.84

2.2

2.3

10.27

10.09

g/l

0.62

944

6540

COPD, early/later onset

1284

7872

1.39

25.84

1.8

2.4

9.99

10.27

g/l

1.33

1137

6929

Memory loss

305

1605

1.98

25.81

2.1

2.4

10.20

10.35

g/l

0.26

264

1424

Other pleural conditions

336

1822

1.91

25.81

3.0

2.4

10.31

10.27

g/l

0.07

302

1581

Encephalitis

103

333

3.29

25.76

1.9

2.7

10.51

10.32

g/l

0.11

306

Localized swelling, mass and lump of skin and subcutaneous tissue

763

5089

1.52

25.76

2.2

2.3

9.96

10.20

g/l

0.70

682

4512

Mental and behavioural disorders due to psychoactive substance use

1353

9136

1.37

25.66

1.7

2.4

10.17

10.23

g/l

0.19

1175

8245

Caries of enamel

2131

10875

1.29

25.63

2.6

2.3

10.07

10.10

g/l

0.13

1910

9772

COPD related to multimorbidity

1150

6986

1.41

25.62

1.8

2.4

9.84

10.30

g/l

2.92

1012

6134

Chronic pancreatitis

352

1941

1.87

25.49

1.8

2.4

9.97

10.11

g/l

0.26

318

1740

Neuromuscular dysfunction of bladder

262

1312

2.07

25.38

2.1

2.6

10.09

10.32

g/l

0.35

237

1165

Degeneration of macula and posterior pole

1405

8042

1.37

25.35

2.3

2.4

10.19

10.16

g/l

0.09

1190

7032

Presence of other functional implants

1554

7981

1.35

25.34

2.3

10.24

g/l

0.00

1340

7074

Myeloid leukaemia

110

375

3.16

25.32

1.8

2.7

9.58

10.99

g/l

2.43

105

338

Disorders of synovium and tendon

1136

6909

1.41

25.25

2.0

2.4

9.72

10.35

g/l

6.28

1006

6148

Other enthesopathies

645

4163

1.57

25.24

1.9

2.4

9.58

10.35

g/l

6.21

574

3722

Substance abuse

1315

8994

1.37

25.22

1.7

2.4

10.17

10.24

g/l

0.26

1141

8124

Disorders of adult personality and behaviour

504

3066

1.67

25.21

1.7

2.2

9.94

10.20

g/l

0.74

464

2830

Disorders of the thyroid gland

2175

11058

1.29

25.17

2.2

2.4

10.00

10.21

g/l

1.44

1937

9849

Panic disorder

260

1295

2.04

25.14

1.7

2.3

9.52

10.43

g/l

2.96

233

1190

Other enthesopathy of foot (+metatarsalgia)

253

1253

2.07

25.09

2.2

9.66

10.30

g/l

1.84

228

1127

Elevated blood glucose level

230

1103

2.16

25.02

2.0

2.2

9.57

10.12

g/l

1.46

201

993

Other complications of surgical and medical care, not elsewhere classified

260

1307

2.05

24.84

2.5

2.3

10.07

10.22

g/l

0.21

234

1170

Vascular disorders of the intestines

224

1070

2.18

24.75

2.4

2.2

9.95

10.37

g/l

0.79

204

921

Conjunctivitis (acute, non atopic), including avohilmo

2301

10972

1.28

24.74

2.3

10.20

10.13

g/l

0.31

2074

9776

Fracture of lower leg, including ankle

1288

9320

1.37

24.74

2.0

2.3

9.92

10.18

g/l

1.57

1129

8300

Mixed and other personality disorders

167

703

2.44

24.72

1.7

2.1

9.77

10.36

g/l

1.02

159

654

Enthesopathies of lower limb, excluding foot

502

3081

1.66

24.40

2.4

2.2

9.72

10.32

g/l

2.81

448

2749

Other or unspecified ileus, impaction or obstruction

485

2957

1.67

24.31

2.9

2.2

10.00

10.26

g/l

0.59

435

2591

COPD, hospital admissions

1260

7817

1.38

24.14

1.8

2.4

9.98

10.27

g/l

1.39

1116

6882

Essential (haemorrhagic) thrombocythaemia

131

502

2.76

24.09

2.4

1.4

10.78

10.40

g/l

0.47

113

436

Diseases of salivary glands

756

5107

1.50

24.02

2.3

9.97

10.11

g/l

0.35

664

4555

Generalized anxiety disorder

271

1391

1.97

23.93

1.8

2.3

9.83

10.39

g/l

1.45

245

1273

Open wound of ankle and foot

262

1340

2.01

23.81

2.2

2.4

10.14

10.29

g/l

0.21

235

1220

Other and unspecified acquired haemolytic anaemias

123

5.10

23.80

2.8

1.7

9.89

10.35

g/l

0.25

112

Nonorganic sleeping disorders

444

2662

1.70

23.64

1.7

2.2

9.85

10.23

g/l

1.27

402

2420

Fracture of forearm

1277

8493

1.36

23.58

2.1

2.3

9.82

10.09

g/l

1.52

1095

7525

Other respiratory disorders and diseases

582

3744

1.59

23.50

2.0

2.3

10.13

10.22

g/l

0.13

509

3273

Other diseases of the respiratory system

582

3744

1.59

23.50

2.0

2.3

10.13

10.22

g/l

0.13

509

3273

5-aminosalicylic acid

401

2344

1.74

23.41

1.9

2.4

10.29

10.10

g/l

0.34

367

2104

Oter anti-inflammatory and antirheumatic agents, non-steroids

568

1944

1.63

23.41

2.4

2.3

10.03

10.65

g/l

2.44

498

1723

Other hammer toe(s) (acquired)

439

2389

1.71

23.40

2.0

2.6

9.76

10.28

g/l

1.82

365

2065

Respiratory insufficiency

229

1121

2.10

23.39

1.7

9.58

10.15

g/l

1.20

198

966

Atopic dermatitis, strict definition with reimbursement

487

2870

1.65

23.38

1.9

2.1

10.13

10.16

g/l

0.05

440

2624

Pneumonia due to other infectious organisms, not elsewhere classified

111

396

2.96

23.35

5.9

1.8

9.48

10.39

g/l

0.66

106

353

Other embolism and thrombosis

346

1950

1.82

23.29

2.9

2.2

10.13

10.18

g/l

0.06

320

1716

Nonischemic cardiomyopathy

290

1550

1.93

23.20

2.3

10.20

10.27

g/l

0.09

265

1360

Other skin changes

534

3384

1.61

23.00

3.3

2.3

9.77

10.29

g/l

1.64

464

2983

Idiopathic urticaria

205

3.78

22.78

1.3

2.0

10.33

10.41

g/l

0.05

193

Eosinophilia

191

3.94

22.25

2.5

2.3

10.08

10.47

g/l

0.30

175

Recurrent aphthous stomatitis , including avohilmo

357

2056

1.78

22.25

2.4

2.3

10.04

10.19

g/l

0.24

321

1831

Amputation of foot

107

387

2.97

22.21

2.6

2.7

10.27

11.09

g/l

1.08

344

Personality disorders

475

2944

1.63

22.15

1.7

2.1

9.93

10.20

g/l

0.74

436

2712

Migraine with aura and triptan purchases

266

1397

1.93

22.13

1.5

2.0

9.52

10.27

g/l

2.70

249

1265

Other/unspecified reactive arthropathies

174

786

2.30

22.11

2.5

10.39

10.30

g/l

0.10

156

719

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1263

8586

1.35

22.09

2.0

2.3

10.14

10.11

g/l

0.12

1145

7738

Personal history of malignant neoplasm

228

1143

2.06

22.06

2.4

2.0

9.24

10.15

g/l

3.13

207

1020

Thyroiditis, ILD-related definition

252

1305

1.98

22.05

2.3

2.4

10.15

10.05

g/l

0.14

223

1162

Other disorders of eyelid

1188

8319

1.37

21.98

2.1

2.4

9.89

10.22

g/l

2.14

1047

7304

Mixed connective tissue disease

197

3.84

21.96

2.0

2.5

13.04

10.82

g/l

1.66

179

Cramp and spasm

135

548

2.57

21.92

2.8

2.4

9.74

10.49

g/l

1.31

123

503

Inflammatory bowel disease

664

4453

1.51

21.86

2.1

2.3

10.31

10.18

g/l

0.30

603

4018

Persistent mood disorders

428

2598

1.68

21.84

2.1

2.3

9.53

10.24

g/l

3.09

391

2322

Protozoal diseases

111

413

2.87

21.77

6.3

2.6

9.21

10.68

g/l

1.49

104

373

Diagnoses used for exclusion with ILD

659

4428

1.51

21.68

2.3

10.29

10.23

g/l

0.12

586

3915

Oxicams

558

2006

1.60

21.67

2.4

2.3

10.07

10.64

g/l

2.20

490

1785

Hydronephrosis

288

1570

1.88

21.62

2.0

2.1

10.32

10.21

g/l

0.18

260

1382

Vitamin B12 deficiency anaemia

298

1645

1.86

21.59

2.2

2.4

10.42

10.33

g/l

0.12

264

1450

Primary biliary cholangitis, wide definition

263

3.37

21.58

1.4

2.4

13.14

10.16

g/l

4.55

237

Fracture of foot, except ankle

519

3312

1.59

21.51

2.4

2.2

9.90

10.18

g/l

0.82

466

3003

Psoriatic arthropathies

230

1166

2.02

21.44

1.8

2.5

10.62

10.29

g/l

0.43

206

1053

Transient ischemic attack

1406

8523

1.33

21.40

2.2

2.4

9.90

10.22

g/l

2.24

1221

7510

Ascites

225

1137

2.05

21.40

1.5

2.5

12.23

10.32

g/l

5.02

205

1011

Benign neoplasm of other and unspecified endocrine glands

349

2024

1.77

21.35

2.4

2.3

9.70

10.23

g/l

1.53

309

1823

Cardiodefibrillation

998

7239

1.40

21.34

2.3

2.4

10.41

10.21

g/l

0.77

907

6352

Bullous disorders

190

906

2.19

21.29

2.0

2.5

9.74

10.47

g/l

1.85

177

808

Carcinoma in situ of skin of other and unspecified parts of face

307

1725

1.85

21.28

2.2

2.4

9.42

10.41

g/l

4.30

273

1491

Benign neoplasm: Transverse colon

332

1905

1.80

21.27

2.8

2.4

10.11

10.19

g/l

0.12

288

1688

Hallux valgus (acquired)

710

3436

1.50

21.23

2.1

2.5

10.04

10.16

g/l

0.28

609

3021

Unspecified acute lower respiratory infection

370

2181

1.73

21.19

3.2

2.2

9.83

10.33

g/l

1.24

338

1956

Abnormality of white blood cells, not elsewhere classified

5.27

21.02

2.2

1.9

9.59

10.46

g/l

0.89

Amiodarone users

312

1766

1.83

21.00

2.1

2.4

9.74

10.22

g/l

1.40

289

1562

Diseases of external ear

858

6094

1.43

20.97

2.2

2.3

9.91

10.22

g/l

1.26

700

5436

Diabetic retinopathy

951

4223

1.42

20.93

1.8

2.1

10.06

10.07

g/l

0.01

844

3775

Paracetamol or NSAID medication

292

774

1.92

20.92

2.5

1.8

10.90

10.97

g/l

0.07

265

712

Migraine without aura and triptan purchases

261

1388

1.91

20.91

1.5

2.0

9.79

10.25

g/l

1.19

244

1268

Malignant neoplasm of urinary organs, including Hilmo

322

1839

1.80

20.84

2.0

1.4

10.70

10.22

g/l

0.90

291

1594

Herpesviral [herpes simplex] infections, including avohilmo

516

3313

1.58

20.82

2.8

2.2

10.23

10.17

g/l

0.10

470

2973

Faecal incontinence

265

1428

1.91

20.78

1.7

2.5

9.80

10.21

g/l

0.86

238

1237

Protozoal diseases, including avohilmo

112

429

2.78

20.75

6.2

2.8

9.22

10.60

g/l

1.37

105

388

Diabetic maculopathy, excluding more controls

271

1469

1.89

20.75

1.5

2.4

10.28

10.42

g/l

0.16

248

1312

Carpal tunnel syndrome

1418

9408

1.32

20.74

2.3

9.73

10.16

g/l

3.79

1288

8351

Scoliosis

188

897

2.15

20.68

2.2

9.49

10.32

g/l

2.23

163

790

Dilated cardiomyopathy

341

1988

1.77

20.62

1.8

2.4

10.15

10.25

g/l

0.16

311

1777

Crystal arthropathies, rheuma endpoint

256

3.37

20.59

1.7

3.1

9.78

11.04

g/l

1.62

223

Pneumonia derived septicemia

112

431

2.74

20.43

6.0

2.5

12.57

10.62

g/l

1.21

386

Sarcoidosis

333

1932

1.77

20.35

1.9

2.3

10.28

10.25

g/l

0.04

308

1743

KRA_PSY_EATING, excluding more controls

103

372

2.78

20.33

1.8

9.21

10.57

g/l

3.19

348

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

378

2267

1.70

20.33

2.6

2.3

10.14

10.20

g/l

0.12

355

2038

Retinal detachments and breaks

936

6792

1.40

20.27

2.6

2.4

10.41

10.15

g/l

1.02

829

6011

Fall on and from stairs and steps

634

4285

1.50

20.26

2.3

9.98

10.15

g/l

0.47

549

3809

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

456

2825

1.61

20.16

2.0

2.3

9.58

10.21

g/l

2.72

407

2608

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

283

1572

1.85

20.16

1.8

1.4

10.57

10.18

g/l

0.63

255

1366

Suppurative and necrotic conditions of lower respiratory tract

175

828

2.20

20.00

2.8

2.5

10.22

10.62

g/l

0.47

163

741

Congenital malformations, deformations and chromosomal abnormalities

1104

7779

1.36

19.99

2.0

2.3

10.07

10.11

g/l

0.11

1008

7012

Disorders of vitreous body and globe

1322

9557

1.32

19.96

2.4

9.98

10.11

g/l

0.50

1173

8456

Congenital malformations of the urinary system, including avohilmo

151

672

2.32

19.90

2.1

2.6

9.72

10.53

g/l

1.77

143

615

Other viral hepatitis

132

553

2.46

19.88

2.1

2.0

12.86

10.31

g/l

4.68

121

517

Coxarthrosis, primary

1601

10403

1.29

19.86

2.2

2.4

9.96

10.20

g/l

1.40

1397

9143

Agoraphobia

189

3.61

19.82

1.8

10.23

10.55

g/l

0.22

179

Restless leg syndrome

365

2187

1.71

19.81

2.0

2.3

9.73

10.16

g/l

1.12

320

1952

Other viral hepatitis, including avohilmo

136

581

2.41

19.60

2.1

12.76

10.33

g/l

4.47

124

545

Radiculopathy

406

2505

1.65

19.59

2.6

2.2

9.76

10.38

g/l

1.95

364

2199

Other and unspecified myopathies

261

1429

1.89

19.56

1.9

2.4

9.92

10.35

g/l

0.78

212

1262

Other local infections of skin and subcutaneous tissue

263

1441

1.87

19.51

3.1

2.4

10.09

10.30

g/l

0.30

231

1289

Congenital malformations of the urinary system

142

621

2.37

19.51

2.1

2.6

9.60

10.50

g/l

2.03

135

569

Benign neoplasm: Sigmoid colon

532

3503

1.55

19.51

2.6

2.3

10.19

10.16

g/l

0.05

472

3096

Injury of unspecified body region

210

1070

2.03

19.50

1.8

2.5

9.93

10.42

g/l

0.89

183

956

Cyst of kidney

225

1178

1.99

19.47

2.5

10.24

10.33

g/l

0.11

207

1054

Other and unspecified drugs and medicaments

225

1177

1.97

19.34

3.4

2.4

10.13

10.36

g/l

0.26

207

1054

Other and unspecified local infections of skin and subcutaneous tissue

250

1353

1.90

19.31

3.2

2.4

10.07

10.30

g/l

0.33

223

1214

Psoriasis vulgaris

439

2771

1.61

19.27

1.9

2.3

10.64

10.14

g/l

1.38

394

2508

COPD, hospital admission 2, with asthma infections

898

5605

1.40

19.21

1.9

2.4

9.95

10.33

g/l

1.51

793

4927

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

266

1472

1.86

19.20

3.1

2.5

10.48

10.32

g/l

0.20

247

1324

Cervical disc disorders

807

5759

1.42

19.20

2.4

2.2

9.70

10.34

g/l

4.32

712

5128

Problems related to lifestyle

215

1107

1.98

19.16

1.6

2.4

9.82

10.15

g/l

0.46

197

995

Conjunctivitis (acute, non atopic)

573

3816

1.51

19.16

2.8

2.1

10.31

10.14

g/l

0.37

515

3423

Oesophageal varices

132

568

2.44

19.04

1.6

2.4

13.95

10.38

g/l

7.00

119

510

Other and unspecified urticaria

397

2450

1.65

19.03

2.3

2.2

9.98

10.25

g/l

0.55

349

2210

Other diseases of pancreas

245

1327

1.91

19.02

2.4

2.5

9.84

10.18

g/l

0.76

220

1190

Viral hepatitis, including avohilmo

159

735

2.22

19.02

2.0

2.1

12.69

10.20

g/l

5.41

143

680

Thoracic aortic aneurysm

404

2514

1.65

19.02

2.4

2.5

10.35

10.21

g/l

0.29

354

2258

Delirium, not induced by alcohol and other psychoactive substances

386

2370

1.67

19.00

2.1

2.3

10.25

10.30

g/l

0.08

332

2065

Misadventures to patients during surgical and medical care

366

2220

1.69

18.96

2.0

2.2

9.72

10.16

g/l

1.16

325

1964

Use of pramipexole

577

3885

1.51

18.96

1.9

2.3

9.91

10.16

g/l

0.76

490

3412

Benign neoplasm: Stomach

282

1597

1.82

18.95

2.5

2.4

9.78

10.21

g/l

0.96

248

1419

Pneumococcal septicemia

106

413

2.70

18.90

5.9

2.5

12.54

10.43

g/l

1.31

372

Disorders of vitreous body

1283

9366

1.32

18.89

2.4

9.98

10.11

g/l

0.52

1138

8293

COPD, hospital admissions 3, with asthma pneumonia sepsis

784

4777

1.43

18.86

1.9

2.4

9.94

10.35

g/l

1.58

694

4173

Chronic tubulo-interstitial nephritis

110

436

2.64

18.85

2.2

2.1

9.89

10.31

g/l

0.40

390

Systemic sclerosis

302

3.03

18.81

2.0

2.2

10.30

10.31

g/l

0.01

273

Other and unspecified visual disturbances

273

1531

1.83

18.81

2.5

2.4

10.17

g/l

0.01

253

1374

Collagenous colitis

247

1345

1.89

18.78

2.8

2.4

10.36

10.24

g/l

0.14

219

1200

Viral hepatitis

154

708

2.24

18.70

1.9

2.2

12.82

10.19

g/l

5.65

138

654

Alcoholic liver disease

273

1537

1.83

18.64

1.4

2.5

12.55

10.08

g/l

9.53

225

1403

Bronchiectasis

244

1331

1.90

18.60

2.8

2.5

10.40

10.27

g/l

0.17

219

1157

Persons with potential health hazards related to communicable diseases

598

4018

1.49

18.57

2.3

2.1

10.04

10.19

g/l

0.38

566

3685

Fissure and fistula of anal and rectal regions

513

3379

1.54

18.54

2.3

9.85

10.21

g/l

1.11

452

3019

Gonarthrosis,primary

2224

10925

1.24

18.44

2.0

2.4

10.03

10.19

g/l

1.00

1957

9698

Emotionally unstable personality disorder

188

936

2.04

18.36

1.7

1.9

9.59

10.42

g/l

2.06

174

874

Biomechanical lesions, not elsewhere classified

155

724

2.23

18.35

2.4

2.6

9.84

10.40

g/l

1.11

145

649

Ulcerative colitis

513

3387

1.54

18.35

2.3

10.46

10.18

g/l

0.64

465

3063

Pyothorax

137

610

2.35

18.27

3.2

2.6

10.39

10.71

g/l

0.30

126

547

Vitreous haemorrhage

275

1563

1.81

18.19

2.1

2.4

10.37

10.23

g/l

0.18

250

1400

Vasomotor and allergic rhinitis

691

4732

1.44

18.05

2.2

9.87

10.19

g/l

1.32

612

4261

Demyelinating diseases of the central nervous system

172

837

2.10

18.03

1.7

2.2

9.98

10.44

g/l

0.57

159

768

Other disorders of ear

2141

11262

1.24

18.02

2.2

2.3

9.98

10.20

g/l

1.45

1859

10100

Sequelae of injuries of lower limb

219

1162

1.93

18.00

2.3

2.5

9.55

10.38

g/l

2.34

202

1057

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

416

2636

1.61

17.98

2.7

2.3

10.08

10.19

g/l

0.23

393

2359

Other viral diseases, not elsewhere classified, including avohilmo

488

3180

1.54

17.92

3.2

2.2

9.73

10.23

g/l

1.75

462

2883

Other disorders of glucose regulation and pancreatic internal secretion

208

1087

1.97

17.92

2.1

2.4

9.98

10.46

g/l

0.91

182

975

Primary biliary cholangitis (PBC)

256

3.16

17.89

1.7

2.0

13.33

10.11

g/l

4.24

230

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

350

2064

1.67

17.86

1.8

2.4

10.07

10.22

g/l

0.29

323

1866

Intestinal malabsorption

132

583

2.36

17.86

1.9

2.6

9.97

10.43

g/l

0.57

123

523

Other viral diseases, not elsewhere classified

364

2227

1.65

17.84

3.4

2.2

9.72

10.30

g/l

1.49

346

2012

Other crystal arthropathies

279

3.08

17.83

1.7

2.3

9.78

10.88

g/l

1.36

242

Intestinal stricture

803

5808

1.40

17.82

2.8

2.3

10.03

10.20

g/l

0.51

713

5099

Carcinoma in situ of skin of scalp and neck

119

508

2.51

17.80

2.0

2.7

10.05

10.93

g/l

1.24

105

449

Guillain-Barre syndrome

186

3.59

17.73

2.7

2.1

10.11

10.84

g/l

0.46

170

Spondylolisthesis/Spondylolysis

412

2615

1.60

17.68

2.7

2.3

9.81

10.35

g/l

1.91

366

2318

Ankylosing spondylitis

194

994

2.00

17.66

1.7

2.2

10.88

10.40

g/l

0.71

185

900

Acute pancreatitis

481

3164

1.55

17.65

2.0

2.3

10.63

10.15

g/l

1.39

431

2816

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

323

1872

1.70

17.51

1.9

2.4

10.01

10.23

g/l

0.42

299

1698

Poisoning by medicine

388

2431

1.62

17.47

2.1

2.2

9.86

10.21

g/l

0.88

350

2234

Chronic viral hepatitis

105

421

2.57

17.44

1.6

1.9

13.35

10.22

g/l

5.06

400

Disease of hard tissues of teeth, NOS

1246

4975

1.32

17.40

2.1

9.98

10.21

g/l

1.07

1086

4434

Fracture of skull and facial bones

475

3124

1.54

17.36

2.8

2.3

10.26

10.19

g/l

0.12

415

2828

Poisoning by drugs, medicaments and biological substances

426

2736

1.58

17.25

2.0

2.2

9.87

10.22

g/l

0.95

382

2506

Mucosal proctocolitis

256

1444

1.81

17.20

2.3

2.4

10.77

10.27

g/l

0.88

244

1325

Neuralgia and neuritis, unspecified

133

599

2.30

17.12

2.5

2.3

9.26

10.42

g/l

2.24

116

541

Cutaneous lupus erythematosus

308

2.90

17.00

2.2

2.1

10.88

10.58

g/l

0.23

276

Other disorders of the musculoskeletal system and connective tissue

384

2428

1.62

16.92

2.5

2.3

10.06

10.15

g/l

0.17

356

2164

Candidiasis

331

2016

1.67

16.89

3.2

2.2

9.73

10.21

g/l

1.01

291

1802

Intestinal adhesions without obstruction

225

1232

1.88

16.85

4.1

2.3

9.83

10.23

g/l

0.78

198

1086

Mental and behavioural disorders due to alcohol

1116

8130

1.32

16.79

1.7

2.4

10.25

10.26

g/l

0.02

981

7364

Transport accidents

869

5316

1.37

16.76

1.9

2.3

10.21

10.27

g/l

0.12

782

4870

Atopic dermatitis, strict definition

452

2890

1.54

16.75

1.9

2.1

10.05

10.19

g/l

0.31

415

2665

1170

8112

1.31

16.74

2.9

2.3

9.93

10.25

g/l

1.53

1009

7051

Herpesviral [herpes simplex] infections

269

1554

1.77

16.73

3.2

2.3

10.20

10.25

g/l

0.05

252

1395

Autoimmune hepatitis, wide definition

116

498

2.41

16.72

1.7

2.6

12.80

10.22

g/l

3.53

105

439

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1117

8244

1.32

16.72

2.4

2.3

9.99

10.22

g/l

0.92

1001

7388

Insulin, fast-acting (human)

273

1583

1.75

16.65

1.7

2.1

10.18

10.39

g/l

0.36

252

1446

Exclusions for E4_PCOS_BROAD

354

2198

1.64

16.60

3.1

2.3

9.31

10.29

g/l

4.01

323

1992

Inflammatory diseases of the central nervous system

202

1074

1.93

16.57

2.6

10.06

10.28

g/l

0.22

178

971

Cystic kidney disease

363

2.69

16.56

2.1

2.5

9.51

10.90

g/l

2.63

329

Traumatic subdural haemorrhage

364

2132

1.63

16.49

2.3

10.20

10.51

g/l

0.59

305

1885

Thyrotoxicosis

560

3855

1.47

16.40

2.0

2.3

9.82

10.13

g/l

1.07

501

3407

Lung cancer and mesothelioma

470

2640

1.54

16.34

2.1

2.0

10.57

10.11

g/l

1.16

419

2292

Ptosis of eyelid

313

1903

1.69

16.27

2.6

2.4

10.10

10.23

g/l

0.23

289

1676

Invasive ventilation

201

1077

1.93

16.21

2.4

2.5

9.91

10.37

g/l

0.80

185

967

Hernia of abdominal wall

1079

8276

1.32

16.16

2.4

2.3

10.17

g/l

0.01

973

7372

Spirochaetal infections, other/unspecified

235

1323

1.83

16.13

2.5

9.86

10.26

g/l

0.76

193

1189

Fenamates

334

1382

1.67

16.06

2.1

2.2

9.68

10.69

g/l

4.33

299

1222

Diseases of inner ear

1323

9963

1.28

16.04

2.0

2.4

9.97

10.15

g/l

0.87

1152

8791

Other/unspecified enthesopathies of lower limb, excluding foot

162

807

2.06

16.03

2.1

9.68

10.37

g/l

1.53

149

728

Folate deficiency anaemia

145

3.88

16.00

2.4

1.9

10.61

10.85

g/l

0.13

128

Other and unspecified mood [affective] disorders

120

531

2.30

15.96

1.7

2.2

9.51

10.39

g/l

1.48

111

489

Fibroblastic disorders

542

3731

1.47

15.90

2.5

2.4

10.25

10.45

g/l

0.43

481

3289

Benign neoplasm: Rectum, anus and anal canal

540

3722

1.48

15.89

2.2

2.3

10.29

10.16

g/l

0.26

482

3285

Drug-induced polyneuropathy

109

4.40

15.88

16.0

1.4

8.73

10.43

g/l

1.83

101

Thyrotoxicosis, other and/or unspecified

435

2867

1.54

15.82

2.1

2.3

9.78

10.16

g/l

1.19

394

2551

Iridocyclitis

508

3458

1.49

15.80

2.4

2.3

10.35

10.14

g/l

0.47

462

3077

Benign neoplasm: Ascending colon

400

2599

1.58

15.78

2.2

2.4

10.18

g/l

0.00

347

2291

Alcohol-induced chronic pancreatitis

164

828

2.05

15.77

1.8

2.5

10.13

10.61

g/l

0.65

143

761

Aortic aneurysm

621

4309

1.44

15.72

2.3

2.4

10.38

10.40

g/l

0.04

545

3806

Other diseases of stomach and duodenum

181

947

1.97

15.71

2.3

2.6

9.74

10.43

g/l

1.11

165

843

Hypothyroidism, other/unspecified

1930

10373

1.23

15.69

2.2

2.3

10.01

10.20

g/l

1.11

1717

9224

Disorders of vestibular function (Vertigo)

1154

8732

1.30

15.63

2.1

2.3

9.97

10.16

g/l

0.83

1001

7679

Cystic kidney disease, including avohilmo

392

2.56

15.57

2.1

2.5

9.61

10.84

g/l

2.28

355

Cardiac arrest

151

622

2.11

15.56

2.2

9.96

10.59

g/l

0.88

134

534

Alcohol induced polyneuropathy

124

4.08

15.56

1.3

2.0

10.13

11.08

g/l

0.64

110

Macular pucker

455

3050

1.53

15.53

2.0

2.5

9.78

10.12

g/l

1.18

389

2680

Other inflammatory liver diseases

169

867

2.01

15.51

1.8

2.7

12.28

10.10

g/l

4.20

148

780

Hyperplasia of prostate

887

3701

1.37

15.51

2.5

2.6

10.00

10.49

g/l

2.61

800

3365

Acute posthaemorrhagic anaemia

102

429

2.48

15.51

2.9

2.7

10.26

10.60

g/l

0.19

376

Abnormal results of function studies

210

1155

1.86

15.50

2.3

2.6

9.77

10.23

g/l

0.91

191

1052

Mental and behavioural disorders due to alcohol, excluding acute intoxication

973

7332

1.33

15.48

1.7

2.4

10.29

10.24

g/l

0.13

851

6642

Heartburn

257

1501

1.75

15.39

2.0

2.4

10.03

10.30

g/l

0.37

221

1333

Skin changes due to chronic exposure to nonionizing radiation

1116

7833

1.31

15.36

2.9

2.3

9.90

10.26

g/l

1.76

963

6796

Actinic keratosis

1096

7714

1.31

15.35

2.9

2.3

9.91

10.26

g/l

1.66

944

6690

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

117

522

2.29

15.30

1.6

1.9

10.90

10.19

g/l

0.76

102

493

Exposure to other and unspecified inanimate mechanical forces

171

884

1.98

15.26

2.7

2.4

10.10

10.33

g/l

0.30

166

807

Early onset COPD

530

3667

1.47

15.24

2.1

2.5

9.64

10.24

g/l

2.44

484

3285

Diplopia

325

2026

1.64

15.23

2.1

2.3

9.60

10.24

g/l

2.15

292

1815

Primary gonarthrosis, bilateral

1338

8874

1.27

15.22

1.9

2.5

10.02

10.19

g/l

0.77

1167

7814

Systemic sclerosis, icd10

333

2.71

15.19

2.0

2.1

10.33

10.38

g/l

0.02

304

Mixed hyperlipidaemia

114

509

2.33

15.13

1.6

2.2

9.36

10.61

g/l

3.26

102

457

Pemphigoid

103

443

2.47

15.11

1.5

2.5

9.49

10.80

g/l

2.82

391

Myocarditis

377

2.53

15.11

2.6

2.2

9.64

10.05

g/l

0.42

332

Other shoulder lesions

200

1091

1.87

15.10

1.5

2.2

9.48

10.35

g/l

2.40

180

986

Ocular pain

191

1029

1.90

15.05

1.6

2.6

9.57

10.30

g/l

1.47

178

922

Unspecified nephritic syndrome

271

2.89

15.05

2.1

2.5

9.68

10.51

g/l

0.86

246

Sequelae of injuries, of poisoning and of other consequences of external causes

504

3459

1.48

15.04

2.6

2.3

9.65

10.22

g/l

2.63

446

3134

Cervicobrachial syndrome

441

2947

1.52

14.99

2.1

2.2

9.91

10.30

g/l

1.03

405

2616

COPD-related respiratory insufficiency

340

2155

1.62

14.98

2.0

2.5

9.64

10.36

g/l

2.70

298

1875

Adhesive capsulitis of shoulder

373

2408

1.58

14.98

2.0

2.4

9.66

10.31

g/l

2.86

334

2137

Allergic rhinitis

494

3330

1.48

14.95

2.2

2.1

9.70

10.15

g/l

1.89

441

3038

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

356

2255

1.60

14.93

2.4

1.4

9.63

10.19

g/l

1.88

311

1922

Barrett oesophagus

146

724

2.09

14.86

2.3

2.8

10.48

10.30

g/l

0.20

125

654

Other and unspecified injuries of head

192

1042

1.89

14.85

1.7

2.4

10.24

10.45

g/l

0.24

162

924

Malignant neoplasm of kidney, except renal pelvis

239

1387

1.77

14.81

1.8

1.4

10.75

10.16

g/l

0.97

216

1207

Open wound of forearm

225

1282

1.79

14.77

2.1

2.4

9.95

10.43

g/l

0.97

197

1159

Striking against or struck by other objects

650

4679

1.40

14.65

2.0

2.3

10.22

10.20

g/l

0.04

565

4258

Juvenile arthritis (FINNGEN)

261

2.82

14.61

2.0

2.1

11.23

10.58

g/l

0.46

243

Mental and behavioural disorders due to sedatives or hypnotics

139

678

2.10

14.61

1.4

2.2

9.86

10.30

g/l

0.61

119

623

Other lack of coordination

199

3.22

14.60

2.1

2.7

9.28

10.56

g/l

1.82

177

Social phobias

118

538

2.23

14.58

2.0

1.9

10.22

10.48

g/l

0.25

111

505

Benign neoplasm: Rectum

482

3311

1.48

14.52

2.2

2.4

10.23

10.12

g/l

0.21

430

2925

Haemorrhoids and perianal venous thrombosis

758

5573

1.36

14.49

2.4

2.3

10.23

10.27

g/l

0.08

660

4903

Fitting and adjustment of other devices

906

6056

1.33

14.46

2.2

10.01

10.26

g/l

0.67

751

5243

Hypothyreosis and Thyroxine purchase for inclusion criteria

2010

10899

1.21

14.45

2.1

2.3

10.00

10.18

g/l

1.06

1786

9686

Specific personality disorders

383

2504

1.55

14.40

1.7

2.2

9.91

10.19

g/l

0.68

350

2304

Malignant neoplasm of urinary organs

258

1541

1.72

14.39

1.7

1.4

10.90

10.16

g/l

1.36

235

1334

Viral and other specified intestinal infections, including avohilmo

445

2885

1.50

14.36

2.2

2.0

9.79

10.34

g/l

2.12

417

2605

Lesion of ulnar nerve

318

2001

1.62

14.32

2.1

2.2

9.89

10.33

g/l

0.98

293

1822

Autoimmune hepatitis

4.47

14.31

1.6

2.4

15.38

10.38

g/l

3.68

Other specified/unspecified bacterial intestinal infections

175

938

1.92

14.16

2.9

2.4

10.43

10.30

g/l

0.13

154

844

Epilepsy

657

4761

1.39

14.14

2.0

2.4

10.43

10.28

g/l

0.30

567

4245

Umbilical hernia

602

4321

1.41

14.07

2.0

2.3

10.16

10.31

g/l

0.39

552

3909

Hypoglycaemia, other or unspecified

162

847

1.96

14.07

1.7

2.3

10.00

10.58

g/l

0.95

143

761

Benign neoplasm: Adrenal gland

213

1217

1.80

14.03

2.2

2.6

9.62

10.33

g/l

1.75

189

1091

Allergic urticaria

168

889

1.93

14.00

1.9

2.4

10.26

10.33

g/l

0.07

151

803

Unstable angina pectoris

961

5798

1.32

13.95

2.4

9.86

10.27

g/l

2.17

868

5007

Acute nephritic syndrome

237

2.94

13.93

2.5

2.6

9.29

10.75

g/l

1.81

214

Other diseases of oesophagus

243

1443

1.72

13.84

2.2

2.5

10.16

10.32

g/l

0.21

220

1280

Internal derangement of knee

713

5216

1.37

13.78

2.1

2.5

9.86

10.23

g/l

1.75

614

4662

Acute gastritis

191

1061

1.85

13.77

1.8

2.5

10.40

10.33

g/l

0.08

164

943

Dementia in Alzheimer disease

257

3478

0.61

13.72

1.5

2.3

10.36

10.41

g/l

0.05

181

3007

Nonhereditary hypogammaglobulinemia

126

3.79

13.62

3.6

1.8

7.57

10.29

g/l

3.44

119

Nummular dermatitis

211

1212

1.79

13.58

2.4

2.6

9.98

10.27

g/l

0.47

189

1080

Speech disturbances, not elsewhere classified

242

1445

1.72

13.57

1.9

2.4

10.40

10.34

g/l

0.07

203

1282

Cholecystectomy

1637

11402

1.23

13.53

2.3

10.11

10.15

g/l

0.16

1461

10073

Acute pancreatitis (for exclusion)

481

3345

1.46

13.53

2.0

2.3

10.63

10.16

g/l

1.37

431

2984

Other symptoms and signs involving the circulatory and respiratory systems

151

781

1.98

13.51

2.2

2.3

10.61

10.30

g/l

0.26

131

687

Olecranon bursitis

157

825

1.96

13.49

2.5

2.3

10.07

10.34

g/l

0.28

139

744

Pollen allergy

257

1530

1.67

13.47

2.5

2.1

10.09

10.29

g/l

0.35

223

1426

Cluster headache, strict

323

2.56

13.24

1.8

2.9

9.20

10.47

g/l

2.34

295

Diseases of male genital organs

1056

4118

1.30

13.24

2.3

2.5

10.02

10.49

g/l

2.86

968

3760

Diseases of the ear and mastoid process

2410

10208

1.19

13.21

2.2

2.3

9.97

10.21

g/l

1.79

2134

9191

Benign thyroid growths and nodules

762

5322

1.35

13.19

2.2

2.4

9.69

10.09

g/l

1.95

673

4646

Other localized connective tissue disorders

239

2.88

13.16

2.7

2.0

10.28

10.23

g/l

0.02

216

Gingival hyperplasia

431

2.34

13.08

3.2

2.6

10.15

10.65

g/l

0.45

392

D07AA Corticosteroids, weak (group I)

272

1680

1.64

13.08

1.9

2.3

10.93

10.34

g/l

1.37

242

1524

Superficial injury of abdomen, lower back and pelvis

327

2115

1.57

13.06

2.1

2.3

9.84

10.27

g/l

1.07

287

1900

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

627

4520

1.38

13.04

2.1

2.2

9.76

10.16

g/l

1.88

563

4137

Other/unspecified rheumatoid arthritis

317

2044

1.59

13.00

1.8

2.3

10.36

10.19

g/l

0.27

282

1782

Arthropathic psoriasis

249

1513

1.68

12.99

1.8

2.5

10.47

10.24

g/l

0.30

223

1378

Other congenital malformations, including avohilmo

224

1320

1.72

12.99

2.0

2.5

10.32

10.24

g/l

0.12

206

1201

Dermatophytosis, including avohilmo

1404

11176

1.24

12.95

2.2

2.3

10.20

10.14

g/l

0.19

1235

10009

Hyperhidrosis

256

2.74

12.95

2.3

2.4

10.07

10.68

g/l

0.60

230

Cluster headache, wide

363

2.44

12.94

1.8

2.7

9.23

10.53

g/l

2.64

329

Ventral hernia

566

4084

1.41

12.92

2.7

2.3

10.10

10.21

g/l

0.26

505

3603

Ankylosing spondylitis, ICD10

184

1030

1.83

12.90

1.7

2.5

10.82

10.34

g/l

0.73

175

946

Drug-induced cataract

288

2.67

12.87

2.3

2.6

8.53

10.60

g/l

3.68

262

Alcohol use disorder, ICD-based

883

6808

1.31

12.82

1.7

2.4

10.34

10.22

g/l

0.31

779

6173

Dermatitis due to substances taken internally

126

624

2.08

12.82

4.2

2.8

10.48

10.23

g/l

0.18

114

562

Special screening examination for neoplasms

149

783

1.95

12.76

3.1

2.2

10.28

g/l

0.00

130

713

Keratitis

752

5676

1.34

12.74

2.2

2.3

10.26

10.14

g/l

0.33

673

5062

Microscopic polyangiitis

4.40

12.67

1.4

2.0

11.10

10.71

g/l

0.22

Other nonthrombocytopenic purpura

118

3.79

12.64

2.0

2.1

11.07

9.85

g/l

0.66

104

Benign neoplasm: Rectosigmoid junction

126

631

2.08

12.63

2.1

2.8

10.60

10.52

g/l

0.07

110

565

Tubulo-interstitial nephritis, not specified as acute or chronic

157

844

1.91

12.57

2.8

2.1

10.66

10.42

g/l

0.25

141

750

Speech and linguistic disorders, excluding more controls

112

498

2.14

12.49

2.3

9.81

10.55

g/l

1.06

100

448

Benign neoplasm of mouth and pharynx

262

1631

1.64

12.48

3.1

2.4

10.30

10.29

g/l

0.02

228

1463

Symptoms and signs involving emotional state

279

2.63

12.48

1.7

2.1

9.45

10.53

g/l

1.44

252

Familial hypercholesterolemia

362

2422

1.52

12.47

2.4

2.3

9.64

10.36

g/l

2.44

312

2088

Benign neoplasm: Caecum

300

1933

1.59

12.44

2.8

2.4

10.10

10.21

g/l

0.16

267

1713

Post-traumatic stress disorder

109

515

2.14

12.40

1.4

1.9

9.21

10.61

g/l

4.73

103

488

Hypermobility syndrome

376

2.36

12.36

2.3

1.9

9.85

10.10

g/l

0.27

357

Personal history of other diseases and conditions

169

928

1.84

12.30

4.3

2.0

9.66

10.19

g/l

0.74

146

845

Erosion of teeth , including avohilmo

477

3367

1.43

12.27

2.3

2.1

9.90

10.15

g/l

0.70

434

3069

Squamous cell neoplasms and carcinomas of the skin

281

1787

1.61

12.25

2.5

1.4

9.56

10.20

g/l

1.86

246

1513

Cardiomyopathy, Hypertrophic obstructive

209

2.93

12.20

1.6

2.8

9.75

10.92

g/l

1.21

186

Mental disorders, not otherwise specified

147

780

1.92

12.19

1.8

2.3

10.06

10.33

g/l

0.30

140

718

Suggestive for eosinophilic asthma

224

1349

1.70

12.19

2.3

2.4

10.15

10.33

g/l

0.25

210

1213

Artificial opening status

152

820

1.91

12.17

3.1

2.3

10.18

10.16

g/l

0.03

139

734

Fall involving bed

112

545

2.15

12.17

2.4

2.5

9.77

10.79

g/l

1.56

479

Sacroiliitis, not elsewhere classified

354

2.40

12.16

2.1

1.9

9.85

10.50

g/l

0.91

326

Emphysema

206

1216

1.74

12.13

2.7

2.5

10.62

10.28

g/l

0.40

189

1067

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

309

2.50

11.93

1.7

1.9

9.79

10.19

g/l

0.42

296

Lesion of lateral popliteal nerve

121

608

2.05

11.91

2.3

2.4

9.77

10.41

g/l

0.92

108

555

Other disorders of bladder

300

1952

1.57

11.85

2.2

2.5

9.94

10.28

g/l

0.71

259

1724

Other specified/unspecified soft tissue disorders

118

589

2.06

11.81

2.4

2.1

10.22

10.44

g/l

0.22

113

514

Crohn disease

243

1504

1.64

11.76

1.6

2.3

9.96

10.33

g/l

0.76

225

1365

Injuries to the neck

445

3129

1.44

11.76

2.7

2.2

9.89

10.23

g/l

1.04

396

2831

Colectomy operation

424

2963

1.46

11.76

2.6

2.3

10.22

10.21

g/l

0.02

384

2594

Inguinal hernia

1293

6959

1.24

11.75

2.7

2.2

9.97

10.33

g/l

2.52

1168

6204

Other specified/unspecified hearing loss

241

1494

1.65

11.75

2.3

9.79

10.31

g/l

1.26

226

1325

Bacterial, viral and other infectious agents, including avohilmo

178

1015

1.79

11.74

3.2

2.3

10.15

10.27

g/l

0.16

166

939

Exclusions for E4_PCOS_CONSORTIUM

1330

6737

1.24

11.67

2.2

9.79

10.13

g/l

2.13

1161

6005

Secondary thrombocytopenia

150

3.29

11.63

3.7

1.6

9.77

10.62

g/l

0.54

138

Calculus of kidney and ureter

703

5335

1.33

11.61

2.1

2.4

10.42

10.27

g/l

0.37

630

4771

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

268

1703

1.59

11.59

2.0

2.3

9.62

10.24

g/l

1.72

241

1580

Retinal vascular occlusion

326

2174

1.53

11.54

2.4

10.55

10.12

g/l

0.97

288

1886

Cervicocranial syndrome

225

1376

1.66

11.47

1.9

2.2

9.63

10.45

g/l

2.77

205

1213

Total colectomy

100

475

2.17

11.47

2.9

2.6

9.79

10.42

g/l

0.81

433

Total colectomy operation

100

475

2.17

11.47

2.9

2.6

9.79

10.42

g/l

0.81

433

Artificial joint re-operation

199

1187

1.73

11.38

1.7

2.5

10.29

10.30

g/l

0.02

176

1042

Mental and behavioural disorders due to opioids

256

2.60

11.34

1.9

11.92

10.29

g/l

1.27

243

Fentanyl

243

1518

1.63

11.31

5.7

1.8

9.73

10.16

g/l

0.60

203

1301

Other and unspecified glaucoma

208

1257

1.70

11.31

2.1

2.5

10.09

10.27

g/l

0.23

179

1091

Other or ill-defined heart diseases

116

585

2.03

11.24

2.2

2.3

10.08

10.26

g/l

0.15

517

Superficial injury of thorax

336

2264

1.51

11.20

1.6

2.3

10.08

10.24

g/l

0.25

289

2031

Acute peritonitis

163

922

1.82

11.20

2.4

2.5

9.97

10.44

g/l

0.61

157

827

Alcohol-induced acute pancreatitis

428

2.23

11.17

2.1

2.7

10.10

10.45

g/l

0.32

395

Viral and other specified intestinal infections

310

2001

1.53

11.11

2.2

2.0

9.77

10.39

g/l

1.71

287

1809

Fall on same level involving ice and snow

1270

10387

1.23

11.10

2.1

2.3

9.99

10.12

g/l

0.57

1105

9245

Other specified and unspecified personality disorders

153

849

1.83

11.06

1.7

2.2

9.65

10.41

g/l

1.61

141

781

Retinal vascular disorders

328

2211

1.51

11.03

2.4

10.55

10.16

g/l

0.85

290

1918

Eating disorder

103

498

2.09

11.03

1.8

1.7

9.21

10.38

g/l

2.82

472

Malignant melanoma

363

2497

1.48

10.95

2.6

1.4

9.81

10.16

g/l

0.96

314

2186

Anterior Iridocyclitis

429

3043

1.43

10.90

2.5

2.3

10.38

10.13

g/l

0.50

390

2726

Infections with a predominantly sexual mode of transmission

448

3190

1.41

10.84

2.1

2.0

9.97

10.15

g/l

0.43

401

2928

Temporomandibular joint disorders, including avohilmo

756

5653

1.30

10.82

2.1

2.2

9.70

10.06

g/l

1.74

680

5100

Carbimazole or st.post thyroidectomy, condition for graves disease

416

2938

1.43

10.81

2.5

2.2

9.76

10.15

g/l

1.43

377

2620

Sulfonylureas

902

5653

1.28

10.81

1.8

2.4

10.31

10.33

g/l

0.04

793

4883

Bullous pemphigoid

346

2.38

10.80

1.4

2.6

9.74

10.80

g/l

1.77

305

Other spirochaetal diseases, including avohilmo

727

5598

1.31

10.80

2.5

2.4

9.98

10.10

g/l

0.34

631

5011

Other bursopathies

291

1920

1.54

10.77

2.3

9.89

10.31

g/l

0.80

265

1695

Vitamin deficiency, wide

117

603

2.00

10.75

2.5

10.54

10.52

g/l

0.02

541

Vitamin deficiency

117

603

2.00

10.75

2.5

10.54

10.52

g/l

0.02

541

Postviral fatigue syndrome

5.52

10.72

1.2

2.3

9.43

10.02

g/l

0.37

Malignant melanoma, including Hilmo

401

2821

1.44

10.72

2.6

1.4

9.91

10.13

g/l

0.51

347

2470

Arterial embolism and thrombosis

156

883

1.82

10.69

1.4

2.5

9.67

10.44

g/l

1.29

137

781

Other spirochaetal diseases

718

5528

1.31

10.68

2.5

2.4

9.98

10.11

g/l

0.37

624

4946

Synovial cyst of popliteal space [Baker]

172

1001

1.76

10.67

2.6

2.2

9.93

10.31

g/l

0.53

156

884

Alcohol abuse, main dg, excluding more controls

282

1850

1.54

10.66

1.2

2.6

9.96

10.22

g/l

0.50

247

1704

Carcinoma in situ of skin of upper limb, including shoulder

480

2.16

10.65

2.7

9.72

10.84

g/l

1.87

419

Ulcerative colitis, NAS

266

1725

1.56

10.62

2.0

2.4

10.14

10.31

g/l

0.27

246

1561

Other congenital malformations

142

780

1.85

10.60

2.2

2.3

10.32

10.33

g/l

0.00

136

714

Anosmia

119

3.30

10.59

3.7

1.3

10.16

10.05

g/l

0.07

103

Spirochaetal infections, other/unspecified, including avohilmo

717

5526

1.31

10.59

2.5

2.4

9.98

10.11

g/l

0.37

623

4944

Allergic contact dermatitis

245

1561

1.59

10.56

1.6

2.4

10.13

10.14

g/l

0.02

220

1402

Polycythaemia vera

466

2.14

10.52

2.6

1.4

10.47

10.45

g/l

0.01

401

Lyme disease, including avohilmo

711

5483

1.31

10.46

2.6

2.4

9.98

10.11

g/l

0.36

617

4910

Lyme disease

711

5483

1.31

10.46

2.6

2.4

9.98

10.11

g/l

0.36

617

4910

Other demyelinating diseases of the central nervous system

329

2.34

10.43

1.8

2.0

11.10

10.71

g/l

0.21

309

Duodenal ulcer

273

1792

1.55

10.42

1.9

2.5

10.47

10.34

g/l

0.16

247

1583

Abscess of anal and rectal regions

162

932

1.77

10.41

1.3

2.3

10.24

10.38

g/l

0.10

147

852

Psoriatic arthropathies, ICD10

224

1405

1.62

10.41

1.8

2.4

10.49

10.25

g/l

0.32

200

1278

Behavioural syndromes associated with physiological disturbances and physical factors

1956

11275

1.18

10.38

2.1

2.3

9.94

10.16

g/l

1.50

1728

10082

Acute and subacute iridocyclitis

399

2820

1.43

10.38

2.5

2.2

10.36

10.14

g/l

0.39

361

2527

Glucagon-like peptide-1 (GLP-1) analogues

627

4760

1.33

10.34

1.7

2.6

9.87

10.15

g/l

0.99

570

4306

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

627

4760

1.33

10.34

1.7

2.6

9.87

10.15

g/l

0.99

570

4306

Deviated nasal septum

692

5319

1.31

10.33

2.8

2.4

9.99

10.26

g/l

1.05

623

4814

Artificial joint operation, meniscal resection

2114

11594

1.17

10.32

2.2

2.4

9.95

10.19

g/l

1.82

1866

10310

Event of undetermined intent

127

681

1.90

10.32

2.2

2.4

9.63

10.40

g/l

1.47

116

625

Trigger finger

292

1946

1.52

10.29

1.7

2.3

9.80

10.28

g/l

1.20

264

1749

Carcinoma in situ of other and unspecified digestive organs

128

693

1.92

10.27

1.8

2.7

10.89

10.47

g/l

0.31

120

621

Parkinson's disease, strict definition, excluding more controls

310

1950

1.51

10.27

1.9

2.5

9.96

10.46

g/l

1.44

267

1727

Otalgia

179

1064

1.72

10.26

2.0

2.3

9.60

10.35

g/l

1.74

151

954

Eating disorders

137

750

1.85

10.26

2.4

1.9

9.43

10.41

g/l

1.96

127

695

Parkinson's disease, excluding more controls

328

2057

1.49

10.26

1.9

2.5

9.93

10.46

g/l

1.64

282

1823

Other and unspecified nerve root and plexus disorders, also in other diseases

425

3043

1.41

10.24

2.5

2.4

9.64

10.20

g/l

2.08

367

2754

Traumatic subarachnoid haemorrhage

463

2.12

10.23

2.5

10.20

10.64

g/l

0.35

421

Pain associated with micturition

267

1751

1.55

10.20

2.5

2.4

9.96

10.33

g/l

0.60

226

1561

Anogenital herpesviral [herpes simplex] infection, including avohilmo

158

907

1.76

10.17

2.3

2.1

10.18

10.39

g/l

0.19

145

844

Pain and other conditions associated with female genital organs and menstrual cycle

318

1794

1.49

10.17

1.9

2.1

9.36

10.18

g/l

3.61

279

1618

Benign neoplasm: Small intestine

121

648

1.94

10.09

2.3

2.6

10.03

10.60

g/l

0.60

108

579

Unspecified misadventure during surgical and medical care

148

842

1.81

10.04

2.0

2.6

10.22

10.47

g/l

0.23

129

764

Malignant neoplasm of other connective and soft tissue

311

2.38

10.04

4.2

1.4

10.50

10.60

g/l

0.04

276

Melanocytic naevi of trunk

251

1630

1.56

10.02

2.3

2.4

9.83

10.26

g/l

0.98

234

1479

Causalgia

147

3.06

9.96

1.5

2.2

9.36

10.55

g/l

0.96

140

Carcinoma in situ of skin

242

1567

1.58

9.96

1.9

2.5

9.62

10.41

g/l

2.37

215

1376

Other superficial mycoses, including avohilmo

187

1132

1.68

9.96

1.8

2.4

10.27

10.35

g/l

0.09

169

1029

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

456

3316

1.39

9.94

2.0

2.2

9.58

10.22

g/l

2.85

407

3047

Hypothyroidism, strict autoimmune, 3 medication purchases required

1769

10083

1.18

9.94

2.0

2.3

10.11

10.16

g/l

0.17

1562

8947

therapeutic use

471

2.10

9.90

2.1

2.5

9.40

10.44

g/l

1.22

418

Monoamine oxidase A inhibitors

245

1589

1.57

9.86

2.1

2.5

10.30

10.27

g/l

0.04

221

1422

Other/unspecified soft tissue disorders related to use, overuse and pressure

294

2.39

9.83

2.4

2.3

9.30

10.63

g/l

2.10

266

Hyperkinetic disorders, excluding more controls

104

490

1.99

9.82

1.4

1.8

9.89

10.67

g/l

1.48

468

Disorders of orbit

106

546

2.00

9.82

3.4

2.5

9.95

10.16

g/l

0.16

495

Cryoglobulinemia

15.07

9.78

4.3

1.1

9.91

9.19

g/l

0.19

Asthma and opportunity respiratory infection

136

763

1.85

9.76

2.5

2.8

9.89

10.45

g/l

0.77

124

663

Propionic acid derivatives

563

2099

1.36

9.75

2.5

2.3

10.46

10.65

g/l

0.39

505

1875

Exposure to other and unspecified animate mechanical forces

270

2.44

9.75

2.9

2.2

9.10

10.44

g/l

2.40

257

Abnormal spermatozoa

133

2310

0.56

9.74

1.9

2.6

9.57

10.34

g/l

1.49

109

2075

Superficial injury of ankle and foot

207

1293

1.62

9.72

1.7

2.4

9.49

10.27

g/l

1.61

182

1192

Urolithiasis

747

5858

1.29

9.72

2.1

2.3

10.37

10.27

g/l

0.23

665

5223

Disorders of oesophagus in diseases classified elsewhere

291

2.42

9.72

4.0

2.9

8.90

10.70

g/l

2.67

257

Crushed, pushed or stepped on by crowd or human stampede

122

658

1.88

9.71

2.7

2.2

9.72

10.39

g/l

1.25

113

607

Coronary artery bypass grafting

663

3779

1.32

9.70

1.7

2.5

10.25

10.37

g/l

0.30

595

3257

Anogenital herpesviral [herpes simplex] infection

491

2.03

9.69

2.3

2.0

9.75

10.49

g/l

1.15

456

Hallux rigidus

294

1990

1.50

9.67

2.3

2.5

10.08

10.27

g/l

0.25

245

1760

Otitis externa

465

3413

1.38

9.67

2.2

10.08

10.18

g/l

0.18

396

3082

Diseases of peritoneum

238

1543

1.57

9.66

2.2

2.4

9.95

10.32

g/l

0.60

217

1370

Background retinopathy and retinal vascular changes

274

2.45

9.57

1.9

2.9

9.98

10.31

g/l

0.23

249

Other hearing loss

766

5848

1.28

9.56

2.3

10.11

10.31

g/l

0.61

654

5141

Carcinoma in situ of colon

437

2.13

9.55

1.7

2.6

10.07

10.81

g/l

0.76

390

Dermatographic urticaria

128

706

1.85

9.54

2.0

2.6

10.03

10.38

g/l

0.39

121

651

Respiratory disorders in diseases classified elsewhere

174

2.87

9.53

1.6

2.2

10.11

10.57

g/l

0.21

159

Acute generalized exanthematous pustulosis

108

566

1.96

9.52

4.5

2.6

10.56

10.38

g/l

0.11

509

Anti-inflammatory and antirheumatic products, non-steroids

561

2099

1.35

9.50

2.7

2.3

10.58

10.65

g/l

0.11

505

1875

Clear cell adenocarcinoma of kidney

122

667

1.89

9.49

1.5

1.4

10.42

10.24

g/l

0.16

109

582

Coeliac disease

239

1555

1.56

9.48

2.4

2.2

10.78

10.25

g/l

0.97

216

1391

Thiazolidinediones

286

1938

1.51

9.47

1.6

2.5

10.38

10.21

g/l

0.23

257

1712

Pneumonia due to Streptococcus pneumoniae

477

2.05

9.45

5.1

1.8

11.97

10.37

g/l

0.84

424

Speech and linguistic disorders

113

573

1.91

9.44

2.3

2.0

9.80

10.44

g/l

0.89

101

521

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

100

513

2.02

9.44

2.4

2.5

10.25

10.50

g/l

0.16

464

Benign paroxysmal vertigo

687

5354

1.30

9.43

2.1

2.4

9.97

10.15

g/l

0.53

595

4718

Other noninfective disorders of lymphatic vessels and lymph nodes

451

2.08

9.42

1.5

2.4

9.53

10.25

g/l

0.90

405

MS-disease / Multiple Sclerosis

124

680

1.86

9.40

1.7

2.2

9.05

10.51

g/l

4.98

118

624

Xerosis cutis

240

2.55

9.40

1.7

2.7

9.22

10.77

g/l

1.88

214

Bacterial, viral and other infectious agents

159

939

1.72

9.37

3.1

2.3

10.08

10.31

g/l

0.34

147

870

Hemiplegia

119

647

1.89

9.36

2.1

2.3

10.08

10.55

g/l

0.55

104

579

IBD patients in KELA-register

401

2888

1.40

9.35

2.3

2.2

10.42

10.18

g/l

0.47

372

2639

Other/unspecified disorders of vestibular function

115

623

1.91

9.23

1.9

2.6

9.71

10.47

g/l

1.19

102

561

Infection due to other mycobacteria, including avohilmo

206

2.65

9.20

2.0

2.3

9.86

10.40

g/l

0.42

178

Malignant neoplasm of digestive organs, including Hilmo

948

5627

1.25

9.19

2.1

1.4

10.22

10.12

g/l

0.29

832

4925

Melanocytic naevi of lower limb, including hip

101

524

1.98

9.17

3.0

2.4

9.71

10.39

g/l

0.97

478

Superficial injury of shoulder and upper arm

249

1648

1.53

9.15

2.2

2.3

9.68

10.37

g/l

1.93

220

1495

Other psoriatic arthropathies

213

1365

1.59

9.10

1.9

2.4

10.50

10.21

g/l

0.40

190

1240

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

213

1367

1.59

9.09

2.4

10.16

10.14

g/l

0.02

179

1218

Other and unspecified psoriasis

160

957

1.71

9.09

2.0

2.6

10.99

10.29

g/l

1.03

148

865

Colonic or urogenital fistula

555

4224

1.33

9.09

2.5

2.4

9.92

10.16

g/l

0.69

486

3782

Follicular lymphoma, hilmo

122

678

1.86

9.08

1.6

2.8

8.68

10.59

g/l

4.81

111

607

Cluster headache, wide,, including avohilmo

100

518

1.97

9.08

1.7

2.3

9.36

10.47

g/l

2.31

476

Procreative management

526

3255

1.34

9.07

1.8

2.1

9.83

10.09

g/l

0.85

497

2976

Cluster headache, strict, including avohilmo

477

2.02

9.05

1.7

2.3

9.34

10.60

g/l

2.62

441

Disorders of psychological development

139

736

1.77

9.03

2.1

1.9

9.88

10.39

g/l

0.75

126

676

Left bundle-branch block

174

1065

1.67

9.02

1.7

2.3

9.80

10.22

g/l

0.68

145

922

Hepatic failure, not elsewhere classified

501

2.00

8.99

1.8

2.8

11.95

10.60

g/l

1.06

450

Blepharochalasis

690

5416

1.29

8.99

2.0

2.4

9.54

10.13

g/l

4.38

606

4754

Impacted cerumen

288

1977

1.48

8.94

2.1

2.4

9.72

10.21

g/l

1.25

199

1757

Chronic laryngitis and laryngotracheitis

309

2147

1.46

8.93

1.7

2.2

9.70

10.27

g/l

1.25

254

1906

Complications of cardiac and vascular prosthetic devices, implants and grafts

296

2.34

8.93

2.2

3.0

10.48

10.55

g/l

0.04

262

Type 1 diabetes, definitions combined

123

681

1.82

8.91

2.0

2.1

10.31

10.41

g/l

0.08

113

638

Suicide or other Intentional self-harm

409

2980

1.39

8.91

2.0

2.2

9.48

10.21

g/l

3.59

366

2730

Chronic conjunctivitis

334

2.23

8.88

2.1

2.2

9.70

10.74

g/l

1.59

300

Crohn's disease NAS

122

679

1.83

8.87

1.8

2.4

9.87

10.35

g/l

0.60

111

621

Type 1 diabetes, strict (exclude DM2)

122

675

1.82

8.86

2.0

2.1

10.32

10.41

g/l

0.07

112

632

Malignant neoplasm of bladder, including Hilmo

285

1935

1.48

8.71

2.4

1.4

10.12

10.34

g/l

0.33

245

1689

Exfoliative dermatitis

116

3.20

8.65

1.6

2.5

10.27

10.65

g/l

0.29

101

Other/unspecified enthesopathies, not elsewhere classified

178

1107

1.64

8.65

1.6

2.1

9.48

10.39

g/l

3.02

159

986

Infections with a predominantly sexual mode of transmission, including avohilmo

548

3822

1.32

8.65

2.1

2.0

10.06

10.10

g/l

0.07

494

3512

Other disorders of adrenal gland

521

1.95

8.64

2.8

2.6

8.76

10.37

g/l

2.47

481

Right bundle-branch block

494

1.98

8.62

2.6

2.4

10.23

10.34

g/l

0.09

432

Other follicular disorders

138

803

1.75

8.62

2.2

2.4

10.53

10.24

g/l

0.31

124

738

Cachexia

4.64

8.61

1.7

1.6

9.16

10.53

g/l

0.84

Dislocation, sprain and strain of joint and ligaments of hip

103

552

1.93

8.58

1.8

2.5

9.97

10.57

g/l

0.66

499

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

164

993

1.66

8.57

1.7

2.3

10.85

10.26

g/l

0.75

154

909

Other and unspecified disorders of vitreous body

987

7924

1.23

8.54

2.3

2.4

9.94

10.10

g/l

0.53

872

7027

Biological medicines for asthma

207

2.55

8.53

1.6

1.8

9.28

10.47

g/l

0.99

197

Cholecystitis

336

2393

1.42

8.51

2.1

2.3

10.67

10.18

g/l

1.08

294

2091

Childhood asthma (age<16), excluding more controls

105

433

1.91

8.50

1.4

10.56

10.61

g/l

0.03

413

Superficial injury of wrist and hand

366

2641

1.40

8.49

2.0

2.2

9.87

10.17

g/l

0.65

328

2397

Idiopathic pulmonary fibrosis

212

1384

1.57

8.48

2.1

2.4

10.72

10.39

g/l

0.55

194

1207

Disorders of breast

899

6428

1.24

8.42

2.0

2.2

9.62

9.99

g/l

2.13

782

5672

Diabetic retinopathy, strict definition

398

2590

1.39

8.39

1.7

2.0

10.36

10.12

g/l

0.43

353

2314

Persons encountering health services in other circumstances

752

5942

1.26

8.36

2.2

2.3

10.00

10.17

g/l

0.49

679

5219

Sleep disorders

1850

11008

1.16

8.35

1.9

2.3

9.94

10.15

g/l

1.49

1637

9846

Vascular diseases of the intestine

112

622

1.86

8.35

2.8

2.4

10.03

10.47

g/l

0.49

103

549

841

5845

1.25

8.34

2.3

10.31

10.19

g/l

0.31

693

5056

Other orthopaedic follow-up care

128

738

1.77

8.33

1.7

2.0

9.95

10.43

g/l

0.72

113

657

Other disorders of nervous system

162

997

1.66

8.30

2.7

2.5

8.94

10.38

g/l

6.53

138

899

Other disorders of iris and ciliary body

364

2.14

8.30

2.0

2.8

10.45

10.53

g/l

0.06

326

Acute bronchiolitis

271

2.23

8.25

4.8

1.9

9.24

10.33

g/l

1.09

245

Abnormal findings on diagnostic imaging of central nervous system

109

601

1.86

8.25

2.3

2.5

10.35

10.17

g/l

0.15

104

551

Disorders of optic nerve and visual pathways

182

1153

1.60

8.20

2.2

2.5

9.63

10.43

g/l

1.80

164

1045

Visual field defects

200

1298

1.57

8.18

2.3

2.2

9.68

10.34

g/l

1.46

177

1159

Diseases of tongue

138

818

1.72

8.12

2.6

2.0

9.87

10.15

g/l

0.31

121

714

Inflammatory bowel disease, strict (require KELA)

401

2960

1.37

8.11

2.3

2.2

10.42

10.17

g/l

0.52

372

2711

Other and unspecified injuries of lower leg

145

871

1.69

8.08

2.4

9.66

10.25

g/l

1.12

133

786

Childhood asthma (age<16)

105

441

1.87

8.07

1.4

10.56

10.61

g/l

0.03

420

Other symptoms and signs involving the urinary system

239

1615

1.51

8.06

2.7

2.4

9.76

10.36

g/l

1.43

215

1435

Malignant neoplasm of other connective and soft tissue, including Hilmo

102

556

1.89

8.06

4.6

1.4

10.12

10.41

g/l

0.19

488

Superficial injury of forearm

184

1173

1.59

8.05

2.2

2.3

9.90

10.39

g/l

0.82

159

1076

Cerebral cysts

113

635

1.82

8.02

1.6

2.4

10.82

10.44

g/l

0.34

101

578

Other/unspecified synovitis and tenosynovitis

217

1437

1.53

8.01

1.9

2.3

10.16

10.31

g/l

0.19

193

1283

Adrenocortical insufficiency

437

2.00

8.01

2.9

2.6

8.09

10.42

g/l

6.87

401

Drug-induced osteoporosis

185

2.64

8.00

1.7

2.2

9.54

10.71

g/l

0.76

169

Thyrotoxicosis with toxic multinodular goitre

154

947

1.67

7.96

1.8

2.4

9.71

10.20

g/l

0.66

135

823

Infection due to other mycobacteria

197

2.56

7.94

2.0

2.2

9.91

10.43

g/l

0.37

169

Ovarian cyst

595

2633

1.30

7.94

2.0

2.1

9.63

10.18

g/l

2.70

532

2339

Follicular cysts of skin and subcutaneous tissue

380

2795

1.38

7.93

2.6

2.3

9.84

10.11

g/l

0.53

345

2516

Other Crohn's disease

118

674

1.78

7.90

1.5

2.2

9.76

10.28

g/l

0.76

109

616

Psoriasis (vulgaris), strict definition

378

2.07

7.85

1.4

2.7

11.77

10.35

g/l

1.07

348

Pediculosis, acariasis and other infestations, including avohilmo

276

1923

1.45

7.84

1.8

2.3

9.91

10.24

g/l

0.79

258

1760

Acute pharyngitis

217

1427

1.52

7.82

2.7

2.0

10.48

10.43

g/l

0.05

200

1320

Mouth breathing

787

6364

1.24

7.82

2.5

2.4

9.99

10.19

g/l

0.69

719

5760

Other renal tubulo-interstitial diseases

229

2.39

7.76

1.8

1.9

10.79

10.12

g/l

0.68

212

Combinations of oral blood glucose lowering drugs

645

5118

1.27

7.75

1.7

2.6

9.77

10.25

g/l

2.59

590

4557

Entropion and trichiasis of eyelid

233

1583

1.50

7.73

2.2

2.5

10.43

10.37

g/l

0.07

203

1383

Other chondrocalcinosis

207

2.52

7.73

1.6

2.4

9.79

10.56

g/l

0.63

184

Alzheimer’s disease (Late onset), excluding more controls

386

1840

1.38

7.72

1.9

2.5

10.36

10.53

g/l

0.26

319

1611

Unspecified/other endometriosis

134

780

1.70

7.72

1.9

9.02

10.31

g/l

4.30

119

705

Chondropathies

277

1942

1.44

7.67

1.8

2.2

10.16

10.22

g/l

0.08

239

1767

Additional codes for the location of defect, injury or illness

129

766

1.72

7.60

1.4

2.6

9.65

10.42

g/l

1.54

123

695

Astigmatism

116

668

1.77

7.54

2.2

2.4

10.06

10.34

g/l

0.34

107

601

Disorders of ocular muscles, binocular movement, accommodation and refraction

872

7097

1.22

7.54

2.1

2.3

10.01

10.13

g/l

0.37

792

6358

Membranous nephropathy

4.58

7.52

3.3

2.3

9.81

10.50

g/l

0.15

Dissociative [conversion] disorders

309

2.15

7.52

1.2

2.0

10.30

10.56

g/l

0.19

285

Gonarthrosis, primary, with knee surgery

1416

9434

1.18

7.51

2.2

2.5

10.04

10.18

g/l

0.64

1235

8324

Other disorders of patella

256

1775

1.46

7.49

2.2

2.5

9.47

10.19

g/l

2.86

228

1628

COPD, hospital admissions 1, only main diagnosis

860

6064

1.23

7.48

1.9

2.4

10.09

10.29

g/l

0.60

753

5326

Benign neoplasm: Descending colon

180

1168

1.58

7.46

2.0

2.6

9.69

10.38

g/l

1.59

150

1053

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

273

1919

1.44

7.45

2.4

2.3

10.67

10.24

g/l

0.74

253

1753

Atypical facial pain

112

645

1.78

7.38

2.0

2.5

9.84

10.52

g/l

0.68

100

574

Paraplegia, diplegia of upper limbs

261

2.27

7.36

2.1

2.5

10.06

10.78

g/l

0.52

237

Ulcerative ileocolitis

373

2.03

7.36

3.0

2.2

11.86

10.51

g/l

1.53

346

Fracture of neck

155

975

1.63

7.34

3.4

2.3

10.16

10.45

g/l

0.35

138

873

Other and/or unspecified nontoxic goitre

185

1211

1.56

7.33

2.4

9.56

10.17

g/l

1.38

169

1071

Oesophagitis

125

745

1.72

7.29

2.3

2.6

9.40

10.34

g/l

1.97

114

676

Plantar fascial fibromatosis

183

1194

1.55

7.29

2.8

2.1

9.66

10.32

g/l

1.64

166

1077

Autonomic disorders

282

2.20

7.25

2.0

2.5

9.59

10.90

g/l

1.40

254

Ulcerative colitis (strict definition, require KELA)

281

1996

1.42

7.24

2.5

2.3

10.66

10.20

g/l

0.82

260

1825

Golimumab

321

2.10

7.24

1.2

1.9

11.06

10.16

g/l

1.00

305

Insomnia

1784

10817

1.15

7.23

2.0

2.3

9.95

10.13

g/l

1.18

1581

9677

Open wound of abdomen, lower back and pelvis

295

2.16

7.21

1.6

2.5

10.81

10.43

g/l

0.17

275

Benign neoplasm: Other and unspecified parts of mouth

462

1.92

7.19

3.1

2.6

10.68

10.56

g/l

0.06

416

Sleep disorders, other/unspecified

322

2.09

7.17

1.4

2.1

9.76

10.51

g/l

1.01

300

Organic, including symptomatic, mental disorders

1352

8139

1.18

7.15

2.2

2.4

10.22

10.20

g/l

0.04

1119

7165

Postzoster neuralgia

220

2.38

7.15

3.3

2.0

9.99

10.65

g/l

0.45

193

Unspecified lump in breast

308

2233

1.40

7.09

1.8

2.3

9.59

10.04

g/l

1.39

274

1956

Pulmonary oedema

259

2.26

7.09

2.9

2.6

10.46

10.59

g/l

0.07

226

Other and unspecified tonsillitis

448

2839

1.32

7.08

1.7

2.0

10.11

10.31

g/l

0.50

423

2638

Deficiency of other B group vitamins

272

2.21

7.08

3.6

2.0

10.31

10.49

g/l

0.11

242

Other infective otitis externa

131

797

1.68

7.07

2.5

2.3

9.57

10.31

g/l

1.50

115

725

Open wound of hip and thigh

338

2.06

7.06

1.3

2.6

9.84

10.44

g/l

0.59

317

Wet age-related macular degeneration

485

3629

1.31

7.04

2.5

2.2

10.29

10.16

g/l

0.24

403

3084

Hyperaldosteronism

374

2.02

7.04

3.4

2.7

10.75

10.60

g/l

0.08

339

Fracture at wrist and hand level

645

5156

1.26

7.04

2.4

2.3

9.71

10.19

g/l

2.39

565

4640

Palmar fascial fibromatosis [Dupuytren]

344

2544

1.37

7.02

2.4

2.3

10.54

10.38

g/l

0.21

301

2236

Congenital malformations and deformations of the musculoskeletal system

120

708

1.71

7.02

1.6

2.1

10.87

10.19

g/l

0.68

114

653

Generalized skin eruption due to drugs and medicaments

494

1.87

7.01

4.8

2.7

10.20

10.37

g/l

0.10

448

Bursitis of shoulder

266

2.21

7.00

3.0

2.2

10.16

10.65

g/l

0.30

240

Benign neoplasm: Parathyroid gland

149

2.71

7.00

2.2

2.0

10.29

10.44

g/l

0.05

138

Disorders of myoneural junction and muscle in diseases classified elsewhere

104

3.10

6.97

1.7

2.2

11.53

10.35

g/l

0.41

Melanocytic naevi

577

4581

1.27

6.91

2.6

2.2

9.92

10.15

g/l

0.73

542

4104

Chronic hepatitis, not elsewhere classified

418

1.94

6.90

1.8

2.6

14.38

10.32

g/l

5.20

385

Nasal polyp

406

3084

1.33

6.90

2.9

2.4

10.27

10.30

g/l

0.06

371

2767

Hypotension due to drugs

205

2.41

6.88

3.3

2.3

10.26

10.56

g/l

0.21

183

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

148

935

1.62

6.88

3.7

1.4

9.97

10.26

g/l

0.29

134

807

Other specified and unspecified retinal disorders

505

1.86

6.88

2.7

2.6

9.86

10.48

g/l

0.90

453

Abnormal blood-pressure reading, without diagnosis

540

1.82

6.87

2.1

2.4

9.29

10.27

g/l

1.92

476

Carrier of infectious disease

262

2.20

6.85

1.4

2.4

11.05

10.61

g/l

0.23

239

Assault

187

1242

1.52

6.84

1.9

2.2

10.47

10.28

g/l

0.20

168

1169

Lactose intolerance

315

2.08

6.84

1.6

9.57

10.46

g/l

1.01

284

Hyphaema and other vascular disorders of iris and ciliary body

270

2.19

6.80

2.0

2.7

10.68

10.51

g/l

0.10

240

Psychotic depression

109

638

1.74

6.76

2.4

2.8

10.02

10.27

g/l

0.25

572

Other sleep disorders

222

1533

1.47

6.75

1.8

2.5

9.65

10.25

g/l

1.61

186

1386

Benign neoplasm: Duodenum

395

1.98

6.74

2.7

10.20

10.44

g/l

0.13

355

Viral warts

175

1152

1.54

6.73

1.9

2.4

9.70

10.28

g/l

0.86

163

1041

Primary coxarthrosis, bilateral

719

5878

1.24

6.70

2.2

2.4

9.92

10.24

g/l

1.07

627

5120

Paget disease

3.53

6.70

1.5

1.3

8.99

10.66

g/l

1.37

Other obstructive and reflux uropathy

407

1.93

6.70

1.9

2.2

10.48

10.52

g/l

0.02

371

Viral warts, including avohilmo

369

2775

1.34

6.69

2.1

2.2

9.78

10.20

g/l

1.10

337

2513

Other benign neoplasms of skin

815

6742

1.22

6.69

3.0

2.3

9.76

10.20

g/l

1.95

698

5958

Carcinoma in situ of skin of trunk

102

593

1.78

6.67

3.1

2.5

9.53

10.72

g/l

2.33

522

Use of antiglaucoma preparations and miotics

206

1410

1.49

6.66

2.3

2.4

11.37

10.29

g/l

1.64

175

1215

Other keratitis

207

1415

1.48

6.63

2.2

10.46

10.30

g/l

0.19

189

1278

Acute laryngitis and tracheitis

147

917

1.59

6.62

1.5

1.9

10.03

10.54

g/l

0.85

134

842

Ganglion

347

2591

1.35

6.60

2.1

2.3

9.48

10.25

g/l

3.55

303

2317

Other salmonella infections

439

1.89

6.58

2.7

2.1

10.52

10.67

g/l

0.08

393

Malignant melanoma of skin

260

1859

1.42

6.57

2.6

1.5

9.49

10.17

g/l

2.18

227

1636

Use of riluzole

3.96

6.57

1.6

2.5

10.92

10.74

g/l

0.04

Other specified/unspecified spondylopathies

335

2.04

6.56

2.7

1.9

11.02

10.88

g/l

0.05

292

Other disorders of optic [2nd] nerve and visual pathways

132

821

1.64

6.56

2.3

2.6

9.40

10.39

g/l

1.82

117

743

Alzheimer disease, excluding more controls

428

2118

1.32

6.54

1.9

2.5

10.30

10.43

g/l

0.24

353

1866

Arthropathy in hypersensitivity reactions classified elsewhere

21.43

6.53

1.8

1.0

10.74

9.72

g/l

—

Impingement syndrome of shoulder

456

3547

1.30

6.51

2.6

2.5

9.88

10.30

g/l

1.07

387

3174

Congenital malformations of the circulatory system

237

1618

1.44

6.50

1.7

2.4

10.43

10.20

g/l

0.36

216

1469

Thyroiditis

137

862

1.62

6.48

2.1

2.4

9.87

10.25

g/l

0.53

119

775

Alcohol dependence

541

4300

1.27

6.48

1.6

2.5

10.19

10.24

g/l

0.09

474

3919

Retinal detachment with retinal break

298

2187

1.38

6.46

3.0

2.4

10.57

10.10

g/l

0.81

264

1945

Bell's palsy

235

1657

1.44

6.42

2.2

2.3

9.89

10.38

g/l

1.01

204

1480

Specific development disorders of speech and language

424

1.87

6.42

1.9

2.2

10.09

10.47

g/l

0.36

381

Injury of eye and orbit

249

1773

1.42

6.40

1.9

2.3

9.74

10.30

g/l

1.06

220

1631

Portal vein thrombosis

186

2.41

6.40

1.8

2.5

11.23

10.55

g/l

0.34

172

Nontoxic goitre/thyroid nodule

627

5080

1.25

6.36

2.3

9.61

10.08

g/l

2.30

556

4445

Malignant melanoma of skin, including Hilmo

309

2286

1.37

6.35

2.5

1.4

9.72

10.17

g/l

1.19

272

2006

Testicular dysfunction

394

1.92

6.33

1.6

2.6

10.28

10.47

g/l

0.17

364

Other specified congenital malformation syndromes affecting multiple systems

103

2.90

6.33

1.6

2.0

9.31

10.03

g/l

0.54

Scleritis and episcleritis

118

720

1.67

6.33

2.2

10.56

10.33

g/l

0.21

109

663

Autoimmune hyperthyroidism

107

636

1.71

6.31

2.3

2.5

9.60

9.95

g/l

0.52

101

569

Other and unspecified vascular occlusions

234

1659

1.44

6.27

2.3

2.4

10.72

10.15

g/l

1.11

206

1447

Tobacco use

106

631

1.71

6.26

1.6

2.4

9.45

10.36

g/l

1.30

100

583

Panniculitis affecting regions of neck and back

396

1.91

6.26

2.0

2.2

9.78

10.87

g/l

1.67

358

Menorrhagia

586

2605

1.26

6.25

1.9

2.1

9.79

10.15

g/l

1.25

480

2303

Alcohol abuse, main dg

282

2060

1.38

6.25

1.2

2.3

9.96

10.21

g/l

0.46

247

1893

Complications of other internal prosthetic devices, implants and grafts

103

610

1.73

6.25

2.7

2.3

10.34

10.42

g/l

0.08

540

Malignant neoplasm of mesothelium and soft tissue

551

1.77

6.21

3.6

1.4

10.25

10.24

g/l

0.01

481

Bronchitis, not specified as acute or chronic

173

1159

1.51

6.18

2.0

2.4

9.83

10.40

g/l

1.33

154

1019

Rosacea

246

1761

1.41

6.18

2.1

2.3

10.53

10.12

g/l

0.64

227

1587

Attention to artificial openings

101

598

1.73

6.14

1.9

2.0

10.10

10.53

g/l

0.55

535

Gluteal tendinitis

530

1.77

6.13

1.9

2.4

9.20

10.36

g/l

1.92

479

Coxarthrosis, primary, with hip surgery

1150

9159

1.17

6.11

2.3

2.4

9.94

10.20

g/l

1.29

1000

8021

Other and unspecified rosacea

181

1228

1.50

6.10

2.2

2.4

10.32

10.11

g/l

0.25

166

1108

severe traumatic brain injury, does not include concussion

522

4166

1.27

6.09

2.3

10.13

10.26

g/l

0.25

444

3654

Thyrotoxicosis with diffuse goitre

245

1756

1.41

6.09

2.3

9.78

10.19

g/l

1.05

225

1579

Adenomyosis (Endometriosis of uterus)

262

1897

1.40

6.09

2.2

9.87

10.09

g/l

0.38

235

1673

Cardiac murmurs and other cardiac sounds

151

973

1.55

6.08

2.5

2.2

10.13

10.24

g/l

0.11

138

855

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

300

2222

1.36

6.08

2.5

2.3

10.62

10.21

g/l

0.74

279

2028

Later onset COPD

762

5072

1.22

6.07

1.6

2.4

10.25

10.33

g/l

0.17

660

4395

Other salmonella infections, including avohilmo

502

1.79

6.06

2.6

2.3

10.53

10.55

g/l

0.01

453

Hypopituitarism

119

735

1.64

6.06

2.9

2.5

8.93

10.63

g/l

4.88

110

685

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

366

2756

1.32

6.05

2.1

10.10

10.24

g/l

0.28

335

2518

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

539

3544

1.26

6.04

2.2

1.5

10.48

10.17

g/l

0.79

483

3094

Scabies, including avohilmo

212

1482

1.44

6.03

1.7

2.3

9.95

10.32

g/l

0.77

199

1372

Crohn's disease of small intestine

117

722

1.64

6.00

1.7

2.4

9.29

10.39

g/l

2.31

107

659

Corneal scars and opacities

353

1.95

6.00

2.8

2.7

10.24

10.72

g/l

0.43

318

Lichen planus, including avohilmo

406

3150

1.30

5.99

2.5

2.4

9.80

10.12

g/l

0.82

362

2790

Other disorders of pigmentation

103

618

1.70

5.96

2.9

2.2

11.16

10.38

g/l

0.66

549

Hordeolum and other deep inflammation of eyelid

118

732

1.64

5.95

2.3

2.7

10.81

10.18

g/l

0.52

671

Somnolence, stupor and coma

536

1.75

5.91

1.4

2.9

9.98

10.83

g/l

1.14

477

Other obstetric conditions, not elsewhere classified

287

1321

1.38

5.91

1.6

1.7

10.26

10.09

g/l

0.29

270

1249

Pure hyperglyceridaemia

272

2.09

5.89

1.3

2.3

9.96

10.54

g/l

0.42

249

Use of donepezil

361

4459

0.76

5.86

1.7

2.2

10.46

10.27

g/l

0.30

277

3803

Pneumothorax

154

1021

1.54

5.85

2.5

2.3

10.17

10.37

g/l

0.25

141

922

Other congenital malformations of skin, including avohilmo

137

884

1.57

5.84

1.9

2.4

10.68

10.34

g/l

0.42

122

800

Left ventricular outflow tract obstruction (LVOTO), broad definition

175

1191

1.49

5.81

1.9

2.4

10.88

10.29

g/l

0.82

161

1099

Disorders of magnesium metabolism

2.93

5.80

1.3

2.4

11.40

10.48

g/l

0.34

Glucosamine medication

1144

7864

1.17

5.80

2.4

9.79

10.18

g/l

2.37

1002

6830

Epiphora

309

2.01

5.78

2.2

2.3

10.42

10.66

g/l

0.13

276

Ulcerative colitis (strict definition, all Crohn cases excluded)

236

1697

1.40

5.78

2.7

2.3

10.66

10.26

g/l

0.56

217

1553

Disorders of refraction and accommodation

461

3631

1.27

5.77

2.0

2.2

10.04

10.15

g/l

0.20

420

3292

Nail disorders

160

1072

1.51

5.75

1.7

2.3

10.15

10.09

g/l

0.07

143

970

malignant neoplasm of male genital organs, including Hilmo

609

2965

1.24

5.75

2.3

1.4

10.29

10.31

g/l

0.04

535

2656

Lactose intolerance, other/unspecified

281

2.04

5.74

1.6

1.7

9.64

10.50

g/l

0.86

254

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

115

717

1.64

5.74

2.0

1.4

11.63

10.32

g/l

1.62

617

Follow-up examination after treatment for malignant neoplasms

199

1392

1.45

5.73

2.5

2.2

10.55

10.16

g/l

0.50

176

1231

Lichen ruber planus, wide definition including periferal and oral lichen planus

475

3780

1.27

5.72

2.4

2.3

9.85

10.11

g/l

0.69

424

3356

Pustulosis palmaris et plantaris

542

1.74

5.71

2.3

2.5

10.34

10.28

g/l

0.04

497

Degenerative macular diseases

290

2166

1.36

5.69

2.3

10.15

10.13

g/l

0.02

255

1880

Other epidermal thickening

101

611

1.69

5.68

2.0

2.6

9.37

10.55

g/l

2.38

550

Other aneurysm

131

845

1.58

5.68

2.4

2.5

10.19

10.41

g/l

0.23

123

759

Disorders of speech understanding and production

351

1.90

5.68

2.0

2.3

9.79

10.53

g/l

0.76

311

Other and unspecified nonorganic psychotic disorders

280

2075

1.36

5.67

1.6

2.3

10.13

10.23

g/l

0.13

249

1912

Spontaneous rupture of synovium and tendon

167

1133

1.50

5.66

1.9

2.2

9.93

10.25

g/l

0.52

142

1008

Aortic valve malfunction, age under 60 years

167

1133

1.49

5.65

1.9

2.3

10.88

10.27

g/l

0.83

153

1047

Melanoma in situ

119

753

1.62

5.65

2.3

2.7

10.68

10.55

g/l

0.11

669

Acidosis

277

2.05

5.65

1.8

2.4

10.50

10.87

g/l

0.17

249

Drug-induced hypoglycaemia without coma

184

2.31

5.64

2.3

2.5

10.59

10.51

g/l

0.05

165

Inflammatory diseases of female pelvic organs

1081

6341

1.17

5.62

1.8

2.3

9.86

9.98

g/l

0.41

934

5622

Extreme obesity with alveolar hypoventilation

545

1.73

5.61

2.1

2.8

10.32

10.35

g/l

0.02

490

Mental and behavioural disorders due to tobacco

168

1144

1.49

5.60

1.8

2.5

9.18

10.25

g/l

2.78

134

1048

Ulcer of oesophagus

154

1032

1.52

5.59

2.1

2.7

10.13

10.38

g/l

0.37

135

919

Obsessive-compulsive disorder

424

1.81

5.59

2.1

9.44

10.56

g/l

1.83

399

Benign neoplasm of urinary organs

113

708

1.63

5.55

2.0

2.7

10.08

10.74

g/l

0.89

102

633

N06DA Anticholinesterases

699

6469

0.83

5.55

2.0

2.3

10.14

10.27

g/l

0.32

553

5597

Use of anticholinesterases

699

6469

0.83

5.55

2.0

2.3

10.14

10.27

g/l

0.32

553

5597

Visual impairment including blindness (binocular or monocular)

159

1074

1.51

5.55

2.1

2.2

9.90

10.43

g/l

0.63

119

943

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

164

1115

1.50

5.54

2.1

2.5

9.62

10.34

g/l

1.45

145

999

Other disorders of penis

197

1384

1.44

5.53

1.7

2.5

9.95

10.40

g/l

0.86

174

1250

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

274

1264

1.37

5.53

1.5

1.7

10.25

10.10

g/l

0.25

258

1198

Lichen planus

282

2106

1.36

5.53

2.8

2.3

9.64

10.13

g/l

1.25

251

1864

Other symptoms and signs involving general sensations and perceptions

547

1.72

5.53

2.2

2.7

11.15

10.69

g/l

0.24

487

Postprocedural disorders of nervous system

100

606

1.67

5.52

2.3

2.1

9.90

10.54

g/l

0.71

563

Diffuse brain injury

348

1.90

5.51

2.6

2.0

10.85

10.77

g/l

0.04

320

Nonsuppurative otitis media, including avohilmo

469

3224

1.26

5.51

2.1

10.22

10.17

g/l

0.08

435

2930

Other disorders of central nervous system

130

2.56

5.49

1.7

2.0

10.17

10.52

g/l

0.20

120

Other congenital malformations of skin

414

1.82

5.48

2.0

2.4

10.75

10.31

g/l

0.45

379

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

204

2.19

5.48

1.7

1.8

9.45

10.47

g/l

1.30

192

Complications of labour and delivery

747

4968

0.83

5.47

2.4

2.2

10.29

9.90

g/l

1.56

681

4415

Amenorrhoea

494

1.74

5.46

1.9

2.0

10.40

10.54

g/l

0.11

456

Lichen simplex chronicus

408

1.83

5.45

2.6

2.9

10.49

10.30

g/l

0.16

370

Other otitis externa (chronic)

137

900

1.55

5.45

2.3

2.5

10.02

10.31

g/l

0.25

111

814

Benign neoplasm of major salivary glands

210

1501

1.42

5.43

1.9

2.5

9.79

10.31

g/l

0.92

192

1339

Pustular psoriasis

604

1.67

5.41

2.2

2.4

10.09

10.29

g/l

0.17

548

Dermatophytosis

289

2174

1.35

5.39

2.6

2.3

10.05

10.23

g/l

0.27

261

1943

Acne, including avohilmo

208

1191

1.42

5.39

1.7

1.8

10.63

10.30

g/l

0.48

195

1109

Postprocedural disorders of digestive system, not elsewhere classified

440

1.80

5.36

1.8

2.8

10.31

10.60

g/l

0.27

397

Burns and corrosions

232

1687

1.39

5.36

2.0

2.3

9.98

10.32

g/l

0.48

209

1546

Other specified disorders of muscle

324

1.93

5.35

1.4

2.2

10.01

10.85

g/l

0.79

288

Spontaneous abortion

489

4068

0.80

5.34

1.9

2.3

9.87

9.96

g/l

0.20

445

3639

Periapical abscess

894

7618

1.18

5.34

2.1

2.4

10.20

10.12

g/l

0.21

800

6873

Smoking dependency

168

1156

1.47

5.33

1.8

2.5

9.18

10.25

g/l

2.79

134

1059

Bicipital tendinitis

591

1.67

5.32

2.1

2.4

9.14

10.39

g/l

3.31

543

Necrosis of pulp, including avohilmo

1051

8960

1.16

5.30

2.2

2.3

9.95

10.13

g/l

0.76

957

8101

Polypectomy (DHB20)

139

924

1.53

5.26

2.7

2.4

10.25

10.44

g/l

0.21

130

840

Contact with sharp object, undetermined intent

216

2.13

5.22

2.7

2.3

8.97

10.42

g/l

2.27

200

Alzheimer’s disease (Early onset)

749

0.46

5.21

1.3

2.2

10.58

10.59

g/l

0.01

650

Other secondary coxarthrosis

452

1.77

5.19

1.7

2.4

9.91

10.62

g/l

0.73

410

Unspecified urinary incontinence

195

1388

1.43

5.18

1.5

2.4

9.47

10.29

g/l

1.74

138

1211

Tinnitus

484

3907

1.25

5.18

2.3

2.4

9.62

10.16

g/l

2.25

441

3513

Complications of genitourinary prosthetic devices, implants and grafts

314

1.93

5.17

1.9

2.1

10.18

10.48

g/l

0.22

277

Excessive, frequent and irregular menstruation

612

2674

1.23

5.17

1.9

2.1

9.89

10.18

g/l

0.82

525

2370

Hepatocellular carcinoma, including Hilmo

401

1.82

5.17

2.5

1.4

12.59

10.54

g/l

2.57

347

Malignant neoplasm, without specification of site

446

1.77

5.12

2.3

1.4

11.26

10.44

g/l

0.39

381

Malignant neoplasm, without specification of site, including Hilmo

107

675

1.61

5.11

2.6

1.4

10.84

10.33

g/l

0.32

576

Chondrocostal junction syndrome [Tietze]

485

1.73

5.07

2.0

2.2

9.37

10.36

g/l

1.36

435

Other ulcerative colitis

614

1.64

5.06

1.4

2.5

10.60

10.31

g/l

0.23

561

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

123

2.51

5.03

4.9

1.8

9.91

10.05

g/l

0.03

113

Colitis, primary sclerosing, strict definition

2.83

5.03

2.8

2.3

12.59

10.15

g/l

1.24

Other arterial embolism and thrombosis

405

1.80

5.01

1.3

2.6

9.57

11.04

g/l

1.71

361

Fibrosis of liver

2.93

5.01

1.5

1.7

12.89

10.56

g/l

1.09

Ectropion of eyelid

109

698

1.60

4.96

1.5

2.5

10.07

10.65

g/l

0.67

604

Other misadventures during surgical and medical care

312

1.92

4.95

1.6

2.9

9.33

10.44

g/l

1.43

283

Injuries to the wrist and hand

2066

12347

1.11

4.94

2.2

2.3

9.92

10.17

g/l

1.93

1850

11029

Other and unspecified follicular disorders

458

1.74

4.93

2.7

2.5

9.90

10.31

g/l

0.45

427

Seborrhoeic keratosis

557

4590

1.22

4.92

2.4

2.3

10.05

10.10

g/l

0.09

496

4018

Iridocyclitis in diseases classified elsewhere

222

2.09

4.92

2.2

10.42

10.44

g/l

0.01

203

Viral infections of the central nervous system

128

849

1.53

4.90

2.2

2.4

9.58

10.36

g/l

1.00

113

765

Benign neoplasm: salivary glands, exclude unknown (D119)

186

1329

1.42

4.87

2.0

2.5

9.95

10.33

g/l

0.51

170

1189

Premature rupture of membranes

115

1247

0.65

4.87

1.6

1.9

10.67

10.09

g/l

0.62

107

1168

Contact with and exposure to communicable diseases

211

2857

0.73

4.84

2.2

2.1

10.05

10.21

g/l

0.26

198

2650

Postmenopausal bleeding

555

2375

1.23

4.82

2.2

10.23

10.09

g/l

0.27

480

2086

Other and specified injuries of hip and thigh

301

1.91

4.80

1.4

2.4

10.78

10.66

g/l

0.05

270

Arterial embolism and thrombosis of lower extremity artery

539

1.67

4.80

1.4

2.7

9.66

10.60

g/l

1.12

480

Retinal breaks without detachment

339

2654

1.29

4.77

2.4

10.17

10.14

g/l

0.05

297

2378

Redundant prepuce, phimosis and paraphimosis

363

2817

1.28

4.76

1.9

2.5

10.29

10.52

g/l

0.46

333

2576

Endometriosis

551

2623

1.23

4.75

1.9

2.1

9.62

10.17

g/l

2.32

492

2325

Urethral stricture

132

889

1.51

4.75

2.2

2.6

10.42

10.45

g/l

0.03

115

792

Benign neoplasm: Spinal meninges

153

2.34

4.75

1.3

1.9

9.07

10.56

g/l

2.41

135

Inflammatory disease of uterus

198

1434

1.39

4.73

1.8

2.2

9.51

10.13

g/l

1.31

175

1298

Maternal care for other conditions predominantly related to pregnancy

226

1627

1.36

4.72

1.9

10.31

10.10

g/l

0.31

215

1521

Dislocation, sprain and strain of joints and ligaments at neck level

230

1707

1.36

4.71

2.2

2.3

9.74

10.29

g/l

1.57

208

1567

Early complications of trauma

549

1.65

4.70

2.5

10.07

10.54

g/l

0.37

503

!Aliquae complicationes praecoces traumatis

549

1.65

4.70

2.5

10.07

10.54

g/l

0.37

503

Polycystic ovarian syndrome, consortium definition

1226

6160

1.15

4.70

1.9

2.2

9.94

9.98

g/l

0.11

1036

5488

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

551

4557

1.22

4.68

2.5

2.3

9.99

10.22

g/l

0.65

492

4106

Scar conditions and fibrosis of skin

435

1.73

4.68

1.9

2.2

9.95

10.20

g/l

0.21

394

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

105

673

1.58

4.67

1.9

2.3

9.92

10.22

g/l

0.34

620

Malignant neoplasm of prostate, including Hilmo

595

2907

1.22

4.66

2.3

1.5

10.35

10.32

g/l

0.06

521

2600

Meralgia paraesthetica

414

1.75

4.65

1.5

2.4

9.58

10.44

g/l

1.14

375

Injury of muscle and tendon at hip and thigh level

186

1339

1.41

4.65

2.1

2.4

9.53

10.32

g/l

2.05

168

1235

Recurrent dislocation and subluxation of joint

542

1.64

4.62

1.9

2.2

9.89

10.31

g/l

0.42

505

Burns and corrosions of external body surface, specified by site

181

1298

1.41

4.61

2.1

2.4

10.03

10.44

g/l

0.47

161

1195

Crohn's disease of large intestine

528

1.65

4.61

1.6

2.3

10.11

10.40

g/l

0.30

481

Viral encephalitis, not elsewhere classified/unspecified

235

2.02

4.59

3.3

2.5

9.88

10.70

g/l

0.50

212

Postpartum haemorrhage

158

1844

0.70

4.59

1.9

2.0

10.14

9.96

g/l

0.22

144

1711

Non-small cell lung cancer, including Hilmo

331

2434

1.29

4.59

2.0

1.4

10.52

10.24

g/l

0.47

294

2114

Cholangitis (primary sclerosing, PSC)

132

896

1.50

4.57

2.0

2.5

11.64

10.30

g/l

2.23

118

799

Other specified/unspecified disorders of bone/cartilage

306

1.87

4.56

2.7

2.1

9.58

10.53

g/l

0.77

285

Benign neoplasm: Kidney

501

1.68

4.54

2.1

2.8

9.84

10.58

g/l

0.86

449

Subacute thyroiditis

432

1.72

4.54

2.6

2.3

9.97

10.40

g/l

0.40

390

Disorder of external ear, unspecified

425

1.73

4.53

2.7

9.23

10.45

g/l

2.13

389

Ulcerative proctitis

103

664

1.57

4.52

1.3

2.3

10.60

10.51

g/l

0.05

603

Type 1 diabetes, strict definition

430

1.71

4.49

1.5

1.7

9.41

10.36

g/l

1.93

411

Disorders of optic nerve, not elsewhere classified

287

1.91

4.49

2.5

2.8

9.05

10.60

g/l

1.73

260

Campylobacter enteritis

308

1.86

4.47

2.1

2.4

10.84

10.71

g/l

0.05

278

Carcinoma in situ of skin of ear and external auricular canal

260

1.96

4.45

1.8

2.5

10.09

11.40

g/l

1.19

220

Post-traumatic wound infection, not elsewhere classified

316

1.85

4.44

2.3

2.6

10.74

10.37

g/l

0.18

288

Benign neoplasm: Parotid gland

166

1184

1.42

4.44

2.1

2.5

9.98

10.40

g/l

0.55

153

1062

Congenital malformations of cardiac septa

100

622

1.58

4.43

1.7

2.3

10.30

10.49

g/l

0.15

570

Diabetic maculopathy

269

1950

1.32

4.42

1.5

2.0

10.30

10.11

g/l

0.22

246

1735

Contact with heat and hot substances

581

1.61

4.42

2.0

2.4

9.88

10.50

g/l

0.60

532

385

1.77

4.39

1.8

2.7

10.31

10.82

g/l

0.39

337

Impotence

123

831

1.51

4.39

1.9

2.4

10.07

10.53

g/l

0.71

110

743

Malignant neoplasm of breast, ER-positive, including Hilmo

580

3596

1.21

4.38

2.1

1.4

9.92

9.94

g/l

0.03

490

3129

Other papulosquamous disorders

139

2.32

4.36

3.3

2.1

10.20

10.36

g/l

0.08

125

Spasmodic torticollis

370

1.77

4.35

1.2

2.2

9.69

10.39

g/l

0.53

341

Single spontaneous delivery

567

3591

0.83

4.34

2.6

2.1

9.92

9.98

g/l

0.13

508

3116

Malignant neoplasm of breast, HER-positive

578

3591

1.21

4.34

2.1

1.4

9.92

9.94

g/l

0.03

488

3125

Pneumonitis due to solids and liquids

188

1375

1.39

4.33

2.2

10.13

10.39

g/l

0.28

154

1216

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

107

703

1.54

4.32

1.6

2.3

9.29

10.44

g/l

1.98

101

641

Other neurotic disorders

609

1.59

4.32

1.6

2.6

10.07

10.32

g/l

0.23

543

Tongue abnormality

131

901

1.48

4.29

2.6

2.5

9.97

10.33

g/l

0.39

114

798

Dissection of aorta

479

1.67

4.27

2.3

2.7

9.61

10.81

g/l

1.99

432

Monocytic leukaemia

3.38

4.26

3.9

1.4

10.58

10.39

g/l

0.05

Vitamin D deficiency

193

2.07

4.25

1.2

2.1

10.82

10.55

g/l

0.14

179

Central retinal artery occlusion

344

1.80

4.25

3.3

2.6

10.26

10.88

g/l

0.47

304

Malignant neoplasm of colon, including Hilmo

395

3182

1.25

4.24

2.4

1.4

10.06

10.14

g/l

0.14

345

2767

Colitis, primary sclerosing

115

2.42

4.23

2.6

2.1

12.22

10.13

g/l

1.14

108

Paralytic ileus

519

1.63

4.21

3.9

2.3

10.16

10.57

g/l

0.27

459

Postprocedural musculoskeletal disorders, not elsewhere classified

160

1146

1.42

4.21

2.8

2.4

10.17

10.29

g/l

0.15

147

1019

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

243

1.95

4.20

3.3

2.5

9.88

10.63

g/l

0.45

220

Viral infections of the central nervous system, including avohilmo

134

929

1.46

4.18

2.2

2.4

9.69

10.26

g/l

0.65

118

839

Other abnormal uterine and vaginal bleeding

415

2416

1.24

4.17

2.0

2.2

10.53

10.15

g/l

0.68

313

2122

Sudden idiopathic hearing loss

214

1607

1.35

4.17

2.0

2.3

10.23

10.19

g/l

0.04

175

1440

Other blood glucose lowering drugs, excl. Insulins

351

2812

1.26

4.15

1.7

2.4

10.29

10.18

g/l

0.12

316

2446

Other and unspecified mononeuropathies, also in other diseases

368

1.75

4.15

2.0

2.4

9.59

10.73

g/l

0.87

329

malignant neoplasm of male genital organs

582

2932

1.20

4.15

2.2

1.4

10.26

10.31

g/l

0.09

511

2625

Other retinal artery occlusion

354

1.77

4.14

1.5

2.9

9.73

10.81

g/l

1.50

318

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

176

1111

1.39

4.14

1.4

1.6

9.67

10.45

g/l

2.29

163

1050

Other noninflammatory disorders of vulva and perineum

162

1164

1.41

4.13

1.7

2.2

9.78

10.19

g/l

0.59

141

1039

Delivery

572

3593

0.83

4.12

2.5

2.1

9.86

9.98

g/l

0.26

515

3118

Nonsuppurative otitis media

307

2093

1.28

4.11

1.9

2.1

10.37

10.29

g/l

0.10

281

1894

Benign neoplasm of meninges

222

1681

1.34

4.10

2.0

2.4

9.38

10.21

g/l

2.54

191

1477

Conductive and sensorineural hearing loss

1757

10546

1.11

4.09

2.3

10.05

10.19

g/l

0.63

1499

9429

Hydrocele

245

1880

1.32

4.09

2.3

2.6

10.27

10.53

g/l

0.47

221

1691

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

155

1109

1.42

4.06

2.3

2.5

9.14

10.32

g/l

2.38

139

991

Nontoxic multinodular goitre

402

3276

1.24

4.06

2.0

2.4

9.57

10.15

g/l

2.25

349

2867

Retinal haemorrhage

394

1.72

4.06

4.2

2.7

10.98

10.53

g/l

0.26

353

Contusion of other and unspecified parts of foot

470

1.64

4.00

2.1

2.4

9.44

10.20

g/l

1.08

433

UC patients in KELA-register (code 208), prior to 1994

558

1.59

3.99

2.4

2.6

10.37

10.51

g/l

0.13

508

Other congenital malformations of the digestive system, including avohilmo

506

1.61

3.98

1.5

2.6

10.17

10.43

g/l

0.21

458

Other, unspecified and serous retinal detachments

442

1.67

3.97

2.0

2.7

11.01

10.68

g/l

0.22

400

Benign neoplasm: Pituitary gland, craniopharyngeal duct

638

1.54

3.96

2.9

2.5

9.42

10.40

g/l

1.79

580

Other deformities of toe(s)

442

1.66

3.95

2.4

2.2

9.13

10.41

g/l

1.87

385

Procedures for purposes other than remedying health state

270

1.86

3.94

2.0

1.6

9.91

10.19

g/l

0.25

250

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

140

992

1.43

3.93

1.9

1.4

11.38

10.26

g/l

1.59

120

856

Malignant neoplasm of bronchus and lung, including Hilmo

467

3226

1.22

3.92

2.1

1.5

10.60

10.19

g/l

1.03

417

2808

Colorectal cancer, including Hilmo

564

4436

1.19

3.91

2.4

1.4

10.15

10.13

g/l

0.03

492

3855

Lagophthalmos

173

2.10

3.90

2.0

2.2

10.06

10.48

g/l

0.15

156

Drug-induced neutropenia

146

1044

1.42

3.90

3.4

2.6

9.76

10.29

g/l

0.56

140

938

Infective dermatitis

211

1597

1.33

3.90

1.6

2.5

9.96

10.24

g/l

0.45

186

1433

Acute alcohol intoxication, ICD10

352

2840

1.25

3.89

1.4

2.4

10.08

10.20

g/l

0.20

311

2609

Malignant neoplasm of digestive organs

813

5392

1.16

3.88

2.2

1.4

10.22

10.11

g/l

0.28

707

4711

Other and unspecified corneal deformities and disorders

391

1.70

3.86

2.0

2.5

10.30

10.45

g/l

0.11

354

Injury of muscle and tendon at lower leg level

282

2222

1.28

3.85

2.6

2.5

9.75

10.30

g/l

1.56

259

2030

Use of memantine

566

5370

0.84

3.84

1.9

2.3

10.48

10.28

g/l

0.40

428

4615

Use of other anti-dementia drugs

566

5370

0.84

3.84

1.9

2.3

10.48

10.28

g/l

0.40

428

4615

Ingrowing nail

603

1.55

3.82

1.9

2.4

10.16

10.17

g/l

0.01

551

Malignant neoplasm of prostate

576

2873

1.19

3.82

2.3

1.5

10.30

10.32

g/l

0.03

505

2568

Status epilepticus

439

1.65

3.79

1.6

2.7

10.27

10.48

g/l

0.13

393

Sequelae of injuries of neck and trunk

333

1.75

3.77

3.0

2.7

11.03

10.78

g/l

0.17

303

Dystonia

102

686

1.51

3.77

1.1

2.5

9.38

10.16

g/l

1.01

624

Disorders of tooth development and eruption

244

1533

1.30

3.77

1.9

2.1

9.92

10.13

g/l

0.39

220

1381

Salpingitis and oophoritis

295

2344

1.27

3.76

1.8

2.4

9.79

10.03

g/l

0.49

262

2087

Single delivery by forceps and vacuum extractor

734

0.64

3.76

1.3

1.6

10.74

10.14

g/l

0.67

687

Senility

115

2.32

3.75

1.4

2.0

10.93

10.90

g/l

0.01

102

Haemorrhagic disorder due to circulating anticoagulants

211

1.97

3.74

1.9

2.4

10.12

10.92

g/l

0.74

185

Inguinal hernia, bilateral

229

1767

1.31

3.73

2.7

2.3

10.43

10.39

g/l

0.04

200

1576

Triptan medication for migraine, min. 3 purchases

795

5155

1.16

3.72

2.2

2.1

9.73

10.04

g/l

1.40

729

4702

Disorders of parathyroid gland, other and/or unspecified

104

2.44

3.72

1.3

1.7

9.30

9.93

g/l

0.40

Malignant neoplasm of bladder

146

1052

1.41

3.72

1.9

1.4

10.15

10.39

g/l

0.26

128

905

Other disorders of cornea

193

1454

1.34

3.72

2.0

2.3

10.41

10.25

g/l

0.23

172

1302

Malignant neoplasm of breast, including Hilmo

707

3895

1.17

3.69

2.1

1.4

9.92

9.93

g/l

0.02

607

3412

Malignant neoplasm of breast, HER2-negative, including Hilmo

707

3896

1.17

3.68

2.1

1.4

9.91

9.93

g/l

0.03

607

3413

Secondary parkinsonism, excluding more controls

291

1.79

3.67

2.5

2.0

9.45

10.79

g/l

1.17

261

Brachial plexus disorders

128

904

1.43

3.64

2.4

9.31

10.31

g/l

2.40

120

843

Benign neoplasm: Skin of eyelid, including canthus

325

2624

1.25

3.64

3.2

2.3

9.78

10.16

g/l

0.83

279

2319

Episcleritis

586

1.54

3.64

2.3

2.2

10.65

10.38

g/l

0.20

542

Inguinal or femoral hernia, bilateral

232

1800

1.30

3.63

2.7

2.3

10.41

10.40

g/l

0.01

203

1607

Atrophic disorders of skin

284

2259

1.27

3.61

1.9

2.2

9.52

10.08

g/l

1.81

254

1985

Lung diseases due to external agents

305

2448

1.26

3.60

2.8

2.3

10.36

10.35

g/l

0.00

258

2150

Other other unspecified disorders of the circulatory system

493

1.59

3.60

2.2

2.6

9.82

10.50

g/l

0.54

440

Oesophageal obstruction

517

1.58

3.60

3.1

2.8

9.95

10.59

g/l

0.68

460

567

4510

1.18

3.57

2.1

2.2

10.11

10.18

g/l

0.13

464

3860

Delivery, wide proxy

479

3032

0.83

3.56

2.4

2.0

9.89

9.98

g/l

0.18

426

2597

Congenital obstruction of the pelviureteric junction

2.52

3.55

3.3

2.3

9.85

10.19

g/l

0.22

Complications peculiar to reattachment and amputation

2.65

3.55

1.9

2.7

10.84

10.51

g/l

0.20

All dysplastic lesions of the cervix uteri, vagina or vulva

356

2833

1.23

3.54

2.1

2.0

9.98

10.05

g/l

0.11

321

2584

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

465

3898

1.20

3.53

1.7

2.3

9.85

10.24

g/l

1.54

418

3549

Orchitis and epididymitis

180

1354

1.34

3.52

2.0

2.4

10.44

10.47

g/l

0.02

159

1217

Myocardial infarction, with ST-elevation

392

3241

1.22

3.51

1.9

2.3

10.07

10.27

g/l

0.39

354

2837

Foreign body entering into or through eye or natural orifice

135

971

1.41

3.50

2.7

2.4

10.31

10.43

g/l

0.08

121

895

Melanocytic naevi of upper limb, including shoulder

266

1.81

3.50

1.9

2.4

10.09

10.64

g/l

0.36

246

Ventricular septal defect, a heart condition

138

2.13

3.50

1.5

1.8

9.64

10.28

g/l

0.47

129

Chronic iridocyclitis

609

1.52

3.48

2.3

2.5

10.64

10.47

g/l

0.13

548

Other and unspecified acute skin changes due to ultraviolet radiation

344

1.70

3.41

2.1

2.4

11.12

10.92

g/l

0.09

305

Malignant neoplasm of breast, HER2-negative

693

3866

1.16

3.40

2.1

1.4

9.90

9.93

g/l

0.04

593

3383

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

154

2.05

3.39

2.7

2.1

9.79

10.50

g/l

0.52

144

Benign neoplasm of eye and adnexa

216

1678

1.30

3.38

1.6

2.4

9.65

10.16

g/l

1.11

187

1498

Other and unspecified trigeminal disorders

162

2.03

3.35

2.0

9.50

10.61

g/l

1.09

147

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

249

3129

0.79

3.35

1.8

1.5

9.86

10.14

g/l

0.58

223

2742

Bitten or struck by other mammals

170

1278

1.34

3.34

3.0

2.5

9.68

10.24

g/l

1.01

160

1164

Malignant neoplasm of breast

693

3872

1.16

3.33

2.1

1.4

9.91

9.92

g/l

0.03

593

3389

Chromophobe cell carcinoma of kidney

2.81

3.32

2.3

1.2

10.28

10.79

g/l

0.14

Strabismus

439

3675

1.20

3.32

2.1

2.3

9.99

10.18

g/l

0.40

396

3292

Status post-ami

599

3906

1.17

3.31

1.7

2.4

10.00

10.36

g/l

1.34

525

3366

Disturbance of activity and attention

662

1.47

3.30

1.4

1.6

9.86

10.39

g/l

0.84

631

Achilles tendinitis

178

1352

1.33

3.28

2.9

2.2

9.90

10.35

g/l

0.77

157

1233

Dissection of cerebral arteries, nonruptured

2.60

3.28

1.7

1.8

8.09

10.28

g/l

1.47

Crohn disease (strict definition, require KELA)

633

1.49

3.27

1.8

2.3

9.87

10.33

g/l

0.59

581

Vulvovaginal ulceration/inflammation in other diseases

633

1.48

3.26

1.8

2.3

9.33

10.02

g/l

1.10

582

Haemangioma, any site

154

1147

1.36

3.26

2.4

2.5

10.34

10.26

g/l

0.08

141

1036

Seborrhoeic dermatitis

186

1424

1.32

3.25

2.2

2.5

10.25

10.26

g/l

0.01

161

1274

Type 1 diabetes, strict definition, subgroup 1

392

1.61

3.25

1.5

1.6

9.26

10.27

g/l

1.97

375

Hyperkinetic disorders

104

704

1.45

3.25

1.4

1.6

9.89

10.33

g/l

0.70

669

Familial hypercholesterolemia, with ischemic heart disease

215

1681

1.30

3.24

2.0

2.4

9.65

10.37

g/l

1.54

183

1450

Endocrine disorders, other/unspecified

220

0.31

3.23

1.6

2.2

12.36

10.48

g/l

—

206

Crohn disease (strict definition, require KELA, min 2 HDR)

619

1.49

3.22

1.8

2.3

9.85

10.33

g/l

0.61

567

Assault by bodily force

643

1.47

3.21

1.9

2.2

9.78

10.37

g/l

0.69

608

Benign neoplasm: Liver/bile ducts

296

1.72

3.21

2.3

2.0

9.97

10.34

g/l

0.38

276

Haemangioma and lymphangioma, any site

162

1219

1.34

3.20

2.6

2.5

10.28

10.26

g/l

0.02

149

1103

Other disorders of the genitourinary system

264

2118

1.26

3.20

2.0

2.3

9.87

10.21

g/l

0.79

234

1852

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

677

1.46

3.19

2.2

2.3

10.07

10.23

g/l

0.18

629

Benign neoplasm of middle ear and respiratory system

157

1178

1.35

3.18

2.6

2.4

9.94

10.33

g/l

0.68

144

1058

Prepatellar bursitis

524

1.53

3.18

2.5

2.3

10.80

10.36

g/l

0.34

471

Atrial septal defect

340

1.66

3.17

1.9

2.1

10.77

10.51

g/l

0.13

313

Hyperfunction of pituitary gland

444

1.57

3.16

2.8

2.1

9.71

10.43

g/l

0.59

413

Otitis externa, unspecified

187

1438

1.31

3.16

2.1

2.3

10.23

10.31

g/l

0.13

166

1301

Other and unspecified mononeuropathies of lower limb

352

1.65

3.14

1.6

2.1

8.93

10.57

g/l

2.92

316

Benign neoplasm: Liver

253

1.77

3.14

2.4

2.1

9.96

10.56

g/l

0.63

236

Malignant neoplasm of respiratory system and intrathoracic organs

456

3199

1.19

3.13

2.1

1.5

10.41

10.19

g/l

0.43

404

2793

Other disorders of breast

220

1730

1.28

3.13

2.3

9.47

10.06

g/l

1.44

188

1537

Alzheimer’s disease (Atypical or mixed)

181

2308

0.77

3.12

1.5

2.2

10.32

10.34

g/l

0.02

146

1954

HSIL lesion of the cervix uteri, vagina or vulva

233

1844

1.27

3.12

2.0

10.40

10.00

g/l

0.74

207

1687

Other disorders of Eustachian tube

368

1.63

3.12

1.6

2.3

10.18

10.60

g/l

0.29

337

Malignant neoplasm of colon

318

2609

1.23

3.11

2.6

1.4

10.05

10.13

g/l

0.11

279

2253

Schizophrenia or delusion, excluding more controls

448

3743

1.19

3.10

1.9

2.4

10.02

10.24

g/l

0.39

391

3403

Benign neoplasm of other and unspecified intrathoracic organs

140

2.07

3.08

2.9

2.2

10.41

10.75

g/l

0.12

126

Burns and corrosions of multiple and unspecified body regions

225

1.81

3.07

2.0

2.8

10.68

10.95

g/l

0.12

210

conjunctival haemorrhage

162

1229

1.33

3.07

2.5

2.3

9.64

10.30

g/l

1.39

146

1092

Corns and callosities

127

928

1.39

3.07

2.3

9.58

10.25

g/l

1.12

111

832

Other acute skin changes due to ultraviolet radiation

458

1.56

3.03

1.9

2.3

10.74

10.61

g/l

0.07

411

Other and unspecified injuries of thorax

197

1.87

3.03

2.2

2.5

10.27

11.20

g/l

0.64

176

Malignant neoplasm of head and neck, including Hilmo

188

1457

1.30

3.02

2.9

1.4

9.73

10.20

g/l

0.85

169

1268

Malnutrition

279

1.72

3.02

1.8

2.1

10.29

10.68

g/l

0.19

247

Malignant neoplasm of small intestine, including Hilmo

419

1.58

3.02

2.1

1.4

9.94

10.34

g/l

0.34

366

Maternal care related to the fetus and amniotic cavity and possible delivery problems

409

2852

0.84

3.02

2.5

2.1

10.12

9.96

g/l

0.34

383

2605

Sequelae of injuries of head

612

1.47

3.02

2.9

2.5

9.62

10.49

g/l

1.55

559

Acute lymphadenitis

579

1.48

3.01

2.5

2.4

10.54

10.41

g/l

0.08

529

Open wound of shoulder and upper arm

212

1.83

3.01

1.4

2.1

10.62

10.59

g/l

0.01

193

Trigeminal neuralgia

109

780

1.41

2.99

2.4

9.35

10.53

g/l

2.68

698

Brain meningioma, including Hilmo

697

1.44

2.98

2.4

1.4

9.48

10.28

g/l

1.35

595

Graves ophthalmopathy, strict

265

1.74

2.98

1.2

1.9

9.69

10.66

g/l

1.23

243

Tracheo-bronchomalasia

4.86

2.95

1.7

3.8

12.05

10.51

g/l

—

Blindness, monocular

122

2.12

2.94

4.4

1.9

9.76

10.29

g/l

0.28

111

Paralytic strabismus

142

1064

1.35

2.94

1.9

2.4

10.01

10.32

g/l

0.34

125

955

Asthma mixed form (mode), excluding more controls

468

1.53

2.94

2.2

1.6

10.27

10.40

g/l

0.09

404

Congenital malformations of heart and great arteries

185

1392

1.30

2.94

2.1

2.4

10.08

10.31

g/l

0.31

166

1268

Other noninflammatory disorders of uterus, except cervix

418

2351

1.19

2.93

2.4

2.2

9.85

10.10

g/l

0.50

361

2061

Other acquired deformities of musculoskeletal system and connective tissue

568

1.48

2.91

2.5

2.3

10.15

10.44

g/l

0.28

515

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

536

1.50

2.90

2.9

2.5

10.20

10.66

g/l

0.52

488

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

683

1.43

2.90

1.7

2.4

9.77

10.36

g/l

0.85

625

Allergic contact dermatitis due to drugs in contact with skin

275

1.71

2.90

1.7

2.1

9.65

10.69

g/l

0.91

252

Irregular menses

674

4432

1.15

2.89

2.0

2.2

9.69

9.98

g/l

1.11

604

4016

Medial epicondylitis

375

1.59

2.89

1.4

2.1

9.78

10.33

g/l

0.52

346

Malignant neoplasm of thymus, including Hilmo

2.92

2.89

4.8

1.2

8.54

10.59

g/l

1.10

Acute alcohol intoxication

469

4014

1.17

2.89

1.5

2.5

10.00

10.25

g/l

0.65

413

3647

Disorders of synovium and tendon in diseases classified elsewhere

230

1.77

2.88

1.8

2.1

9.21

10.55

g/l

1.82

209

Other specified disorders of kidney and ureter

416

1.57

2.88

2.5

2.8

9.69

10.60

g/l

0.93

379

Malignant neoplasm of endocrine gland, including Hilmo

137

1024

1.35

2.87

2.7

1.4

10.04

10.20

g/l

0.15

124

892

Congenital iodine-deficiency syndrome/hypothyroidism

401

1.58

2.86

2.7

1.9

9.10

10.38

g/l

1.47

354

Other and unspecified injuries of ankle and foot

400

1.57

2.85

1.3

2.4

9.69

10.34

g/l

0.66

369

Non-small cell lung cancer, adenocarcinoma

132

984

1.36

2.85

1.9

1.4

10.84

10.28

g/l

0.61

117

852

Supplementary factors related to causes of morbidity and mortality classified elsewhere

571

4966

1.16

2.84

1.9

2.3

10.06

10.20

g/l

0.28

463

4432

Myopia

166

1276

1.31

2.84

2.1

2.4

10.16

10.32

g/l

0.15

155

1169

Sensorineural hearing loss

1674

10267

1.09

2.83

2.3

2.4

10.07

10.20

g/l

0.50

1428

9161

Triptan medication for migraine, single purchase ok

1237

7602

1.10

2.83

2.2

2.3

9.72

10.07

g/l

2.38

1131

6862

Migraine, single triptan purchase ok & required. ICD-code if available is included

1237

7602

1.10

2.83

2.2

2.3

9.72

10.07

g/l

2.38

1131

6862

Crohn disease (strict definition, all UC cases excluded)

506

1.50

2.81

1.6

2.5

9.62

10.37

g/l

1.02

466

Injuries involving multiple body regions

419

1.55

2.78

2.3

2.4

10.06

10.40

g/l

0.33

385

Hypertrophic disorders of skin

573

1.46

2.78

2.5

2.3

10.57

10.42

g/l

0.12

524

Postpartum care and examination

585

0.65

2.77

1.1

1.6

10.52

10.32

g/l

0.12

550

Septal defects

585

1.45

2.77

1.7

2.3

10.30

10.35

g/l

0.04

536

Hereditary sideroblastic anaemia

3.18

2.77

2.5

1.5

10.08

8.99

g/l

0.45

Benign neoplasm of breast

212

1690

1.27

2.76

2.1

2.2

10.18

9.99

g/l

0.31

184

1473

Melanoma in situ of other and unspecified parts of face

220

1.79

2.75

2.2

2.7

10.36

10.14

g/l

0.11

196

Other problems related to primary support group, including family circumstances

120

860

1.36

2.74

1.9

2.2

10.05

10.27

g/l

0.27

110

798

Varicose veins

1280

8813

1.10

2.73

2.4

2.3

10.25

10.13

g/l

0.44

1113

7775

Brain meningioma

676

1.42

2.73

2.4

1.4

9.45

10.24

g/l

1.32

577

Nonspecific lymphadenitis

625

1.44

2.73

1.8

2.2

9.95

10.12

g/l

0.15

576

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

5.33

2.72

10.4

1.1

9.20

10.79

g/l

—

Other disorders of bone density and structure

257

1.70

2.71

1.6

2.1

9.44

10.58

g/l

1.52

238

Other disorders of choroid

198

1.82

2.70

1.9

3.0

11.06

10.19

g/l

0.46

180

Malignant neoplasm of liver and intrahepatic bile ducts

439

1.53

2.69

1.8

1.4

12.50

10.46

g/l

1.61

382

Systemic sclerosis,strict definition

106

2.15

2.69

1.3

1.7

10.68

9.96

g/l

0.32

Focal epilepsy, strict definition

363

3062

1.19

2.69

2.1

2.3

10.09

10.22

g/l

0.19

311

2734

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

102

737

1.40

2.69

1.6

1.4

11.30

10.28

g/l

0.96

631

Postpartum hemorraghe, all women as controls

158

1988

0.77

2.68

1.9

10.14

10.06

g/l

0.09

144

1858

Laparoscopic right hemicolectomy

133

1004

1.35

2.68

2.2

2.5

10.35

10.43

g/l

0.06

111

888

Disorders of lacrimal system and orbit in diseases classified elsewhere

289

1.66

2.68

1.1

2.0

9.63

10.54

g/l

1.11

265

Contusion of toe(s) without damage to nail

235

1.73

2.68

1.3

2.5

9.01

10.46

g/l

1.91

223

Other and unspecified primary disorders of muscles

2.34

2.67

1.2

2.5

9.74

10.45

g/l

0.38

Injury of nerves and spinal cord at neck level

282

1.67

2.66

2.8

2.9

9.94

10.68

g/l

0.66

253

Alkalosis

3.87

2.65

2.0

2.7

10.68

10.13

g/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

195

1545

1.27

2.65

2.0

2.1

9.83

10.28

g/l

0.89

171

1429

Meningitis

571

1.45

2.65

2.7

2.4

9.73

10.35

g/l

0.55

522

Pre-eclampsia or poor fetal growth

354

2970

1.19

2.63

2.1

9.93

10.01

g/l

0.11

324

2710

Degeneration of nervous system due to alcohol

299

1.64

2.62

1.3

2.7

10.20

10.72

g/l

0.55

270

Postpartum hemorraghe, parous women as controls

158

1701

0.77

2.62

1.9

2.0

10.14

10.02

g/l

0.13

144

1588

Malignant neoplasm of hypopharynx, including Hilmo

2.44

2.61

4.2

1.2

9.09

10.78

g/l

1.23

Acute nasopharyngitis (common cold)

173

1346

1.28

2.58

1.9

2.1

9.91

10.29

g/l

0.60

161

1244

Effects of foreign body entering through natural orifice

410

3509

1.17

2.57

2.2

2.4

10.19

10.24

g/l

0.09

369

3190

Pyoderma

216

1.75

2.57

2.0

2.4

10.05

10.82

g/l

0.35

199

Glaucoma secondary to other eye disorders

601

1.44

2.56

2.5

2.7

11.35

10.45

g/l

0.71

534

Benign neoplasm: Cerebral meninges

193

1540

1.27

2.54

2.1

2.4

9.47

10.21

g/l

1.88

169

1359

Excessive attrition of teeth

1059

9520

1.10

2.54

2.4

2.3

9.87

10.14

g/l

1.50

947

8608

Sexual dysfunction

172

1.84

2.54

2.5

2.4

10.69

10.26

g/l

0.17

161

Degeneration of the brain due to alcohol

302

1.63

2.53

1.3

2.8

10.20

10.67

g/l

0.47

274

Neovascular glaucoma

603

1.43

2.52

2.5

2.4

11.35

10.64

g/l

0.51

536

Explicit viral Sepsis

7.67

2.51

1.4

1.0

10.04

11.57

g/l

—

Burn and corrosion of wrist and hand

365

1.55

2.51

1.6

2.4

9.77

10.42

g/l

0.52

337

Benign neoplasm: Prostate

2.18

2.51

3.5

3.4

10.34

11.04

g/l

0.22

Other noninflammatory disorders of vagina

130

987

1.33

2.50

2.2

9.42

10.22

g/l

1.43

110

872

Malignant neoplasm of small intestine

303

1.62

2.50

2.5

1.4

10.44

10.57

g/l

0.07

265

Acute suppurative otitis media

288

2231

1.21

2.49

2.8

2.1

10.27

10.25

g/l

0.02

262

2060

Unspecified mental disorder

641

5673

1.13

2.48

2.0

2.3

9.89

10.19

g/l

1.07

578

5104

Explicit viral Sepsis, including avohilmo

7.40

2.48

1.4

1.0

10.04

11.57

g/l

—

Medical abortion

1071

5256

1.11

2.48

1.9

2.3

9.94

9.98

g/l

0.11

932

4624

Vascular dementia

236

1861

1.23

2.48

2.6

2.3

10.08

10.50

g/l

0.73

194

1600

Ulcerative rectosigmoiditis

124

937

1.33

2.47

1.9

2.4

11.29

10.48

g/l

0.76

109

863

Graves ophthalmopathy

296

1.62

2.46

1.1

2.0

9.63

10.58

g/l

1.26

270

Schizophrenia

155

1976

0.78

2.45

2.5

2.3

9.81

10.23

g/l

0.52

135

1812

Pre-eclampsia or eclampsia

281

2338

1.21

2.45

2.1

2.2

9.86

10.01

g/l

0.22

256

2119

Other facial nerve disorders

328

1.58

2.44

2.1

2.2

9.82

10.51

g/l

0.38

295

Malignant neoplasm of head and neck

155

1210

1.29

2.44

2.2

1.4

9.69

10.22

g/l

0.94

140

1057

Macular cyst

508

1.47

2.43

2.5

2.8

9.55

10.46

g/l

1.21

457

Contraceptive management

432

3495

0.86

2.41

2.3

2.1

10.07

10.04

g/l

0.06

397

3236

Benign neoplasm: Skin of other and unspecified parts of face

210

1703

1.24

2.41

3.5

2.4

9.52

10.32

g/l

2.21

179

1514

Benign neoplasm: Skin of ear and external auricular canal

584

1.43

2.40

2.6

2.5

9.39

10.97

g/l

2.97

522

Other diseases of gallbladder

652

1.40

2.38

2.5

2.6

10.17

10.40

g/l

0.21

574

Dislocation of lens

214

1.72

2.37

2.8

2.6

10.15

10.26

g/l

0.06

198

Other and unspecified mononeuropathies of upper limb

323

1.57

2.36

1.5

2.4

9.62

10.58

g/l

1.35

299

Focal epilepsy

381

3268

1.17

2.35

2.1

2.3

10.17

10.20

g/l

0.05

326

2920

Injury of other and unspecified intrathoracic organs

119

903

1.33

2.34

1.8

2.4

9.63

10.58

g/l

1.79

108

815

Alport

5.03

2.34

1.5

4.0

7.13

10.68

g/l

—

Pedestrian injured in transport accident

118

894

1.33

2.33

1.5

2.3

9.35

10.32

g/l

1.96

103

807

Chondromalacia

325

1.56

2.31

1.4

2.2

10.66

10.26

g/l

0.19

307

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

117

888

1.33

2.29

2.3

1.4

9.68

10.22

g/l

0.63

102

774

Graves disease, strict definition

151

1186

1.28

2.28

2.6

2.2

9.55

10.20

g/l

1.54

136

1076

Hypertrophic scar

522

1.43

2.27

2.7

2.2

10.51

10.40

g/l

0.08

477

Corneal ulcer

307

2597

1.19

2.27

2.2

10.37

10.19

g/l

0.34

276

2337

Malignant neoplasm of thyroid gland, including Hilmo

119

907

1.32

2.27

2.8

1.4

10.01

10.19

g/l

0.16

106

790

HSIL lesion of the cervix uteri

191

1542

1.24

2.26

1.9

2.0

10.51

10.11

g/l

0.66

172

1423

Melanoma in situ of trunk

233

1.68

2.26

1.9

2.8

10.76

10.68

g/l

0.03

208

Hypertrophy of tongue papillae

165

1.80

2.24

2.1

2.4

9.55

10.43

g/l

0.62

154

Intercostal neuropathy

2.14

2.22

3.9

2.5

10.97

10.67

g/l

0.12

Colorectal cancer

484

4073

1.15

2.22

2.6

1.4

10.16

g/l

0.00

423

3534

Other disorders of male genital organs

426

1.47

2.20

1.6

2.5

9.63

10.57

g/l

1.27

384

Pleural plaque without asbestos

664

1.38

2.19

1.8

2.6

10.95

10.69

g/l

0.21

585

Uterine polyps

487

2488

1.15

2.19

1.9

2.2

9.99

10.12

g/l

0.29

427

2197

Corneal degeneration

243

1.64

2.18

1.4

2.4

10.41

10.84

g/l

0.31

218

Alzheimer’s disease (Early onset), excluding more controls

531

0.61

2.18

1.3

2.2

10.58

10.81

g/l

0.14

457

Vascular dementia (subcortical)

656

1.38

2.17

3.3

2.3

10.28

10.73

g/l

0.44

568

Occupational exposure to risk-factors

449

0.57

2.17

4.1

2.7

9.51

10.75

g/l

0.70

412

Other peripheral vertigo

180

1457

1.25

2.14

1.8

2.6

10.29

10.30

g/l

0.01

154

1300

Other maternal disorders predominantly related to pregnancy

649

4540

0.89

2.14

2.1

2.2

9.75

9.97

g/l

0.76

596

4093

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

2.70

2.14

1.2

8.90

9.95

g/l

0.49

Use of peginterferon beta-1a

3.32

2.13

1.9

1.1

9.45

10.38

g/l

—

Other changes in lacrimal passages

3.82

2.13

3.1

1.6

10.60

10.25

g/l

—

Abdominal aortic aneurysm (AAA)

214

1751

1.22

2.12

1.7

2.3

10.45

10.58

g/l

0.16

188

1516

Type of accident

526

4657

1.13

2.11

1.9

2.2

10.10

10.21

g/l

0.23

420

4167

Other disorders of conjunctiva

285

2415

1.19

2.11

2.8

2.3

9.63

10.20

g/l

1.74

257

2138

Atopic conjunctivitis

430

1.46

2.11

1.5

2.0

9.99

10.41

g/l

0.47

394

Alcohol withdrawal state with delirium

122

945

1.30

2.10

1.3

2.4

10.65

10.59

g/l

0.04

867

Other strabismus

319

2716

1.17

2.10

2.2

2.3

10.01

10.23

g/l

0.44

290

2452

Dronedarone medication

407

1.48

2.10

1.9

2.6

9.19

10.61

g/l

2.35

352

Recurrent and persistent haematuria

2.04

2.10

1.4

2.4

10.35

10.36

g/l

0.00

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

217

1794

1.21

2.07

1.9

2.1

9.67

10.30

g/l

1.63

191

1665

Other or unspecified paralytic strabismus

2.18

2.07

1.1

2.4

8.92

10.06

g/l

0.91

Recurrent dislocation of patella

277

1.56

2.06

1.2

1.9

9.64

9.92

g/l

0.26

263

All dysplastic lesions of the vagina

294

1.55

2.06

1.6

1.9

9.02

10.18

g/l

1.91

272

Caught, crushed, jammed or pinched in or between objects

533

1.40

2.05

1.4

2.5

9.46

10.45

g/l

1.87

493

All dysplastic lesions of the cervix uteri

279

2325

1.18

2.05

2.2

2.0

10.13

10.02

g/l

0.18

254

2142

Appendectomy

1115

9771

1.09

2.05

2.4

2.2

9.87

10.11

g/l

1.21

996

8815

Other factor of the environment

140

1.83

2.05

3.9

1.9

10.47

10.52

g/l

0.01

129

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

392

1.47

2.05

1.6

2.4

10.44

10.31

g/l

0.08

360

Malignant neoplasm of oral cavity, including Hilmo

585

1.38

2.04

2.3

1.4

10.17

10.26

g/l

0.06

512

Any dementia, excluding more controls

891

5573

1.10

2.04

2.1

2.5

10.23

10.28

g/l

0.11

729

4862

Aneurysms, operations, SAH

314

2691

1.17

2.04

1.8

2.3

9.60

10.13

g/l

1.50

266

2394

Striae atrophicae

104

1.97

2.03

1.6

2.3

9.95

10.16

g/l

0.12

Contact with other hot metals

155

1.78

2.03

1.6

2.5

9.89

11.00

g/l

0.86

139

Malignant neoplasm of bronchus and lung

389

2828

1.16

2.03

1.9

1.5

10.53

10.19

g/l

0.65

343

2458

Focal brain injury

106

809

1.32

2.03

2.2

2.4

10.05

10.57

g/l

0.50

732

Other lesions of median nerve

377

1.48

2.02

1.3

2.3

9.36

10.54

g/l

1.65

329

Presbycusis

355

3036

1.16

2.02

2.5

2.2

10.14

10.37

g/l

0.40

295

2615

Renal agenesis and other reduction defects of kidney, including avohilmo

2.37

2.02

1.4

2.6

9.50

10.05

g/l

0.36

Benign neoplasm: Lip

288

1.56

2.02

2.4

2.3

11.08

10.69

g/l

0.17

255

Other and unspecified degenerative diseases of nervous system

461

1.44

2.01

2.2

2.6

9.18

10.69

g/l

2.09

412

Pedestrian injured in collision with pedal cycle

369

1.48

2.01

1.6

2.5

9.58

10.61

g/l

1.06

333

Transient acantholytic dermatosis [Grover]

2.96

2.01

1.2

2.5

11.28

10.16

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

741

1.33

2.00

2.2

2.3

10.07

10.20

g/l

0.14

685

Flat foot [pes planus] (acquired)

146

1164

1.26

2.00

1.7

2.6

9.58

10.24

g/l

1.22

126

1037

Convergent concomitant strabismus

519

1.40

1.99

2.2

9.53

10.40

g/l

1.12

476

Palindromic rheumatism

105

1.95

1.99

1.4

1.6

9.27

10.50

g/l

0.65

Toxic colitis

2.58

1.99

2.0

1.8

12.42

9.63

g/l

1.07

Tonsillectomy and adenotomy

580

4514

0.89

1.97

1.9

2.1

9.91

10.12

g/l

0.65

529

4179

Other congenital malformations of the digestive system

400

1.45

1.97

1.5

2.5

9.68

10.57

g/l

1.00

359

Other drug-induced secondary parkinsonism

135

1.83

1.96

1.9

2.3

9.11

10.56

g/l

0.86

123

Use of disulfiram, acamprosate or naltrexone

128

1007

1.28

1.96

1.6

2.3

9.41

10.23

g/l

1.31

111

936

Glaucoma suspect

656

7262

0.90

1.96

2.2

2.4

10.11

10.10

g/l

0.00

579

6363

Maternal care for (suspected) damage to fetus from alcohol

3.88

1.96

1.2

1.0

10.88

9.16

g/l

—

Lateral epicondylitis

191

1572

1.22

1.95

1.8

2.2

9.53

10.23

g/l

2.03

171

1424

Benign neoplasm: Choroid

132

1045

1.28

1.95

1.7

2.7

9.22

10.30

g/l

2.42

112

935

Residual foreign body in soft tissue

530

1.39

1.95

2.0

2.4

9.30

10.35

g/l

1.90

487

Transient global amnesia

125

1579

0.78

1.94

2.8

2.4

10.25

10.27

g/l

0.02

103

1413

Other symptoms and signs involving the digestive system and abdomen

287

2452

1.18

1.94

2.0

2.4

9.46

10.29

g/l

3.24

230

2165

Use of galantamine

124

1567

0.78

1.94

1.4

2.4

10.39

10.38

g/l

0.00

1341

Acquired absence of limb

128

1.85

1.94

1.4

1.9

9.75

10.60

g/l

0.41

118

Non-small cell lung cancer

212

1745

1.21

1.93

1.8

1.4

10.91

10.32

g/l

0.93

188

1500

Pilonidal cyst

102

781

1.31

1.92

2.1

2.2

10.22

10.31

g/l

0.07

735

Cerebral aneurysm, nonruptured

154

1243

1.25

1.92

1.7

2.4

9.58

10.14

g/l

0.98

135

1118

Papillary adenocarcinoma of thyroid gland

610

1.36

1.90

1.9

1.4

10.49

10.12

g/l

0.27

537

Arthropathy in Crohn disease

100

1.94

1.89

1.1

2.2

9.44

10.22

g/l

0.51

Maternal care for other known or suspected fetal problems

134

1056

0.79

1.87

1.6

1.8

10.19

10.09

g/l

0.10

128

997

Moderate visual impairment, binocular

443

1.42

1.85

1.6

2.1

9.60

10.40

g/l

0.73

390

Sixth [abducent] nerve palsy

477

1.40

1.85

2.4

2.7

10.60

10.68

g/l

0.04

422

Lifestyle-related condition

130

1.81

1.85

4.2

1.9

10.65

10.38

g/l

0.06

118

114

1446

0.78

1.85

1.3

2.4

12.99

10.34

g/l

4.16

1299

Malignant neoplasm of nasal cavity and sinuses

2.12

1.84

5.5

1.2

10.77

10.06

g/l

0.26

Congenital varicose veins

2.65

1.83

2.3

2.1

10.23

10.14

g/l

—

Vascular dementia (other)

109

1.90

1.82

1.7

2.6

10.83

10.44

g/l

0.13

Use of rivastigmine

297

3424

0.86

1.82

2.4

2.2

10.05

10.30

g/l

0.50

246

2907

Proteinuria and renal glomerular damage; focal glomerulonephritis

3.70

1.81

1.3

3.1

8.48

10.34

g/l

—

Pregnancy, childbirth and the puerperium

444

2622

0.88

1.81

1.8

2.1

9.94

10.08

g/l

0.24

386

2226

Amblyopia ex anopsia

394

1.44

1.81

1.4

2.2

9.85

10.35

g/l

0.41

364

Other infective spondylopathies

2.69

1.80

4.6

1.1

9.18

10.69

g/l

—

Asthma mixed form (mode)

521

1.37

1.80

2.2

1.6

10.27

10.33

g/l

0.04

453

Leiomyoma of uterus

1083

5610

1.09

1.79

2.2

9.79

10.01

g/l

0.87

923

4952

Conductive hearing loss, unspecified

141

1137

1.25

1.79

2.0

2.3

10.07

10.32

g/l

0.23

127

1023

Hereditary corneal dystrophies

532

1.37

1.78

1.6

2.6

10.37

10.41

g/l

0.03

472

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

487

1.38

1.78

2.8

1.9

10.29

10.27

g/l

0.01

454

Ill-defined and unknown causes of mortality

148

1812

0.81

1.76

2.3

2.4

10.43

10.41

g/l

0.01

127

1583

Open wound of wrist and hand

770

6797

1.10

1.76

2.4

2.2

10.10

10.25

g/l

0.43

701

6159

Myositis ossificans

2.80

1.76

2.1

2.5

9.50

10.30

g/l

—

Undefined dementia

191

2107

0.83

1.76

2.0

2.3

10.20

10.50

g/l

0.35

156

1773

Maze procedure for atrial fibrillation

2.16

1.76

1.3

2.0

13.25

10.23

g/l

0.84

Tuberculosis, IBD comorbidity

139

1123

1.25

1.75

2.3

10.59

10.31

g/l

0.24

116

982

Contact with machinery

129

1602

0.80

1.75

2.4

2.3

9.95

10.26

g/l

0.27

115

1463

Carcinoma in situ of skin of lip

2.33

1.74

1.2

1.5

9.83

10.56

g/l

0.33

Varicose veins of other sites

105

821

1.29

1.74

2.6

2.4

10.27

10.33

g/l

0.05

742

Malignant neoplasm of ureter, including Hilmo

111

1.86

1.73

2.5

1.4

11.08

11.06

g/l

0.01

Glaucoma-related operations

125

1002

1.26

1.71

2.7

2.6

10.63

10.46

g/l

0.15

108

871

Other acantholytic disorders

2.40

1.70

1.4

2.8

11.24

10.34

g/l

0.53

Granuloma annulare

172

1.66

1.70

2.0

1.8

9.66

9.98

g/l

0.20

158

Malignant neoplasm of pancreas

1071

0.76

1.70

1.8

1.4

10.14

10.21

g/l

0.06

927

Dentofacial anomalies [including malocclusion]

1146

8331

1.08

1.70

2.2

2.3

9.80

10.08

g/l

1.50

1022

7537

Other and unspecified abdominal hernia

597

1.34

1.70

1.4

2.1

10.53

10.44

g/l

0.07

537

Pedal cyclist injured in noncollision transport accidents

173

1435

1.21

1.69

1.8

2.3

10.12

10.31

g/l

0.25

151

1312

Lesion of radial nerve

443

1.39

1.68

2.0

2.4

9.99

10.62

g/l

0.29

402

Use of levodopa decarboxylase inhibitor

310

2703

1.15

1.68

2.0

2.4

10.09

10.27

g/l

0.38

264

2353

Vascular dementia (mixed)

335

1.46

1.67

2.5

2.2

9.62

10.89

g/l

1.02

292

Thyroiditis, unspecified

173

1.65

1.67

1.3

1.7

10.14

10.45

g/l

0.16

159

Unspecific neurodegenerative disorder

937

6938

0.92

1.67

1.9

2.4

10.26

10.25

g/l

0.02

737

6049

Hepatocellular carcinoma

310

1.47

1.67

2.0

1.4

13.22

10.49

g/l

2.45

268

Alzheimer disease

723

5648

0.91

1.65

1.8

2.3

10.45

10.26

g/l

0.49

585

4851

Malignant neoplasm of endocrine gland

112

889

1.27

1.65

2.2

1.4

10.24

10.22

g/l

0.01

103

775

Sequelae of injuries of upper limb

151

1239

1.23

1.65

2.7

2.5

9.40

10.29

g/l

1.96

132

1125

Car occupant injured in other and unspecified transport accidents

266

2295

1.16

1.64

1.9

2.3

10.40

10.27

g/l

0.15

239

2082

Right hemicolectomy

119

954

1.26

1.64

3.3

2.5

10.14

10.47

g/l

0.30

114

846

Noninflammatory disorders of female genital tract

591

2676

1.11

1.63

2.3

2.1

9.95

10.18

g/l

0.65

520

2372

Reduction defects of lower limb, including avohilmo

2.59

1.62

3.1

3.7

10.44

10.09

g/l

—

Benign neoplasm of other and unspecified female genital organs

592

0.68

1.62

1.8

2.4

9.84

10.04

g/l

0.11

526

Schizoaffective disorder

776

1.28

1.62

1.9

2.3

9.67

10.31

g/l

1.03

718

Excessive earwax

1338

11362

1.07

1.61

2.5

2.3

10.18

10.16

g/l

0.06

1138

10101

Benign neoplasm: Larynx

430

1.39

1.61

2.7

9.91

10.95

g/l

1.03

387

Single delivery by caesarean section

136

955

0.81

1.61

2.3

1.6

10.16

10.03

g/l

0.18

127

898

Whooping cough, including avohilmo

121

1.76

1.60

1.4

2.5

9.82

10.11

g/l

0.20

116

Pre-eclampsia

243

2087

1.17

1.60

2.2

2.1

10.02

10.01

g/l

0.00

219

1893

Malignant neoplasm of hypopharynx

2.36

1.59

1.0

1.2

9.80

10.65

g/l

—

Pathological resorption of teeth

448

1.38

1.59

1.1

2.6

10.55

10.45

g/l

0.05

413

All dysplastic lesions of the vulva

517

1.35

1.58

1.9

2.3

9.50

10.10

g/l

0.42

473

Otitis media, unspecified

122

904

1.25

1.58

2.6

2.1

10.32

10.29

g/l

0.02

116

828

Diseases of appendix

1334

11181

1.07

1.58

2.7

2.2

9.94

10.16

g/l

1.18

1189

10058

Dislocation, sprain and strain of joints and ligaments of knee

983

8244

1.08

1.58

2.0

2.4

9.74

10.19

g/l

3.61

881

7480

Contact with other hot fluids

289

1.47

1.56

1.5

2.3

8.63

10.57

g/l

2.66

269

Other female pelvic inflammatory diseases

248

2139

1.17

1.56

1.7

2.4

9.45

10.08

g/l

1.65

193

1888

Chronic postrheumatic arthropathy [Jaccoud]

3.57

1.56

2.2

2.0

10.40

10.03

g/l

—

Other and unspecified injuries of shoulder and upper arm

373

1.41

1.56

1.9

2.6

9.57

10.61

g/l

1.08

338

Other diseases of biliary tract

169

1413

1.20

1.55

2.4

10.21

10.18

g/l

0.04

150

1250

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

231

1983

1.17

1.55

2.6

2.4

9.89

10.24

g/l

0.49

204

1797

Benign neoplasm of male genital organs

282

1.48

1.55

2.4

2.9

9.40

11.24

g/l

1.74

255

Carcinoma in situ of other and unspecified sites

695

1.30

1.55

3.2

2.6

9.57

10.74

g/l

2.10

625

Maternal care for known or suspected abnormality of pelvic organs

189

1512

0.84

1.55

2.8

2.1

10.23

10.05

g/l

0.29

174

1401

HSIL lesion of the vulva

225

1.54

2.6

2.1

9.68

10.11

g/l

0.18

207

Benign neoplasm: other/unspecified salivary gland

383

1.40

1.54

1.5

2.5

8.64

10.54

g/l

3.32

340

Tuberculosis, wide

143

1179

1.22

1.53

2.3

2.4

10.57

10.40

g/l

0.13

119

1034

Malignant neoplasm of oral cavity

460

1.36

1.53

2.1

1.4

10.05

10.31

g/l

0.18

404

Vascular dementia (undefined)

733

1.28

1.52

2.1

2.2

10.22

10.82

g/l

0.55

626

Parkinson's disease, including avohilmo

347

3073

1.14

1.52

1.9

2.4

9.92

10.24

g/l

0.89

296

2681

Tuberculosis, wide, including avohilmo

145

1199

1.22

1.51

2.3

2.4

10.61

10.38

g/l

0.19

121

1052

Perforation of tympanic membrane

166

1390

1.20

1.51

2.3

10.01

10.24

g/l

0.30

146

1242

Seminoma of testis, including Hilmo

2.10

1.51

1.9

1.3

9.68

10.44

g/l

0.51

Chorioretinal inflammation

359

1.41

1.51

1.5

2.3

10.63

10.34

g/l

0.19

330

Polyp of the female genital tract

496

2528

1.11

1.49

1.9

2.2

9.83

10.13

g/l

0.91

438

2231

Separation of retinal layers (serosa)

531

1.33

1.49

2.4

2.6

10.61

10.47

g/l

0.10

486

Respiratory tuberculosis, confirmed

235

1.51

1.49

1.9

2.5

10.87

10.98

g/l

0.05

206

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

230

1980

1.17

1.49

2.0

2.1

9.99

10.07

g/l

0.11

208

1777

Cysts of oral region, not elsewhere classified

752

1.27

1.47

2.7

2.5

9.74

10.42

g/l

0.74

686

Unspecified dementia

190

2002

0.85

1.47

2.0

2.3

10.22

10.56

g/l

0.40

155

1717

Oral lichen planus, including avohilmo , including avohilmo

125

1022

1.23

1.46

2.5

10.15

10.09

g/l

0.06

111

916

Benign neoplasm of brain and other parts of central nervous system

108

869

1.25

1.46

2.1

2.5

9.87

10.34

g/l

0.47

782

Ménière disease

174

1469

1.19

1.46

1.9

2.5

10.12

10.37

g/l

0.32

154

1307

Carcinoma in situ, bladder

631

1.30

1.45

3.4

2.6

9.53

10.88

g/l

2.32

568

Other fall from one level to another

357

3173

1.13

1.45

2.3

10.28

10.24

g/l

0.07

326

2867

Parkinson's disease, strict definition

310

2736

1.14

1.45

1.9

2.4

9.96

10.26

g/l

0.74

267

2392

Obstructed labour due to malposition and malpresentation of fetus

162

1784

0.84

1.44

1.6

2.0

10.44

9.93

g/l

0.85

154

1668

Colorectal neuroendocrine tumor and carcinoma

141

1.66

1.44

4.2

1.4

9.83

10.24

g/l

0.15

126

Benign neoplasm: Heart

2.18

1.43

1.5

1.9

12.34

9.62

g/l

0.61

Inflammatory disorders of male genital organs, not elsewhere classified

157

1.62

1.43

1.2

3.1

11.33

11.17

g/l

0.04

139

Other condition

226

1952

1.16

1.43

2.2

10.23

10.27

g/l

0.04

203

1762

Examination and encounter for administrative purposes

130

1070

1.22

1.42

2.5

2.4

10.03

10.20

g/l

0.19

119

966

Disturbances of smell and taste

553

1.32

1.42

3.1

3.0

9.94

10.48

g/l

0.60

498

Small plaque parapsoriasis

2.31

1.41

1.9

2.1

13.29

9.61

g/l

—

Hypertrophy of breast in women and men

279

2449

1.14

1.40

1.9

2.3

9.55

10.16

g/l

2.15

248

2211

Other puerperal infections

466

1.34

1.40

1.3

1.6

9.99

10.27

g/l

0.17

443

Glaucoma

1271

10156

1.06

1.40

2.2

2.4

10.34

10.16

g/l

0.66

1103

8920

Diseases of middle ear and mastoid

909

6902

1.08

1.40

2.4

2.2

10.22

10.14

g/l

0.20

831

6198

Other ill-defined and unspecified causes of mortality

138

1655

0.83

1.40

2.2

2.4

10.50

10.40

g/l

0.06

118

1445

Neuroendocrine tumor and carcinoma of rectum

2.28

1.40

4.9

1.1

9.03

10.50

g/l

—

Presbyopia

115

937

1.24

1.40

1.5

2.4

10.62

10.22

g/l

0.37

105

869

Tuberculosis of other organs, strict, including avohilmo

365

1.39

1.40

2.8

2.5

10.42

10.84

g/l

0.24

321

Oral lichen planus

391

1.37

1.39

2.5

2.4

9.42

10.46

g/l

1.13

355

Erectile dysfunction

163

1377

1.19

1.38

2.4

2.5

10.66

10.37

g/l

0.34

145

1224

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

596

0.72

1.38

1.8

2.3

11.33

9.90

g/l

1.31

538

Appendicitis, broad definition

1313

11097

1.06

1.38

2.7

2.3

9.94

10.17

g/l

1.18

1172

9985

Benign mammary dysplasia

246

2146

1.15

1.37

2.6

2.3

9.87

10.04

g/l

0.24

212

1867

Other sideroblastic anaemias

2.21

1.37

1.2

1.4

14.60

10.33

g/l

—

LSIL lesion of the vagina

159

1.60

1.36

1.2

1.8

8.38

10.05

g/l

1.77

150

Focal epilepsy, mode (most common among epilepsy diagnosis)

324

2878

1.13

1.36

2.2

2.3

10.22

10.23

g/l

0.00

273

2571

Nontoxic single thyroid nodule

122

1004

1.22

1.36

2.5

2.3

10.27

10.22

g/l

0.04

110

897

Typhoid and paratyphoid fevers, including avohilmo

1.96

1.36

1.2

1.3

11.49

10.08

g/l

0.68

Acute appendicitis

1218

10633

1.06

1.35

2.6

2.3

9.96

10.16

g/l

0.96

1091

9579

Other acquired deformities of ankle and foot

1.82

1.35

1.4

2.0

9.54

10.35

g/l

0.35

Abnormal findings in secretions and smears from cervix uteri vagina vulva

668

4521

1.09

1.35

2.1

2.2

10.10

9.92

g/l

0.47

609

4048

Tuberculosis of other organs, strict

359

1.38

1.35

2.8

2.5

10.43

10.81

g/l

0.20

315

Congenital malformations of genital organs

738

1.26

1.35

1.5

2.0

10.08

10.17

g/l

0.08

687

Respiratory tuberculosis, confirmed, including avohilmo

241

1.47

1.35

1.9

2.5

10.87

10.98

g/l

0.05

211

Long labour

190

1877

0.86

1.34

2.3

2.0

9.92

9.98

g/l

0.08

178

1736

Other diseases of spinal cord

359

1.38

1.34

2.4

2.8

9.27

10.80

g/l

1.98

328

Benign neoplasm: Endocrine pancreas

1.82

1.33

1.9

2.5

9.77

10.08

g/l

0.14

Other intracranial haemorrhages

490

1.32

2.0

2.6

10.37

10.75

g/l

0.25

432

Acute poliomyelitis, including avohilmo

172

0.51

1.32

1.3

2.2

10.31

10.25

g/l

—

155

Injury of muscle and tendon at shoulder and upper arm level

707

6543

1.08

1.31

2.4

9.92

10.23

g/l

1.32

634

5886

Other and unspecified disorders of orbit

2.00

1.31

1.5

2.6

9.92

9.67

g/l

0.08

Benign neoplasm of bone and articular cartilage

121

1000

1.22

1.30

1.8

2.4

9.99

10.17

g/l

0.17

912

Acute appendicitis, no complications

897

8323

1.07

1.30

2.7

2.3

9.98

10.15

g/l

0.59

814

7555

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

463

4080

1.10

1.29

2.9

1.5

9.50

10.12

g/l

2.30

409

3592

Felty syndrome

1.88

1.29

1.5

2.0

9.46

10.09

g/l

0.33

Erythema intertrigo

328

1.39

1.28

2.6

3.0

9.56

10.43

g/l

0.78

296

Other vitreous opacities

581

1.29

1.27

3.4

2.7

9.31

10.36

g/l

1.68

526

Tuberculosis of other organs

304

1.40

1.26

2.8

2.5

10.39

10.82

g/l

0.21

267

Divergent concomitant strabismus

104

850

1.23

1.26

1.9

2.3

10.87

10.32

g/l

0.60

771

Benign neoplasm: Pancreas

443

1.33

1.24

2.7

2.9

9.11

10.51

g/l

1.93

396

Parkinson's disease

328

2939

1.12

1.24

1.9

2.3

9.93

10.24

g/l

0.81

282

2570

Non-allergic asthma

134

1124

1.20

1.24

2.2

2.5

10.48

10.40

g/l

0.06

124

1009

Mixed conductive and sensorineural hearing loss

244

2148

1.14

1.23

2.5

2.3

9.92

10.20

g/l

0.44

205

1902

Respiratory tuberculosis, bacteriologically and histologically confirmed

246

1.44

1.23

1.9

2.5

10.87

10.95

g/l

0.04

215

Benign lipomatous neoplasm

538

4940

1.09

1.23

2.6

2.4

9.69

10.15

g/l

1.72

482

4396

Reduction defects of lower limb

2.72

1.23

4.4

3.1

10.96

10.28

g/l

—

Right side

1.81

1.23

1.4

1.7

8.97

10.34

g/l

1.59

Secondary parkinsonism+Parkinsonism in other disease

400

1.34

1.23

2.5

2.8

9.36

11.04

g/l

1.77

358

Malignant neoplasm of thyroid gland

101

826

1.23

1.22

2.3

1.4

10.35

10.15

g/l

0.15

721

Leisure time condition

310

2770

1.12

1.22

1.6

2.3

10.20

10.23

g/l

0.04

228

2474

Endometriosis diagnosis and infertility diagnosis occurring together

111

916

1.22

1.5

2.2

10.02

10.28

g/l

0.28

849

Foreign body in alimentary tract

728

1.25

1.21

1.5

2.5

10.63

10.49

g/l

0.13

658

Acute poliomyelitis

171

0.52

1.20

1.3

2.2

10.31

10.25

g/l

—

154

Benign neoplasm: Orbit, unspecified

1.82

1.20

2.8

2.2

9.92

9.68

g/l

0.10

Vestibular neuronitis

154

1314

1.18

1.19

2.2

2.6

9.84

10.36

g/l

1.02

136

1180

Renal cell carcinoma of kidney

437

1.32

1.19

2.1

1.5

10.68

10.54

g/l

0.08

375

Bacterial meningitis

402

1.33

1.19

3.4

2.6

9.80

10.44

g/l

0.45

367

Lack of expected normal physiological development

2.13

1.18

1.0

1.1

11.38

10.73

g/l

—

Fistulae involving female genital tract

224

1.45

1.16

2.1

2.2

11.94

10.24

g/l

1.12

200

Intestinal helminthiases, other/unspecified, including avohilmo

2.06

1.15

3.2

1.4

9.37

10.22

g/l

—

Foreign body in respiratory tract

616

1.26

1.15

2.8

2.4

10.11

10.41

g/l

0.21

557

Gonococcal infection, including avohilmo

369

1.34

1.15

2.2

1.9

10.27

10.30

g/l

0.02

339

Convalescence

644

1.25

1.14

1.9

2.1

11.04

10.48

g/l

0.28

575

Pedal cyclist injured in transport accident

346

3125

1.11

1.14

2.1

2.3

10.27

10.16

g/l

0.16

308

2836

Dementia in other diseases classified elsewhere

781

1.23

1.13

1.6

2.5

9.93

10.66

g/l

0.84

693

Secondary parkinsonism

389

1.33

1.12

2.5

2.6

9.45

11.16

g/l

1.71

347

Oligomenorrhoea

311

1.36

1.11

1.5

2.3

10.51

10.47

g/l

0.02

281

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1061

0.82

1.11

2.7

2.4

9.23

10.33

g/l

2.37

970

Colon adenocarcinoma

234

2073

1.13

1.10

2.6

1.4

9.97

10.14

g/l

0.22

200

1782

Malignant neoplasm of stomach, including Hilmo

103

856

1.21

1.09

1.2

1.4

9.31

10.28

g/l

1.99

732

Embedded teeth, including avohilmo

656

1.24

1.09

2.0

1.9

9.80

10.60

g/l

1.17

611

Peritonsillar abscess

277

2480

1.12

1.08

3.0

2.2

10.23

10.32

g/l

0.14

258

2261

Struck by thrown, projected or falling objec

550

1.26

1.08

1.2

2.6

9.76

10.54

g/l

0.86

510

Other specified disorders of external ear

542

1.27

1.08

2.0

2.7

10.28

10.63

g/l

0.27

495

Other mental disorders due to brain damage and dysfunction and to physical disease

251

2238

1.13

1.07

2.9

2.3

9.67

10.18

g/l

1.26

207

1963

Malignant neoplasm of other and unspecified urinary organs

2.19

1.07

1.0

1.3

12.37

10.69

g/l

—

Frontotemporal dementia

1.72

1.07

2.2

1.9

9.30

10.29

g/l

—

Antepartum haemorrhage, not elsewhere classified

595

1.25

1.07

2.5

1.9

10.06

10.28

g/l

0.24

561

Morphin

297

1.36

1.06

1.7

11.79

10.98

g/l

0.31

256

Suppurative and unspecified otitis media

455

3699

1.09

1.06

2.5

2.1

10.16

g/l

0.00

420

3363

Malignant neoplasm of nasopharynx

2.13

1.05

1.3

1.1

8.17

10.21

g/l

—

Hypermetropia

823

1.21

1.04

2.3

2.4

9.30

10.20

g/l

1.90

745

Alzheimer disease, including avohilmo

844

6208

0.94

1.04

1.9

2.3

10.43

10.21

g/l

0.62

682

5363

Accidental poisoning by and exposure to alcohol

150

0.53

1.04

1.8

2.8

12.88

10.50

g/l

—

140

Radial styloid tenosynovitis [de Quervain]

562

1.25

1.04

2.8

2.2

9.48

10.39

g/l

1.07

516

Disorders of globe

368

1.32

1.03

2.4

2.6

10.40

10.43

g/l

0.01

330

Universal erythroderma, KELA reimbursement

163

1.49

1.03

1.3

2.4

11.42

10.83

g/l

0.10

148

Macular hole

119

1010

1.19

1.03

1.9

2.6

10.19

10.14

g/l

0.04

103

896

Gonococcal infection

359

1.32

1.03

2.3

1.9

10.24

10.34

g/l

0.05

330

Burn and corrosion of trunk

333

1.33

1.03

1.3

2.7

10.62

10.70

g/l

0.03

305

Maltreatment syndromes

385

1.31

1.03

2.3

2.0

11.11

10.42

g/l

0.33

363

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

107

900

1.20

1.02

2.0

2.5

9.76

10.06

g/l

0.30

799

Deep bite

126

941

1.18

1.02

2.2

2.4

9.28

10.24

g/l

2.16

107

867

Other benign neoplasm of uterus: Corpus uteri

1.65

1.02

3.4

2.0

8.48

9.99

g/l

—

Orthopaedic devices associated with adverse incidents

300

1.35

1.01

1.1

2.3

8.70

10.48

g/l

1.82

268

Exposure to other specified electric current

189

0.58

1.01

2.5

2.1

8.85

10.52

g/l

1.41

177

Unattended death

131

0.53

1.01

4.9

1.7

10.44

10.68

g/l

—

115

Hypertrophy of breast

229

2039

1.13

1.01

1.4

2.2

9.40

10.02

g/l

1.87

202

1839

Unknown and unspecified causes of morbidity

728

1.21

1.00

2.1

2.2

9.88

10.49

g/l

0.67

648

Discharge from other and unspecified firearms

0.00

0.99

0.0

2.5

—

10.73

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

113

1328

0.85

0.99

3.0

2.5

9.28

10.35

g/l

2.34

104

1207

Gestational diabetes (for exclusion)

272

2079

0.90

0.98

1.7

1.9

9.95

10.04

g/l

0.15

251

1954

Abrasion of teeth

615

5748

1.07

0.96

2.4

10.17

10.06

g/l

0.24

544

5153

Other appendicitis

123

1054

1.17

0.96

3.2

2.4

9.54

10.35

g/l

1.51

106

966

Seminoma of testis

1.79

0.95

2.2

1.3

9.81

10.45

g/l

—

Aggressive periodontitis

277

1.35

0.95

2.4

2.5

9.97

10.55

g/l

0.42

254

Other diseases of peritoneum

615

1.23

0.95

1.8

2.5

10.05

10.34

g/l

0.23

550

Dislocation, sprain and strain of joints and ligaments of head

373

1.29

0.94

1.1

2.0

9.45

10.56

g/l

1.51

342

Dementia, including avohilmo

1142

7408

1.05

0.94

2.0

2.4

10.22

10.24

g/l

0.05

916

6489

Unequal limb length (acquired)

1.91

0.94

1.1

2.4

9.74

9.11

g/l

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.71

0.93

1.7

2.2

11.37

10.03

g/l

0.27

Frontotemporal dementia, wide, incl. Pick's disease

102

1.61

0.93

2.1

1.9

9.27

10.50

g/l

—

L01XE Protein kinase inhibitors

828

1.19

0.92

3.1

2.7

9.80

10.52

g/l

0.67

750

Other complications of labour and delivery, not elsewhere classified

591

0.79

0.92

1.5

1.7

10.36

10.39

g/l

0.01

559

Necrobiosis lipoidica, not elsewhere classified

1.79

0.92

3.5

2.4

13.73

10.01

g/l

1.05

Dengue, including avohilmo

2.16

0.91

4.8

1.1

10.35

9.65

g/l

—

Generalized epilepsy, strict definition

176

1.43

0.91

1.4

2.2

10.56

10.36

g/l

0.10

166

Heterophoria

101

856

1.18

0.90

3.0

2.4

9.80

10.29

g/l

0.64

779

LSIL lesion of the cervix uteri, vagina or vulva

154

1349

1.14

0.90

2.6

2.1

9.35

10.17

g/l

1.65

140

1234

Specific developmental disorder of motor function

2.09

0.90

1.0

2.4

10.52

10.19

g/l

—

Benign neoplasm: Skin of trunk

547

1.23

0.89

3.0

2.4

9.98

10.36

g/l

0.25

496

Unspecified jaundice

711

1.20

0.89

1.6

2.5

11.16

10.42

g/l

0.52

633

Von Willebrand disease

119

1.53

0.89

2.4

2.1

9.84

10.22

g/l

0.16

111

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

134

1165

1.16

0.89

2.0

2.5

9.68

10.18

g/l

0.67

121

1047

Whooping cough

1.89

0.88

1.0

3.4

8.65

10.55

g/l

—

Retained placenta and membranes, without haemorrhage

118

1366

0.86

0.87

2.0

2.2

10.59

9.93

g/l

0.65

107

1238

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

1.71

0.87

1.5

2.2

9.82

9.97

g/l

0.07

Non-small cell lung cancer, squamous, helper endpoint

846

0.82

0.87

1.7

2.5

10.52

10.59

g/l

0.04

743

Malignant neoplasm of nasopharynx, including Hilmo

1.86

0.87

1.3

1.2

7.66

10.28

g/l

—

Fall on and from ladder

132

1149

1.16

0.87

3.7

2.6

9.88

10.38

g/l

0.65

119

1043

Other and unspecified intracranial injuries

370

1.28

0.86

2.1

2.6

11.53

10.64

g/l

0.42

332

Superficial injuries involving multiple body regions

282

1.32

0.86

3.1

2.4

9.87

10.39

g/l

0.47

261

Malignant neoplasm of nasal cavity and middle ear

1.80

0.85

5.5

1.2

9.70

10.03

g/l

—

Malignant neoplasm of stomach

733

1.19

0.85

1.2

1.4

9.29

10.33

g/l

1.94

633

Outcome of delivery

139

743

1.15

0.84

1.7

1.9

11.05

10.14

g/l

1.47

133

703

Malignant neoplasm of ovary, including Hilmo

853

0.83

0.84

2.6

1.4

9.56

9.95

g/l

0.32

732

Tooth eruption problems

109

904

1.17

0.84

1.8

1.9

9.79

10.50

g/l

1.29

101

841

Burn and corrosion confined to eye and adnexa

214

1.37

0.83

2.1

2.4

9.81

10.42

g/l

0.37

203

Mumps

284

0.70

0.83

1.7

2.3

13.75

10.49

g/l

1.55

258

Lichen sclerosus et atrophicus

188

1681

1.12

0.82

2.0

2.2

9.44

10.17

g/l

2.07

164

1456

Pedal cyclist injured in other and unspecified transport accidents

163

1445

1.13

0.82

2.3

10.20

10.33

g/l

0.15

146

1311

Disorders of eyelid in diseases classified elsewhere

400

1.26

0.82

1.2

2.7

9.96

10.47

g/l

0.41

361

Malignant neoplasm of accessory sinuses, including Hilmo

1.73

0.82

4.5

1.2

12.11

10.15

g/l

—

Poor fetal growth

745

1.18

0.81

1.8

1.9

10.16

10.28

g/l

0.08

702

Other helminthiases

0.00

0.81

0.0

3.3

—

10.29

—

Motor disorders

1.87

0.81

1.0

2.2

10.52

9.97

g/l

—

Foreign body or object entering through skin

682

1.19

0.81

3.3

2.5

9.69

10.37

g/l

0.81

629

Mumps, including avohilmo

293

0.71

0.79

1.9

2.3

13.51

10.44

g/l

1.51

266

Nontoxic diffuse goitre

429

1.25

0.79

3.2

2.3

9.25

10.09

g/l

1.16

380

Endometriosis of ovary

239

2045

1.10

0.77

1.8

2.2

9.63

10.08

g/l

0.91

206

1827

Fractures involving multiple body regions

2.25

0.77

1.6

1.1

10.80

10.92

g/l

—

Eustachian salpingitis and obstruction

695

1.18

0.77

2.4

2.1

9.64

10.26

g/l

0.88

643

Persistent delusional disorders

1049

0.85

0.77

1.9

2.4

9.82

10.32

g/l

0.54

935

Benign neoplasm: Long bones of lower limb

332

1.27

0.77

1.7

2.0

9.98

10.29

g/l

0.16

308

Other specified and unspecified disorders of lens

158

1.42

0.76

1.6

2.6

10.56

10.00

g/l

0.29

142

Beningn neoplasm: Meninges, unspecified

218

1.35

0.76

1.5

2.2

9.45

10.54

g/l

0.68

192

Labour and delivery complicated by fetal stress [distress]

150

1101

0.88

0.76

1.7

10.07

g/l

0.00

143

1040

Myocardial infarction, unclassifiable

418

4003

0.93

0.76

1.8

2.3

9.93

10.41

g/l

1.58

363

3452

Other congenital malformations of respiratory system

2.17

0.76

1.0

11.60

11.08

g/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

866

7055

0.95

0.75

2.2

2.3

10.14

10.06

g/l

0.22

781

6320

Malignant neoplasm of palate

1.85

0.74

2.4

1.1

11.79

10.15

g/l

—

Acute and transient psychotic disorders

152

1353

1.13

0.74

2.2

2.4

10.24

10.27

g/l

0.02

134

1238

Other contact dermatitis

108

940

1.15

0.74

1.5

2.6

10.83

10.28

g/l

0.52

846

2.04

0.73

7.2

2.9

6.86

11.82

g/l

—

Pleural plaque

200

1812

1.11

0.73

2.2

2.3

10.76

10.32

g/l

0.64

173

1585

Ankyloglossia

1.61

0.72

1.1

1.9

9.86

9.96

g/l

—

Inflammatory diseases of prostate (prostatitis)

222

2023

1.10

0.71

2.1

2.6

9.81

10.59

g/l

2.41

197

1829

Tetralogy of Fallot, a congenital heart defect.

1.95

0.71

1.4

2.5

7.98

9.92

g/l

—

Use of rasagiline

400

1.24

0.71

1.4

2.9

8.57

10.83

g/l

6.16

358

Non-small cell lung cancer, adenocarcinoma, helper endpoint

132

1171

1.13

0.70

1.9

2.5

10.84

10.42

g/l

0.41

117

1043

Acute drug-induced interstitial lung disorder

110

1.48

0.70

9.9

1.9

10.53

10.56

g/l

0.01

Wilms' tumor, including Hilmo

1.63

0.70

1.0

1.2

10.50

10.00

g/l

0.16

Vertigo of central origin

222

1.32

0.69

1.5

2.8

10.50

10.62

g/l

0.04

196

Benign lipomatous neoplasm of other sites/unspecified

152

1363

1.12

0.68

3.1

2.4

9.53

10.32

g/l

1.66

140

1212

Calcaneal spur

136

1.41

0.67

1.1

1.5

9.72

11.18

g/l

0.98

122

Malignant neoplasm of adrenal gland, including Hilmo

1.59

0.66

2.1

1.2

9.38

11.32

g/l

0.80

FESS (DNB20)

148

1647

0.90

0.66

2.3

2.4

9.93

10.24

g/l

0.43

132

1503

Postpartum haemorrhage due to retained placenta

830

0.85

0.65

2.2

1.8

10.23

10.14

g/l

0.05

782

Communicating hydrocephalus

287

1.27

0.64

1.4

2.8

10.40

10.65

g/l

0.16

258

Kela-code for behavioural disturbances in mental retardation

102

0.58

0.63

1.7

2.0

9.72

10.40

g/l

—

Mental retardation, excluding more controls

260

1.27

0.63

1.6

2.5

10.41

10.61

g/l

0.11

237

Erosion and ectropion of cervix uteri

406

1.22

0.63

3.4

2.2

9.96

10.04

g/l

0.05

360

Congenital malformations of breast, including avohilmo

121

1.41

0.62

1.5

2.1

10.04

10.15

g/l

0.04

115

LSIL lesion of the cervix uteri

108

954

1.13

0.62

3.0

2.2

9.44

10.22

g/l

1.24

891

Endometriosis ASRM stages 1,2

203

1858

1.09

0.62

1.5

2.0

9.70

10.10

g/l

0.80

179

1685

Endometriosis of pelvic peritoneum

197

1637

1.10

0.61

1.5

2.2

9.67

10.14

g/l

0.97

175

1472

Perforation of oesophagus

1.56

0.60

1.1

2.4

8.25

10.53

g/l

2.10

Chalazion

168

1527

1.10

0.60

3.1

2.4

10.28

10.25

g/l

0.03

146

1376

Malignant neoplasm of renal pelvis

1.55

0.60

1.3

12.66

10.61

g/l

0.29

Anisometropia and aniseikonia

381

1.21

0.60

2.9

2.5

10.48

10.76

g/l

0.17

345

Pregnancy hypertension

496

4195

1.06

0.59

2.2

2.1

9.98

9.94

g/l

0.06

459

3782

Excessive vomiting in pregnancy

686

1.15

0.59

1.8

2.3

9.10

10.27

g/l

1.97

635

Other disorders of binocular vision

1.46

0.59

5.6

2.3

9.86

10.55

g/l

0.25

Kela-code for severe mental illness

539

5118

1.05

0.59

2.1

2.3

9.82

10.22

g/l

1.42

482

4604

Congenital malformations of breast

114

1.41

0.59

1.6

9.99

10.09

g/l

0.03

108

Gastrointestinal stromal tumor and sarcoma

149

1.36

0.58

1.3

1.4

8.44

10.66

g/l

2.92

131

Other and unspecified injuries of abdomen, lower back and pelvis

158

1.34

0.58

2.0

2.2

12.61

10.38

g/l

0.81

144

Malignant neoplasm of eye and adnexa

1.45

0.57

1.9

1.1

9.90

10.47

g/l

0.18

Gender identity disorders

1.49

0.57

1.0

1.9

10.46

9.82

g/l

—

Disorders of plasma-protein metabolism, not elsewhere classified

1.53

0.57

4.5

1.4

12.82

10.35

g/l

0.42

Embolic stroke

746

1.14

0.56

2.0

2.5

10.12

10.49

g/l

0.34

665

Any dementia

971

6466

1.04

0.56

2.1

2.4

10.20

10.22

g/l

0.05

791

5614

Toxic effects of substances chiefly nonmedicinal as to source

125

1387

0.90

0.56

1.7

2.4

9.74

10.36

g/l

0.96

113

1268

Pleural plaque with presence of asbestos

123

1363

0.90

0.55

2.5

10.99

10.45

g/l

0.53

104

1195

Vasomotor rhinitis (mode)

110

986

1.12

0.53

2.1

2.7

10.23

10.32

g/l

0.07

887

False labour

224

1501

0.92

0.53

1.8

1.9

9.73

10.01

g/l

0.69

217

1415

Stenosis and insufficiency of lacrimal passages

158

1445

1.10

0.53

2.2

2.5

10.15

10.30

g/l

0.16

136

1271

Abscess of Bartholin gland

250

1.25

0.53

3.6

2.2

10.93

10.26

g/l

0.18

233

Malignant neoplasm of gallbladder

1.43

0.52

1.2

1.1

8.67

10.58

g/l

—

Malignant neoplasm of penis

1.52

0.52

4.0

1.3

7.57

10.27

g/l

—

malignant neoplasm of female genital organs, including Hilmo

283

2525

1.07

0.52

2.1

1.4

9.88

9.91

g/l

0.04

249

2155

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

114

1027

1.11

0.51

1.9

2.2

9.72

10.04

g/l

0.38

107

925

Acute appendicitis, with complications

321

3021

1.06

0.51

2.5

2.3

9.91

10.24

g/l

0.87

277

2731

Calculus of lower urinary tract

848

1.13

0.51

2.3

2.6

9.95

10.59

g/l

0.76

760

Maternal care for known or suspected malpresentation of fetus

118

932

0.90

0.50

1.9

1.7

10.30

10.13

g/l

0.22

113

879

Abnormalities of forces of labour

867

1.12

0.50

1.4

2.1

10.44

9.90

g/l

0.56

821

Infliximab

136

1.33

0.49

1.2

1.8

11.00

10.30

g/l

0.36

129

Vertical strabismus

418

1.18

0.49

1.8

2.6

9.58

10.65

g/l

0.84

381

Androgenic alopecia

1.41

0.49

1.1

2.0

10.58

9.90

g/l

0.51

Thromboangiitis obliterans

1.52

0.48

1.0

2.9

10.16

10.36

g/l

—

Congenital malformations of eye, ear, face and neck

568

1.15

0.48

3.7

2.2

10.02

10.40

g/l

0.24

517

Alcoholic cardiomyopathy

1.49

0.48

1.3

2.9

11.72

11.46

g/l

—

Benign neoplasm: Conjunctiva

429

1.17

0.47

1.4

2.7

10.03

10.53

g/l

0.41

393

L02BA Anti-estrogens

261

2449

1.07

0.47

2.0

2.3

10.08

10.01

g/l

0.09

226

2155

Dysplasia of cervi uteri

287

1897

1.06

0.47

2.2

2.0

10.05

10.15

g/l

0.14

252

1697

Lesion of sciatic nerve

675

0.87

0.46

1.3

2.4

10.30

10.61

g/l

0.16

586

Postmenopausal atrophic vaginitis

453

2350

1.05

0.46

2.3

2.2

9.85

10.10

g/l

0.60

395

2074

Oral leukoplakia, including avohilmo

375

1.18

0.46

1.3

2.4

10.82

10.70

g/l

0.06

341

Pregnancy with abortive outcome

1053

5313

1.03

0.45

1.9

2.3

10.03

9.99

g/l

0.09

919

4663

Malignant neoplasm of vulva, including Hilmo

183

1.27

0.45

2.3

1.5

10.97

10.40

g/l

0.11

157

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

1.39

0.44

3.6

1.2

11.57

10.36

g/l

—

Dementia due to Parkinsons disease, excluding more controls

330

1.19

0.44

1.3

2.5

9.10

10.95

g/l

3.19

293

Benign neoplasm of thyroid gland

448

0.84

0.44

2.5

2.4

9.33

10.39

g/l

0.73

408

Pterygium

442

1.16

0.44

2.8

2.7

9.10

10.80

g/l

2.70

401

Schizophrenia or delusion

448

4280

1.05

0.44

1.9

2.2

10.02

10.17

g/l

0.25

391

3874

Drug-induced tremor

1.40

0.43

1.3

2.4

10.91

10.34

g/l

0.16

Pedestrian injured in collision with car, pick-up truck or van

285

1.20

0.43

1.5

2.3

9.94

10.41

g/l

0.28

259

Female infertility

342

1944

1.06

0.42

2.0

2.1

9.91

10.19

g/l

0.67

312

1752

Disorder of visual pathways, unspecified

0.00

0.41

0.0

1.7

—

10.71

—

Benign neoplasm: Pineal gland

0.00

0.41

0.0

1.1

—

10.80

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.41

0.0

3.4

—

10.36

—

Congenital malformations of nose

0.00

0.41

0.0

1.0

—

10.92

—

Infections of genitourinary tract in pregnancy

994

0.90

0.41

1.9

2.2

9.71

10.20

g/l

0.61

897

Severe visual impairment, monocular

132

1.30

0.41

1.2

2.6

12.55

9.80

g/l

0.46

120

Isolated growth hormone deficiency

0.00

0.41

0.0

3.9

—

9.88

—

Obstetric embolism

0.00

0.40

0.0

1.1

—

10.66

—

Carcinoma in situ of breast, lobular

1.36

0.40

4.6

2.1

8.98

10.15

g/l

0.58

Dementia due to Parkinson's disease

453

0.86

0.40

1.3

2.5

9.10

11.05

g/l

3.70

398

Subarachnoid haemorrhage

178

1663

1.07

0.39

1.9

2.4

9.68

10.30

g/l

1.23

147

1472

Toxic effect of contact with venomous animals

495

0.87

0.39

2.5

9.93

10.39

g/l

0.32

453

Valgus deformity, not elsewhere classified

1.33

0.38

1.1

1.6

9.53

10.91

g/l

—

Short Achilles tendon (acquired)

279

0.82

0.37

3.0

2.5

9.52

10.40

g/l

0.54

254

Other congenital malformations of limb(s)

1.36

0.37

1.0

2.1

6.86

9.91

g/l

—

Malignant neoplasm of breast, ER-negative, including Hilmo

336

3001

1.05

0.36

1.9

1.4

9.76

9.91

g/l

0.27

289

2580

Disorders of pituitary gland, other and/or unspecified

0.64

0.36

1.2

1.8

6.78

9.89

g/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

152

1626

0.93

0.36

2.8

1.4

10.59

10.17

g/l

0.52

128

1418

Circumscribed brain atrophy

329

1.16

0.35

1.9

2.8

10.66

10.61

g/l

0.02

295

Other obstructed labour

774

0.90

0.35

1.5

2.4

9.98

9.92

g/l

0.05

717

Male infertility

341

0.85

0.35

2.0

2.2

9.95

10.45

g/l

0.30

319

Intermittent heterotropia

498

1.12

0.35

2.1

2.2

9.84

10.51

g/l

0.83

454

Other benign neoplasms of connective and other soft tissue

145

1354

1.07

0.34

2.7

2.4

10.13

10.34

g/l

0.19

127

1217

Medical treatment for female infertility

142

1507

0.93

0.34

1.7

1.8

10.16

10.05

g/l

0.13

133

1420

Malignant neoplasm of retroperitoneum and peritoneum

100

1.31

0.34

2.5

1.4

12.80

10.96

g/l

0.33

Other disorders of amniotic fluid and membranes

947

0.92

0.34

1.6

1.8

10.62

10.06

g/l

0.68

894

Convergence insufficiency and excess

109

1.29

0.33

1.4

2.0

10.13

10.70

g/l

0.28

101

Schizophrenia, schizotypal and delusional disorders

448

4317

1.04

0.33

2.0

2.2

10.01

10.16

g/l

0.25

391

3909

Malignant neoplasm of rectosigmoid junction, including Hilmo

397

1.14

0.33

2.7

1.4

10.19

10.49

g/l

0.18

348

Anomalies of pupillary function

219

1.19

0.33

2.8

2.2

10.44

10.74

g/l

0.14

203

Colorectal adenocarcinoma

374

3546

1.04

0.33

2.6

1.4

10.11

10.15

g/l

0.05

317

3084

Dental pulpitis, including avohilmo

1489

9723

0.98

0.33

2.0

2.3

9.96

10.14

g/l

1.00

1369

8802

Mild mental retardation

209

0.81

0.32

1.6

2.1

10.32

10.66

g/l

0.17

197

Varus deformity, not elsewhere classified

119

1.27

0.32

1.3

2.3

9.81

10.71

g/l

0.36

108

Alzheimer’s disease, strict definition

576

4795

0.97

0.32

1.9

2.3

10.42

10.29

g/l

0.26

470

4106

Deep endometriosis

108

1164

0.93

0.32

1.5

2.2

9.63

10.04

g/l

0.52

1030

L02BG Aromatase inhibitors

505

5152

0.97

0.31

2.2

2.4

9.77

9.95

g/l

0.40

428

4483

Nontraumatic intracranial haemmorrhage

384

3696

1.04

0.31

2.3

2.2

10.04

10.20

g/l

0.30

329

3229

Other osteochondropathies

762

1.09

0.31

2.3

10.31

10.35

g/l

0.02

700

Disorders of acoustic nerve

390

1.13

0.31

3.0

2.5

9.10

10.70

g/l

1.65

351

Acute otitis externa, noninfective

193

1.20

0.31

1.3

2.4

10.10

10.67

g/l

0.45

176

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

138

1.24

0.30

2.1

2.5

9.98

10.88

g/l

0.29

125

Sequelae of infectious and parasitic diseases

103

956

1.08

0.30

3.0

2.2

10.25

10.42

g/l

0.14

859

Ethmoidectomy

162

1716

0.94

0.30

2.8

2.4

9.97

10.22

g/l

0.34

146

1567

Primary open-angle glaucoma

670

6621

0.97

0.30

2.3

10.45

10.15

g/l

0.80

566

5724

Mental retardation

294

1.15

0.29

1.6

2.0

10.41

10.38

g/l

0.02

273

Hydatidiform mole

130

0.76

0.29

4.5

2.1

10.47

10.93

g/l

—

122

Cholesteatoma of middle ear

775

0.91

0.29

2.2

2.4

10.22

10.49

g/l

0.28

695

Respiratory tuberculosis

842

1.08

0.29

2.2

2.5

10.51

10.50

g/l

0.01

739

Respiratory tuberculosis, confirmed and not-confirmed

842

1.08

0.29

2.2

2.5

10.51

10.50

g/l

0.01

739

Unspecified chronic bronchitis

506

1.11

0.29

2.0

2.8

10.24

10.88

g/l

0.48

448

Preterm labour and delivery

284

2961

0.96

0.29

2.8

2.2

10.15

9.88

g/l

0.54

264

2687

Puerperal sepsis

151

1600

0.94

0.29

2.4

2.3

10.16

10.01

g/l

0.15

139

1452

Antenatal screening

197

1046

1.05

0.28

2.0

1.9

10.27

9.99

g/l

0.45

192

988

Medicines for HER+ breast cancer

603

5769

0.97

0.27

2.1

2.3

9.91

9.95

g/l

0.08

512

5043

Follow-up care involving plastic surgery

432

1.11

0.27

2.0

10.15

10.37

g/l

0.12

390

Colon adenocarcinoma, helper endpoint

234

2444

0.96

0.27

2.6

2.4

9.97

10.26

g/l

0.40

200

2139

Carcinoma in situ of cervix uteri

807

1.08

0.27

2.1

2.0

10.56

10.21

g/l

0.31

748

Adenocarcinoma and papilloma adenocarcinoma of rectum

146

1543

0.94

0.27

2.9

1.4

10.38

10.12

g/l

0.30

122

1342

Anomalies of dental arch relationship, including avohilmo

219

1892

1.05

0.26

2.0

2.4

9.66

10.20

g/l

1.36

183

1740

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

573

4832

1.03

0.26

2.2

9.96

9.93

g/l

0.04

530

4328

Mucinous and mucinous cystic tumor, including Hilmo

0.69

0.26

9.0

1.5

6.96

10.13

g/l

—

Obstructed labour due to maternal pelvic abnormality

180

1890

0.95

0.26

2.0

2.3

9.65

9.88

g/l

0.34

159

1697

Benign neoplasm: Short bones of upper limb

169

1.19

0.26

1.8

2.2

10.61

10.31

g/l

0.11

157

Benign neoplasm: Retina

1.26

0.26

1.1

2.2

9.81

10.16

g/l

—

Unspecified renal colic

1.26

0.26

2.2

1.2

9.88

10.20

g/l

—

Persons encountering health services in circumstances related to reproduction

776

5321

0.98

0.26

2.2

2.3

10.06

10.08

g/l

0.03

719

4867

Ectopic pregnancy

184

1930

0.95

0.25

1.7

2.4

9.62

10.02

g/l

0.79

164

1763

788

1.08

0.25

2.0

2.4

10.07

10.50

g/l

0.41

664

Other benign neoplasms of uterus

888

1.07

0.25

2.9

2.2

9.83

10.13

g/l

0.28

756

Malignant neoplasm of eye, brain and central nervous system

521

1.10

0.25

1.8

1.4

10.31

10.27

g/l

0.02

461

Carcinoma in situ of vulva

105

1.25

0.25

1.5

2.3

8.30

10.02

g/l

—

Motorcycle rider injured in noncollision transport accidents

245

1.15

0.25

1.8

2.0

10.00

10.27

g/l

0.15

231

Other and unspecified disease of Bartholin gland

388

1.11

0.24

1.3

2.4

10.09

10.07

g/l

0.01

350

Malignant neoplasm of pancreas, including Hilmo

128

1353

0.94

0.24

2.2

1.4

10.10

10.15

g/l

0.06

115

1177

Endometriosis of rectovaginal septum and vagina

1014

0.94

0.24

1.6

2.2

9.76

10.21

g/l

0.49

899

Diabetes mellitus in pregnancy

241

1595

0.96

0.24

1.5

1.9

9.86

10.09

g/l

0.52

225

1503

Inflammatory disease of cervix uteri

890

0.93

0.24

1.4

2.3

10.54

10.01

g/l

0.48

787

Primary open-angle glaucoma, strict

544

5565

0.97

0.24

2.3

10.47

10.11

g/l

0.90

461

4799

Malignant neoplasm of corpus uteri, including Hilmo

149

1417

1.05

0.23

1.5

1.4

9.94

9.86

g/l

0.07

126

1203

Femoral hernia

669

1.08

0.23

2.4

2.2

9.72

10.49

g/l

0.82

604

Normotensive glaucoma

155

1624

0.95

0.22

2.1

2.4

10.52

10.18

g/l

0.44

134

1422

Osteitis due to dental implant

116

1.22

0.22

3.6

1.9

10.31

10.53

g/l

0.05

103

malignant neoplasm of female genital organs

228

2316

0.96

0.22

1.8

1.4

9.64

9.90

g/l

0.39

200

1972

Neurological devices associated with adverse incidents

0.00

0.22

0.0

1.0

—

9.52

—

Tuberculosis

106

1001

1.06

0.22

2.0

2.5

10.53

10.43

g/l

0.06

873

Foreign body on external eye

201

1930

1.04

0.22

2.2

2.3

10.16

10.22

g/l

0.08

183

1785

Plasmodium vivax malaria, including avohilmo

0.00

0.22

0.0

1.1

—

9.83

—

Plasmodium vivax malaria

0.00

0.22

0.0

1.1

—

9.83

—

Glanders and melioidosis, including avohilmo

0.00

0.22

0.0

1.0

—

11.34

—

Glanders and melioidosis

0.00

0.22

0.0

1.0

—

11.34

—

Secondary sideroblastic anaemia due to drugs and toxins

0.00

0.22

0.0

1.0

—

9.55

—

Pinta [carate], including avohilmo

0.00

0.22

0.0

1.0

—

10.20

—

Ascariasis, including avohilmo

0.00

0.22

0.0

1.2

—

10.99

—

Corrosions classified according to extent of body surface involved

0.00

0.21

0.0

2.1

—

10.79

—

Underdevelopment of the second kidney

0.00

0.21

0.0

4.8

—

9.81

—

Injury of muscle and tendon at wrist and hand level

198

1902

1.04

0.21

2.0

2.4

10.25

10.27

g/l

0.02

185

1726

Supernumerary ureter

0.00

0.21

0.0

1.0

—

9.69

—

Serous carcinoma of ovary

103

0.77

0.21

2.0

1.5

8.49

10.33

g/l

—

Other congenital musculoskeletal deformities

0.00

0.21

0.0

1.0

—

11.38

—

Congenital malformation of optic disc

0.00

0.21

0.0

1.1

—

10.11

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

0.21

0.0

1.0

—

10.17

—

Thyrotoxicosis with toxic single thyroid nodule

104

0.76

0.21

2.8

2.1

9.21

10.25

g/l

—

Birth injury to peripheral nervous system

0.00

0.21

0.0

4.2

—

9.33

—

Constitutional tall stature

0.00

0.21

0.0

1.0

—

10.14

—

Degenerative diseases of the nervous system

844

6182

0.98

0.21

1.8

2.3

10.34

10.25

g/l

0.24

691

5345

Typhoid and paratyphoid fevers

1.17

0.21

1.0

1.4

8.86

10.04

g/l

—

Unicornuate uterus

0.00

0.21

0.0

1.0

—

9.78

—

Other congenital musculoskeletal deformities, including avohilmo

0.00

0.21

0.0

1.0

—

11.11

—

Other congenital malformations of spinal cord

0.00

0.20

0.0

1.0

—

10.55

—

Sequelae of infectious and parasitic diseases, including avohilmo

104

986

1.06

0.20

3.0

2.2

10.26

10.37

g/l

0.09

883

Contact with sharp glass

346

1.10

0.19

2.3

2.1

9.26

10.44

g/l

1.67

323

Malignant neoplasm of corpus uteri

136

1300

1.05

0.19

1.5

10.04

9.85

g/l

0.18

116

1107

Malignant neoplasm of rectum, including Hilmo

199

1919

1.04

0.19

2.7

1.4

10.43

10.14

g/l

0.41

173

1663

Exposure to excessive heat of man-made origin

109

1.20

0.19

4.5

2.9

12.64

10.86

g/l

0.41

Mental retardation, wide definition

325

1.10

0.18

1.6

2.1

10.12

10.42

g/l

0.18

301

Toxic effect of other gases, fumes and vapours

1.21

0.18

1.3

2.6

9.40

10.77

g/l

—

Impacted teeth

138

1134

1.04

0.18

1.3

1.9

9.97

10.44

g/l

0.68

129

1059

Open bite that required surgery (Lefort1 or BSSO)

1.15

0.17

1.0

1.8

9.61

10.13

g/l

—

Benign neoplasm: Cranial nerves

397

1.09

0.17

3.0

2.4

9.12

10.81

g/l

1.63

353

Tooth agenesis EXCLUDE clefts and syndromes

205

0.88

0.17

1.2

1.6

9.04

10.31

g/l

0.45

199

Supervision of high-risk pregnancy

171

989

1.04

0.17

1.8

10.30

9.98

g/l

0.45

160

932

Carcinoma in situ of middle ear and respiratory system

0.74

0.17

2.8

2.0

9.28

10.93

g/l

—

ILD medications: nintedanib

0.73

0.17

1.0

1.4

11.06

10.49

g/l

—

Melanocytic naevi, other sites/unspecified

1039

0.95

0.17

1.9

2.5

9.64

10.43

g/l

1.40

948

Anxious personality disorder

129

1.17

0.17

3.0

1.9

9.91

10.39

g/l

0.18

122

Dementia

1039

7003

1.01

0.17

2.1

2.4

10.24

10.23

g/l

0.03

831

6119

Helminthiases, including avohilmo

379

1.08

0.16

2.6

2.4

10.00

10.40

g/l

0.30

350

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

302

1.10

0.16

4.0

2.6

9.59

10.61

g/l

0.57

276

Coarctation of the aorta

1.13

0.16

9.5

1.9

10.60

10.15

g/l

—

Chronic myringitis

0.79

0.16

3.2

1.9

11.67

10.19

g/l

—

Benign neoplasm: Skin of upper limb, including shoulder

235

1.11

0.16

3.4

2.7

9.13

10.54

g/l

1.26

216

Glaucoma, exfoliation

209

2152

0.97

0.15

2.5

2.3

10.50

10.24

g/l

0.25

171

1835

Pityriasis rosea

1.14

0.15

1.3

2.1

9.94

10.19

g/l

—

Simple and mucopurulent chronic bronchitis

595

1.06

0.15

1.7

2.4

10.16

10.58

g/l

0.23

520

Female infertility, cervical, vaginal, other or unspecified origin

304

1897

1.03

0.15

2.1

9.80

10.18

g/l

0.93

278

1708

Sequelae of other and unspecified infectious and parasitic diseases

566

1.06

0.15

2.8

2.1

9.79

10.48

g/l

0.72

522

Other benign neoplasm of uterus: Other parts/unspecified

714

1.05

0.14

2.8

2.2

10.07

10.09

g/l

0.01

599

Chronic suppurative otitis media, including avohilmo

105

1008

1.04

0.14

1.6

2.5

9.95

10.38

g/l

0.68

907

Haemorrhage in early pregnancy

300

2980

0.98

0.14

2.2

2.1

9.53

10.05

g/l

1.49

275

2697

Patellar tendinitis

122

1.15

0.14

1.2

1.8

9.30

10.86

g/l

0.95

117

Other noninflammatory disorders of cervix uteri

715

1.05

0.13

2.8

2.2

9.50

10.15

g/l

0.64

622

Fourth [trochlear] nerve palsy

286

1.09

0.13

1.5

2.9

9.57

10.72

g/l

0.71

259

Otosclerosis

114

1099

1.04

0.13

1.8

2.6

9.93

10.33

g/l

0.60

985

Other specified and unspecified strabismus

113

1.15

0.13

1.4

2.3

9.68

10.58

g/l

0.49

102

L02BB Anti-androgens

172

1770

0.97

0.13

1.6

2.4

9.75

10.50

g/l

1.80

146

1547

Postpartum haemorrhage due to anatomy

530

0.94

0.13

1.8

1.7

10.21

10.41

g/l

0.15

502

Protein-energy malnutrition of moderate and mild degree

127

0.86

0.12

1.4

1.8

8.90

10.25

g/l

—

110

Chronic diseases of tonsils and adenoids

1223

7784

0.99

0.12

2.0

2.3

9.76

10.17

g/l

3.02

1124

7005

Presence of other devices

489

4739

1.02

0.12

2.6

2.3

9.66

10.28

g/l

2.03

406

4152

L02BX Other hormone antagonists and related agents

101

1046

0.96

0.11

1.7

2.6

9.64

10.53

g/l

1.42

930

Cervical polyps

137

1330

1.03

0.11

2.0

2.2

9.67

10.12

g/l

0.88

128

1178

Pneumoconiosis due to asbestos and other mineral fibres

342

0.93

0.11

2.2

2.5

11.97

11.42

g/l

0.24

300

Malignant neoplasm of rectum

152

1560

0.97

0.10

2.6

1.4

10.21

10.16

g/l

0.05

132

1359

Vascular syndromes of brain in cerebrovascular disorders

741

1.04

0.10

2.7

2.6

9.82

10.58

g/l

0.59

664

Burn and corrosion of hip and lower limb, except ankle and foot

241

1.08

0.10

1.2

2.7

9.81

10.68

g/l

0.63

222

Benign leiomyoma with endometriosis

248

2432

1.02

0.10

2.3

9.56

10.05

g/l

1.12

213

2123

Benign neoplasm of ovary

265

2601

1.02

0.10

2.2

2.3

9.55

10.01

g/l

1.10

236

2267

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

574

1.05

0.10

2.8

2.1

9.79

10.54

g/l

0.81

528

Hydrocephalus

121

1245

0.97

0.10

2.2

2.6

9.97

10.41

g/l

0.78

100

1091

Malignant neoplasm of other and ill-defined sites

1.12

0.10

2.0

1.2

10.76

10.72

g/l

—

Embedded and impacted teeth

213

1693

1.02

0.09

1.6

2.0

9.92

10.40

g/l

1.05

198

1584

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

940

0.97

0.09

3.0

2.5

9.69

10.26

g/l

0.83

851

Malignant neoplasm of breast, HER-negative

305

2881

1.02

0.09

1.9

1.4

9.75

9.91

g/l

0.26

260

2468

Malignant neoplasm of meninges, including Hilmo

1.14

0.09

1.0

1.2

8.93

10.02

g/l

—

Pneumoconiosis due to dust containing silica

1.10

0.09

2.7

10.98

11.21

g/l

—

Female genital prolapse

441

2483

0.99

0.09

2.1

2.2

9.67

10.13

g/l

1.39

386

2187

Premature separation of placenta [abruptio placentae]

165

0.91

0.09

1.5

2.2

11.01

10.02

g/l

0.49

158

Cyst of Bartholin Gland

390

1.05

0.08

2.7

2.1

9.68

10.25

g/l

0.33

362

Benign neoplasm: Bronchus and lung

175

0.91

0.08

1.5

2.1

8.47

10.69

g/l

2.26

160

Other bursal cyst

175

1.09

0.08

2.5

1.9

9.43

11.08

g/l

1.99

157

Complications following abortion and ectopic and molar pregnancy

479

1.05

0.08

1.4

2.6

10.92

10.06

g/l

0.50

429

Intracerebral haemorrhage

236

2321

1.02

0.08

2.5

2.3

10.32

10.35

g/l

0.03

207

2019

Family history of certain disabilities and chronic diseases leading to disablement

401

1.05

0.08

1.5

2.1

9.46

10.08

g/l

0.75

370

Superficial frostbite

0.83

0.07

1.0

2.4

10.15

10.36

g/l

—

Benign neoplasm: Rectum/anal canal icd-9

137

1.10

0.07

1.3

1.8

8.47

10.85

g/l

—

116

Cervical root disorders

1.07

0.07

1.0

1.8

10.55

11.26

g/l

—

Lymphangioma, anys site

1.05

0.07

7.8

2.6

8.63

10.43

g/l

—

Helminthiases

184

0.92

0.07

3.2

2.1

9.24

10.29

g/l

0.67

167

Primary angle-closure glaucoma

712

0.97

0.07

2.4

2.6

9.98

10.37

g/l

0.37

621

Pedal cyclist injured in collision with pedestrian or animal

1.03

0.07

2.9

2.2

12.01

10.30

g/l

—

Endometriosis ASRM stages 3,4

302

2981

1.01

0.07

1.8

2.2

9.66

10.05

g/l

0.87

262

2627

Crossbite

479

1.04

0.07

1.4

2.1

10.72

10.15

g/l

0.48

453

Glaucoma secondary to eye trauma

1.06

0.07

1.2

2.5

10.62

10.21

g/l

—

Family history of malignant neoplasm

126

1287

0.98

0.07

3.1

2.1

9.88

10.14

g/l

0.29

116

1159

Malignant neoplasm of gallbladder, including Hilmo

1.06

0.07

1.2

8.67

10.33

g/l

—

Gestational [pregnancy-induced] hypertension

253

2489

1.01

0.07

2.6

2.0

10.19

9.98

g/l

0.27

242

2252

Other disorders affecting eyelid function

118

1.11

0.07

2.7

2.2

8.95

10.69

g/l

1.35

106

Contact with other specified venomous animals

1.05

0.07

1.1

2.7

10.39

10.34

g/l

—

Use of selegiline

721

0.97

0.07

2.2

2.5

9.27

10.70

g/l

3.14

641

Normal-pressure hydrocephalus

862

0.97

0.06

2.6

2.5

9.95

10.52

g/l

0.89

756

Other menopausal disorders

411

2266

1.01

0.06

2.3

2.2

9.77

10.09

g/l

0.93

374

2023

Benign neoplasm: Skin of lower limb, including hip

355

1.04

0.06

2.8

2.2

9.93

10.69

g/l

0.45

326

Lesion of plantar nerve

850

1.02

0.06

2.3

2.4

9.73

10.18

g/l

0.44

750

Alzheimer’s disease (Late onset)

550

4560

0.99

0.06

1.9

2.3

10.42

10.31

g/l

0.21

447

3895

Calcific tendinitis of shoulder

662

1.03

0.05

2.2

10.77

10.41

g/l

0.16

607

Other abnormal products of conception

285

1849

1.01

0.05

1.9

2.0

9.77

10.08

g/l

0.80

267

1726

Malignant neoplasm of brain, including Hilmo

594

1.03

0.05

2.4

1.4

10.47

10.34

g/l

0.08

524

Frostbite

110

0.91

0.05

1.0

2.1

9.75

10.56

g/l

—

103

Use of biperiden

608

1.02

0.03

1.6

2.5

9.76

10.31

g/l

0.50

550

Complications predominantly related to the puerperium

267

2689

0.99

0.03

2.1

10.04

10.02

g/l

0.01

246

2452

Malignant neoplasm of brain

380

0.97

0.03

1.6

1.4

10.74

10.53

g/l

0.07

341

Dislocation, sprain and strain of joints and ligaments of elbow

651

0.98

0.02

2.1

2.2

9.72

10.35

g/l

0.74

601

Pedestrian injured in other and unspecified transport accidents

142

1.06

0.02

1.1

2.3

9.25

10.23

g/l

0.76

128

Other and unspecified hydrocephalus

242

1.03

0.02

1.6

2.3

9.46

10.18

g/l

0.56

216

Carcinoma in situ of breast, intraductal

129

1279

1.01

0.02

2.1

2.2

9.74

9.99

g/l

0.23

107

1135

Non-small cell lung cancer, squamous

692

1.01

0.01

1.7

1.5

10.52

10.36

g/l

0.10

596

Alzheimer’s disease (Atypical or mixed), excluding more controls

165

1239

0.99

0.01

1.6

2.3

10.37

10.67

g/l

0.35

134

1072

Prolapse and hernia of ovary and fallopian tube

636

1.01

0.01

1.9

2.0

8.89

10.20

g/l

1.69

526

Supervision of normal pregnancy

175

1003

1.00

0.01

2.4

1.9

10.43

10.02

g/l

0.69

166

947

Spinal instabilities

296

0.98

0.00

1.3

2.0

9.18

10.62

g/l

1.28

273

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS